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Abstract 
Hybrid material systems possess multi-functional properties which make them intriguing 
for the materials science community since very early dates. However, it is not 
straightforward to produce such material systems. A smart and efficient approach is 
necessary to extract the desired properties of each component under the desired 
conditions. This study evolved to its last form primarily around this notion, where the 
development of a hybrid material is the core of the work. This hybrid material is then 
further explored for two different applications in the catalysis and drug delivery fields. 
A nanoassembly was established around a mesoporous silica support. SBA-15 was picked 
as this support among the other mesoporous silica due to its well-defined pore structure 
and accessible pore volume. The silica framework was doped with Zr atoms and the pores 
were partly infiltrated with Cu nanoparticles resulting in a hybrid material with tunable 
properties. SBA-15 was synthesized by a sol-gel method where a micellar solution was 
employed as a template for the silica framework. To achieve the doped version, a Zr 
precursor was added to the synthesis solution. The effects of different synthesis 
conditions, such as the synthesis catalyst (F- or a Cl- salt) and the Si source (tetraethyl 
orthosilicate (TEOS) or sodium metasilicate (SMS)) on the characteristics of the final 
material were investigated. It was observed that these changes in the synthesis conditions 
yielded different particle morphology, pore size (11-15 nm), and specific surface area 
(400-700 m2/g). Cu nanoparticles (NPs) were grown in the (Zr-)SBA-15 support using 
infiltration (Inf) or evaporation induced wetness impregnation (EIWI) methods. The 
infiltration method is based on functionalizing the (Zr-)SBA-15 support surfaces before 
the Cu ion attachment whereas EIWI is based on slow evaporation of the liquid from the 
(Zr-)SBA-15 - Cu aqueous suspension. Both methods are designed to yield preferential 
growth of Cu NPs in the pores with a diameter smaller than 10 nm and in oxidized form. 
However, depending on the loading method used, different chemical states of the final 
material were achieved, i.e. Zr content and porous network properties are different.  
Cu-Zr-SBA-15 nanoassemblies produced under various synthesis conditions were used 
for the catalytic conversion of CO2 into valuable fuels such as methanol and dimethyl ether 
(DME). The effect of different chemical states of the catalyst arising from variations in the 
synthesis parameters was investigated. It was found that the Si precursor (TEOS or SMS) 
had a considerable impact on the overall performance of the catalyst whereas the Cu 
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loading method (Inf or EIWI) changed the catalytic selectivity between DME and 
methanol. The activity of the catalyst was further investigated in a time-evolution study 
where the accumulation of each product in the gas phase and the molecular groups 
attached to the catalyst surface were recorded over time. Accordingly, thermodynamic 
equilibrium was achieved on the 14th day of the reaction under 250°C and 33 bar. The 
resulting total CO2 conversion was 24%, which is the thermodynamically highest possible 
conversion, according to theoretical calculations. It was also concluded from the 
experimental results that, DME is formed by a combination of two methoxy surface 
groups. Additionally, the formation of DME boosts the total CO2 conversion to fuels, 
which otherwise is limited to 9.5%. 
The design of Cu-Zr-SBA-15 was also investigated for drug delivery applications, due to 
its potential as a biomaterial, e.g., a filler in dental composites, and the antibacterial 
properties of Cu. Also, the bioactivity of SiO2 and ZrO2 was considered to be an advantage. 
With this aim, Cu infiltrated Zr doped SBA-15 material was prepared by using TEOS as 
the silica precursor and the Inf-method to grow Cu NPs. The performance of the final 
material as a drug delivery vehicle was tested by an in-vitro delivery study with 
chlorhexidine digluconate. The nanoassemblies show a drug loading capacity of 25-40% 
[mg drug / mg (drug+carrier)]. The drug release was determined to be composed of two 
steps. First, a burst release of the drug molecules that are loosely held in the voids of the 
mesoporous carrier followed by the diffusion of the drug molecules that are attached to 
the carrier surface. The presence of Zr and Cu limits the burst release and beneficially 
slows down the drug release process.  
The effect of pore properties of SBA-15 was explored in a study where the antibiotic 
doxycycline hyclate was loaded in SBA-15 materials with different pore sizes. It was 
observed that the pore size is directly proportional to the drug loading capacity [mg drug 
/ mg (drug+carrier)] and the released drug percentage (the released drug amount/total 
amount of loaded drug). The drug release  was fast due to its weak interactions with the 
SBA-15 materials.  
In summary, this work demonstrates the multifunctional character of a smart-tailored 
nanoassembly which gives valuable insights for two distinct applications in catalysis and 
drug delivery.   
   
 
 v 
Popularvetenskaplig sammanfattning 
Hybridmaterial består av minst två komponenter, vilket ger dem mångfacetterade 
egenskaper. Detta har gjort att denna typ av material attraktiva sedan länge. Det är dock 
inte enkelt att tillverka dessa materialsystem. Ett enkelt och effektivt tillvägagångssätt 
behövs för att tillvara ta de önskade egenskaperna hos varje komponent och få dem att 
samverka. Denna avhandling bygger huvudsakligen på utvecklingen av ett hybridmaterial. 
Materialet testas sedan i två olika tillämpningar: katalys och läkemedelstransport. 
Ett hybridmaterial med en sammansättning bestämd på nanonivå, tillverkades med 
mesoporös kiseldioxid, SBA-15, som stomme. SBA-15 valdes framför andra typer av 
mesoporös kiseldioxid på grund av dess väldefinierade porstruktur och stora, tillgängliga 
porvolym. Kiseldioxiden dopades med zirkoniumatomer och porerna fylldes delvis med 
kopparnanopartiklar, vilket resulterade i ett hybridmaterial med egenskaper som kunde 
varieras. SBA-15 tillverkades via en våtkemisk metod där en micellösning används som 
mall för kiseldioxidens struktur. Vid dopningen tillsätts en zirkoniumkälla till 
synteslösningen. Effekterna av olika tillverkningsparametrar, till exempel salter med 
katalytiska egenskaper (salter med F- eller Cl-), olika kiselkällor (tetraetyl ortosilikat eller 
natriummetasilikat), på materialens egenskaper studerades. Variationer av dessa 
parametrar ger material med olika form, porstorlekar (11 – 15 nm) och specifik yta (400 
– 700 m2/g). Kopparnanopartiklar växtes i (Zr-)SBA-15-stommarna med två metoder: 
infiltration (Inf) eller indunstningsinducerad våtimpregnering (EIWI). Inf baseras på 
funktionalisering av (Zr-)SBA-15-stommen innan kopparjoner fick reagera med ytan. 
EIWI bygger på en blandning av (Zr-)SBA-15 och kopparsalt i en lösning där vätskan 
långsamt får avdunsta. Båda metoderna är designade för framställning av oxiderade 
kopparnanopartiklar, mindre än 10 nm i diameter, som ska växa i stommens porer. Dock 
påverkar infiltrationsmetoden den kemiska sammansättningen hos det slutliga materialet 
då Zr-koncentrationen och porositeten i stommen ändras.  
Cu-Zr-SBA-15-sammansättningar, tillverkade med varierande syntesparametrar, 
användes som katalysatorer för omvandling av CO2 till bränslen såsom metanol och 
dimetyleter (DME). Resultaten visar att valet av kiselkälla har en stor inverkan på 
katalysatorns prestanda, samt att metoden för att introducera koppar ändrar den 
katalytiska selektiviteten mellan DME och metanol. Katalysatorns aktivitet undersöktes 
även över tid. Ackumuleringen av varje produkt, både i gasfas och på katalysatorns yta, 
registrerades över tid. Termodynamisk jämvikt nåddes efter att reaktionen fortgått i 
fjorton dagar vid 250 °C och 33 bar. Den totala CO2-omvandlingen var 24 %, vilket, enligt 
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teoretiska beräkningar, är den termodynamiskt högsta möjliga omvandlingen. Det 
observerades att DME bildas genom en kombination av två metoxygrupper på 
katalysatorns yta, samt att bildandet av DME ökar den totala omvandlingen av CO2 till 
bränsle, vilken annars är begränsad till 9.5 %. 
Cu-Zr-SBA-15-sammansättningen användes även i läkemedelstillämpningar. De kan 
användas som biomaterial, e.g., fyllnadsmaterial i tandkompositer, och koppar har 
antibakteriella egenskaper. Dessutom kan kiseldioxid och zirkoniumdioxid vara bioaktiva 
vilket ses som en fördel. För denna tillämpning tillverkades Cu-Zr-SBA-15 med TEOS 
som kiselkälla och Inf-metoden för att växa kopparnanopartiklar. Cu-Zr-SBA-15 
lämplighet som bärare av läkemedelet klorhexidindiglukonat testades in vitro. I detta fall 
uppvisar bäraren en laddningskapacitet [massa laddat läkemedel/(massa laddat läkemedel 
+massa bärare)] på 25 – 40 %. Frisättningen av läkemedel skedde i två steg. Först frisattes 
en stor mängd läkemedelsmolekyler. Dessa var löst placerade i håligheter i de mesoporösa 
stommarna. Därefter frisattes läkemedel via diffusion av molekyler som bundit till 
stommens yta. De två stegen representerar växelverkan mellan läkemedel – läkemedel- och 
läkemedel – bärare. Närvaron av zirkonium och koppar begränsar den första frisättningen 
och förlänger den aktiva tiden, vilket är fördelaktigt ur tillämpningsperspektiv. 
Effekten av porstorlek hos SBA-15 vid läkemedelsfrisättning undersöktes också i en studie 
där SBA-15 fylldes med doxycyklinhyklat. Laddningskapaciteten och mängden frisatt 
läkemedel och andelen av laddat läkemedel som frisätts var båda direkt proportionella mot 
porstorleken där frisättningen av doxycyklinhyklat dominerades av läkemedel – 
läkemedelsväxelverkan. Doxycyklinhyklat är en mindre molekyl jämfört med 
klorhexidindiglukonat och växelverkar svagare med SBA-15 på grund av sin mer anjoniska 
natur. 
Sammanfattningsvis visar arbetet den multifunktionella karaktären hos en skräddarsydd 
nanosammansättning, vilket ger värdefulla insikter i två användningsområden: katalys och 
läkemedelstransport. 
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Resumen 
Los sistemas de materiales híbridos poseen propiedades multifuncionales, lo que ha 
suscitado el interés de la comunidad científica de materiales desde fechas muy tempranas. 
Sin embargo, no es sencillo producir dichos materiales. Es necesario un enfoque 
inteligente y eficiente para extraer las propiedades deseadas de cada componente, en las 
condiciones deseadas. Este estudio evoluciona en torno a esta noción, siendo el desarrollo 
de un material híbrido el núcleo del trabajo. Adicionalmente, este material híbrido se 
explora para dos aplicaciones diferentes que son la catálisis y la administración de 
fármacos. 
En este trabajo se desarrolló un nanoensamblaje alrededor de un soporte de sílice 
mesoporoso. Como soporte se seleccionó SBA-15 debido a su estructura de poro bien 
definida y volumen de poro accesible. La matriz de sílice fue dopada con átomos de Zr y 
los poros se infiltraron parcialmente con nanopartículas de Cu dando como resultado un 
material híbrido con propiedades ajustables. La síntesis de SBA-15 se realizó mediante un 
método de sol-gel en el que se empleó una solución micelar como plantilla para el sílice. 
Para lograr la versión dopada, se añadió un precursor de Zr a la solución de síntesis. Se 
investigaron los efectos de diferentes condiciones de síntesis, como el catalizador (sales de 
F o de Cl) así como la fuente de Si (ortosilicato de tetraetilo (TEOS) o metasilicato sódico 
(SMS)) en las características del material final. Se observó que los cambios en estas 
condiciones de síntesis dieron lugar a partículas con distinta morfología, tamaño de poro 
(11-15 nm) y área superficial específica (400-700 m2/g). Las nanopartículas de Cu (NP) 
se hicieron crecer en el sustrato (Zr-) SBA-15 usando los métodos de infiltración (Inf) o 
de impregnación húmeda inducida por evaporación (EIWI). El método de infiltración se 
basa en funcionalizar las superficies de soporte (Zr-) SBA-15 antes de la unión del ion Cu, 
mientras que EIWI se basa en la evaporación lenta del líquido de la suspensión acuosa (Zr-
) SBA-15-Cu. Ambos métodos se han diseñado para producir un crecimiento preferencial 
de Cu NP en los poros con un diámetro inferior a 10 nm y en forma oxidada. Sin embargo, 
dependiendo del método de infiltración utilizado, se logran diferentes estados químicos 
del material final, es decir, el contenido de Zr y las propiedades de red porosa son 
diferentes. 
Los nanoensamblajes de Cu-Zr-SBA-15 producidos bajo diversas condiciones de síntesis 
se usaron para la conversión catalítica de CO2 en combustibles valiosos tales como 
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metanol y dimetil éter (DME). Se investigó el efecto de diferentes estados químicos del 
catalizador obtenidos modificando los parámetros de síntesis. Se encontró que el 
precursor de Si (TEOS o SMS) tuvo un impacto considerable en el rendimiento global del 
catalizador mientras que el método de carga de Cu (Inf o EIWI) cambió la selectividad 
catalítica entre DME y metanol. Por otra parte, la actividad del catalizador se investigó 
evaluando la acumulación de cada producto en la fase gaseosa y los grupos moleculares 
unidos a la superficie del catalizador a lo largo del tiempo. Se llegó al equilibrio 
termodinámico en el día 14 de la reacción a 250 ° C y 33 bar. La conversión total resultante 
de CO2 fue del 24%, que es la conversión termodinámicamente más alta posible, según los 
cálculos teóricos. También se concluyó a partir de los resultados experimentales que, el 
DME está formado por una combinación de dos grupos superficiales metoxilados. 
Asimismo, la formación de DME también aumenta la conversión total de CO2 en los 
combustibles, que de lo contrario se limita al 9,5%. 
El material híbrido sintetizado Cu-Zr-SBA-15 también se investigó para aplicaciones de 
administración de fármacos, debido a su potencial como material de relleno en 
compuestos dentales y las propiedades antibacterianas del Cu. Por otra parte, la 
bioactividad de SiO2 y ZrO2 podría ser ventajosa para esta aplicación. Con este objetivo, 
se preparó SBA-15 dopado con Zr e infiltrado con Cu utilizando TEOS como el precursor 
de sílice y el método Inf para cultivar Cu NP. El rendimiento del material final como 
vehículo de administración de fármacos se probó mediante un estudio de liberación in 
vitro con digluconato de clorhexidina. Los materiales desarrollados muestran una elevada 
capacidad de carga de fármaco (25-40%). Los perfiles de liberación del fármaco muestran 
dos etapas: una primera etapa de liberación rápida de las moléculas del fármaco unidas con 
interacciones más débiles al sustrato mesoporoso, seguida por la difusión de las moléculas 
del fármaco que están unidas a la superficie del portador. La presencia de Zr y Cu limita la 
liberación inicial y reduce la velocidad de liberación del fármaco. 
En otro estudio se evaluó el efecto del tamaño de poro de SBA-15 en la liberación del 
antibiótico hiclato de doxiciclina. Se observó que el tamaño de poro es directamente 
proporcional a la capacidad de carga de fármaco, el porcentaje y la cantidad de fármaco 
liberado. En este estudio el perfil de liberación fue rápido, debido a las interacciones 
débiles del fármaco con el SBA-15 y el menor tamaño de molécula del fármaco en relación 
al digluconato de clorhexidina del estudio anterior. 
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En resumen, este trabajo demuestra el carácter multifuncional de una nanomatriz diseñada 
a medida que proporciona información valiosa para dos aplicaciones en catálisis y 
liberación de fármacos. 
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1 
INTRODUCTION 
Modifying materials for achieving certain functionalities goes back to the prehistoric ages 
where men first used stone as a tool for different purposes such as modifying surfaces, 
farming or hunting. These ages of humanity are named after their primary source of tool 
materials: 1) stone, 2) bronze and 3) iron age. The first use of ceramics was during the 
stone age with flint, whereas the glass was not produced until late iron age. Until this day, 
tremendous progress was made in synthesis, processing, modifying, and analysis of many 
material types and the field has evolved around metals, ceramics, polymers and different 
composites.  
Materials science serves many application areas such as energy, medicine, electronics, and 
machinery and it is typically multidisciplinary where a material can be investigated for 
many different purposes. It is quite remarkable that a material with certain properties can 
have various functions and thus have different identities such as a catalyst, a drug carrier, a 
nano-mold or a coating. Therefore, a cross-disciplinary outlook on different application 
fields of materials is a source for further improvement of material properties. 
1.1 Motivation 
The motivation of this thesis lies in the multidisciplinary character of materials science. 
The focus is to modify a mesoporous silica, SBA-15, to gain advantageous properties for 
two different applications areas: catalysis and drug delivery. SBA-15 is a type of 
mesoporous silica characterized by a large pore volume, considerably large pore size, and 
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robustness in terms of hydrothermal and chemical stability allowing it to maintain its 
hexagonal pore packing structure under rather harsh conditions. Thus, it can serve these 
two areas very well and be a perfect complementary material for many active substances. 
In the field of catalysis, SBA-15 can be used as a support and a promoter for the catalytically 
active phase. It has been shown to support active metal phases, such as Cu, especially 
during heterogeneous catalysis of a gas phase reaction. In this work, such a catalyst system 
was prepared by growing Cu nanoparticles on a Zr-doped SBA-15 support. This material 
was later used for CO2 hydrogenation reaction to convert one of the most significant 
anthropogenic greenhouse gas CO2 to valuable fuels such as methanol and DME. 
Although CO2 hydrogenation into methanol has been studied earlier, the search for a 
suitable catalyst is an on-going process due to the thermodynamic limits. On the other 
hand, CO2 hydrogenation to DME is a considerably new field, and the findings so far 
indicate that it requires a complex catalyst that can catalyze both CO2 hydrogenation to 
methanol and methanol dehydration to DME.  
Another field where SBA-15 has been recognized and used is drug delivery. Due to its 
favorable porous structure, it can accommodate many different sizes of drug molecules 
and thus can be used as a drug carrier. Its large pore volume can host a drug amount higher 
than the minimum effective concentration of a chosen drug. Cu is a common antibacterial 
agent and in this thesis, it is investigated as nanoparticles embedded in the mesopores of 
an SBA-15 framework with the aim of prolonged ion release. Moreover, Cu nanoparticles 
can form obstacles in the pores and can cause partial blockage, which results in prolonged 
ion release. Zirconia, as a bioactive material, was also used as a complementary unit to the 
SBA-15 framework in order to improve the number of active sites on the surface 
contributing to the drug loading. 
The aim of this project was to produce a Cu-Zr-SBA-15 material by doping Zr into the 
SiO2 framework and loading Cu nanoparticles into the mesoporous structure. This 
material was then tested as a high-performance catalyst for CO2 hydrogenation as well as 
a favorable drug carrier for in-vitro delivery of Chlorhexidine digluconate (an antiseptic 
agent) and Doxycycline hyclate (an antibiotic) for dental applications such as 
implantation or dental composites. 
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1.2 Outline 
In this thesis, a general overview of SBA-15 synthesis and modification is presented in 
Chapter 2, where its structural properties, synthesis mechanisms, and modification 
methods are discussed. Environmental significance of CO2 utilization is described in 
Chapter 3 where the mechanisms behind the CO2 hydrogenation to methanol and DME 
and the applicability of these two fuels in the industry are explained. Chapter 4 is dedicated 
to the general aspects of drug delivery, drug delivery systems, drug release profiles and 
models and lastly nanostructured drug carriers. Chapter 5 includes short information 
regarding the analysis methods used during this work. Chapter 6 summarizes the results 
and discussions of the appended papers and in Chapter 7 conclusions and future work is 
discussed. At last, papers are appended. 
  24 
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2 
MESOPOROUS SILICA 
 
2.1 Porous materials 
Porous materials are solid materials with voids within their structural configuration. The 
voids which are deeper than they are wide are called pores, and they have a great range of 
morphologies that are typically channels but also cavities and interstices. The pores can 
have an open or closed nature. The closed pores can be used for altering the overall 
material properties (e.g., density), mechanical properties (e.g. hardness and elasticity), 
and conductivity. On the other hand, open porosity provides extra surface and inner 
volume to the material improving its carrier properties for guest molecules1.  
Pores, according to IUPAC’s definition, can be classified into three groups: macropores 
with the pore width larger than 50 nm, mesopores with the pore width between 2 and 50 
nm and micropores with the pore width smaller than 2 nm2. Among the unlimited 
possibilities of the porous world, mesoporous materials, amorphous or crystalline, have 
gained a significant amount of attraction due to their large internal surface and pore 
volume allowing them to host molecules of various morphologies and sizes3.  
Mesoporous silica was first reported by researchers at Mobil Corporation in 19924, and 
they named this ‘first of its kind’ mesoporous silica MCM-X where MCM represents 
‘Mobil Crystalline Material’ and X represents different structural properties within the 
same material group. The ordered porosity of this silica material was obtained by a liquid-
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crystal templating approach that enables the formation of silicate walls between the 
surfactant micelles with an ordered hexagonal pattern. As a result, cylindrical pores 
between the walls with a narrow pore size distribution are obtained3,4.  Moreover, with its 
large surface and pore volume, mesoporous silica is very suitable for hosting various 
molecules and particles, and thus it is used in many applications such as catalysis, drug 
delivery, sensing, and separation5,6. The uniform and organized pores enable controlled 
loading and release of guest molecules depending on the nature of the attachment between 
the guest and the host5–9. They also show high thermal, chemical10 and mechanical stability 
and are therefore favorable for applications that require extreme conditions11.  
2.2 SBA-15 
SBA-15 was the next breakthrough in the field of mesoporous silica synthesis after MCM. 
This type of mesoporous silica was first reported in 1998 by Zhao et al. and named as SBA-
X where SBA stands for ‘Santa Barbara Amorphous’ and X stands for different pore 
structures and surfactants12. SBA-15 has similar hexagonal pore packing structure as 
MCM-41, but a larger tunable pore width and higher hydrothermal and chemical stability 
due to its thicker walls. These features make SBA-15 more popular compared to its MCM 
ancestors6,12,13. Also among all the other SBA materials, SBA-15 is particularly attractive 
due to its highly stable structure offering flexibility in the synthesis conditions and 
possibilities to affect structural parameters such as particle morphology and pore size 
without destroying the SBA-15 structure14.  
The morphologies of SBA-15 reported so far include rods15, fibers16, sheets17, spheres18 
and hollow spheres10 (Figure 1). It has cylindrical pores with a cross-sectional diameter 
between 5-30 nm, although pore size above 11 nm is rare12,19. Its mesopores are 
interconnected with micropores, which can constitute a significant portion of the total 
pore volume. For example, a microporosity of 50% has been reported by Hartmann et.al. 
and 15-30% by Björk et.al.14,20,21. SBA-15 has been successfully used in various applications 
because of its combination of these interesting characteristics, e.g., a template, catalyst 
support, drug carrier, selective adsorbent etc11,14.  
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Figure 1. Different particle morphologies of SBA-15: small particles (left), long fibers 
(middle), sheets (right)16. 
2.2.1 SBA-15 synthesis 
SBA-15 is typically synthesized via a sol-gel technique where a solution, sol, of templating 
micelles is prepared at a suitable pH and then mixed with a silica precursor. As a result, a 
silica network forms through a series of hydrolysis and condensation reactions 
constituting a gel that typically separates from the solution. During hydrolysis, silicon 
hydrolizes and become silicic acid and then condenses to form Si-O-Si framework as seen 
in Eq. 2.1 and 2.222. 
During  
Hydrolysis ºSi-OR + H2O     ®     Si(OH)4 + ROH      (2.1) 
Condensation  ºSi-OH + HO-Siº     ®     Si-O-Si         + H2O      (2.2) 
Upon condensation, a maturation period is typically needed and the final material is 
obtained after removal of the micelles.  
For the modification of the morphological (pore or particle) characteristics, it is also 
possible to add salt and swelling agent into the synthesis solution. 
The micellar solution is an aqueous solution of templating micelles which are based on 
surfactants. Surfactants are amphiphilic low molecular weight materials or block 
copolymers possessing a hydrophilic head group (ionic or non-ionic) and a hydrophobic 
non-polar chain. Due to this structure, they can self-assemble in an aqueous solution with 
a concentration that is above the critical micelle concentration. This self-assembly forms a 
liquid crystal in the end by creating water-oil interfaces within some degree of ordering23,24.  
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For the synthesis of SBA-15, the surfactants mostly reported in the literature are Pluronics, 
CTAB, and PEO surfactants. Pluronics are non-ionic block polymers made up of a 
polypropylene oxide block (PO)x placed in the middle of two polyethylene oxide blocks 
(EO)x. Pluronics, when combined with an acidic solution, form sphere-like micelles hiding 
the hydrophobic part in the center of the sphere and exposing the hydrophilic ends to the 
solution forming a corona25. Therefore the length of the chains can affect the shape and 
size of the micelles. 
Among the pluronics, a symmetric block copolymer P123 (PEO-PPO-PEO) has been 
shown to yield a consistent and robust structure when synthesizing SBA-15 with different 
particle morphologies, including platelets and short rods with easily accessible pores21. In-
situ SBA-15 synthesis studies have shown that P123 form spherical micelles which then 
open up to cylindrical structures as silica condensation proceeds and form cylindrical 
pores15,22,26.  
The silica precursor is typically chosen from alkoxides, which is mostly tetramethyl 
orthosilicate (TMOS) and tetraethyl orthosilicate (TEOS). Some studies also have 
reported sodium metasilicate to form the hexagonal SBA-15 structure20. 
Additives can be used in the synthesis of SBA-15 and are typically salts or oils.  
Salts can act as catalysts for SBA-15 synthesis affecting the reaction rate by changing the 
cloud point, and it can also decrease the critical micelle temperature. This occurs because 
a salt can change the solubility of the surfactants by its salting out or salting in effect. For 
example, when an anion, such as F-, is released to the synthesis medium by compound 
dissolution, it demonstrates salting out effect that leads to partial dehydration of EO chains 
and causes hydrophobic core enlargening inside the micelles16,25. Cations were shown to 
demonstrate a similar but weaker effect27. The salting out effect during SBA-15 synthesis 
is typically achieved with F-, Cl- or I- by using NH4F or NaI salts and it leads to increased 
pore size25,28. 
Swelling agents are organic materials such as alkanes, amines or substituted benzene 
compounds29,30. When added to the synthesis solution, they can penetrate into the micellar 
structures and settle in the hydrophobic centre causing micelle swelling. During SBA-15 
synthesis, since the micelle size determines the pore size, an addition of a swelling agent 
can directly affect the pore size31. Alkanes can increase the pore size to around 26 nm while 
maintaining the hexagonal pore order32. By changing the pore order, e.g., changing to 
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MCF (mesostructured cellular foam), much wider pores can be obtained31. It was also 
shown that heptane could increase the pore size above 12 nm when used in a low 
temperature synthesis of SBA-15 together with NH4F salt21. 
Hydrothermal treatment or aging, constitutes the maturation period of SBA-15. 
Hydrothermal treatment is a post-synthesis re-structuring procedure typically required in 
case of using non-ionic oligomeric surfactants, such as P123. Aging at high temperature, 
which is typically around 100°C, causes dissolution-reprecipitation of Si atoms to the 
formed walls. During reprecipitation of the silicate species, they get rearranged to a more 
thermodynamically favorable position minimizing the surface energy, i.e., become 
smoother33. 
Surfactant removal can be performed by a chemical assisted extraction method that 
involves stirring the freshly prepared SBA-15 with an oxidizing agent. However, a more 
straightforward method is calcination where the polymer is decomposed and combusted 
with air at high temperature, typically higher than 500°C 34. 
2.2.2 SBA-15 modification routes 
SBA-15 has been modified with numerous types of different atoms, molecules and 
molecular groups as described in earlier reports. Many earlier studies focusing on 
modification of SBA-15 are based on physical mixing35, however, improved procedures 
can improve the interface between different components of hybrid materials that promote 
their activity in the target application36–38. The most common methods are in-situ 
incorporation39–43,  co-precipitation / deposition-precipitation44–48, post-grafting49,50, 
impregnation51–55, incipient wetness impregnation31,42,56–58, and infiltration59,60. A crucial 
issue for almost all of these methods is to obtain uniform distribution of the modifier 
throughout the catalyst61. The selection of the proper method depends on the desired 
characteristics of the catalyst. For example, to prepare a Zr doped SBA-15, an in-situ 
incorporation technique can be used.  
In-situ incorporation62–66 can be performed by adding the relevant precursor into the 
synthesis batch of a chosen material to induce doping. It is typically used to add functional 
groups or atoms into the framework of a matrix such as SBA-15. It was also shown for 
polymer growth in SBA-15 porous network67. For example, adding a precursor into the 
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synthesis solution of SBA-15 right before the gel formation leads to a mesoporous 
heteroatomic network with Si, O, and the additional atom obtained from the precursor.  
The impregnation67–69 method includes stirring of the main supporting matrix, e.g., SBA-
15, MCM-41, H-ZSM-15 with a precursor solution (e.g., a sulfate or nitrate salt), filtration, 
washing, and drying.  
The Incipient Wetness Impregnation66,70,71 is a modified version of impregnation; 
however, due to the high level of interest by the research community and many reports 
focusing on this method, it deserves to be mentioned separately. It is, indeed, performed 
in a very similar way to impregnation technique except for the part where the same volume 
of precursor solution of the metal salt as the pore volume of the relevant porous material 
is used. The aim is to direct the metal ions into the pores such that out-of-particle 
aggregation is minimized. 
Post-grafting49,65,66,71,72 takes place when the SBA-15 is suspended in a precursor solution 
typically with a solvent like ethanol or toluene, stirred for a long time under high 
temperature, filtered, washed with the same solvent and dried at high temperature. The 
most significant differences between grafting and impregnation appears in the surface 
properties. During grafting the attachment of the guest to host occurs on a molecular level 
where chemical bonds are formed, while impregnation only causes deposition of the guest 
on the surface of the porous host. Grafting can be referred as a post-synthesis surface 
doping method. 
Infiltration59,73 is a technique that focuses on the minimization of the outer-mesoporous 
particle attachment of the metal nanoparticles. For that purpose, the outer surface of the 
mesoporous particles is first passivated, and then the inner surface of the mesopores is 
activated with functional groups. The functionalization enables the metal ions to attach to 
the inner functional groups so the nanoparticles can grow only on the inside the pores. 
However, it is a challenging process, and in some cases, metal nanoparticles are still 
obtained on the outer surface of the mesoporous particles. 
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3 
CATALYSIS 
 
 
3.1 Industrial revolution and greenhouse gases 
The industrial revolution started in the 1760s in Britain with the discovery of new fuel 
sources and the development of new industrial processes replacing the hand-based 
production methods. This revolution was triggered by the invention of the steam engine 
by Thomas Newcomen in early 1700s, although there are records of using steam power 
for processing purposes in different parts of the world at earlier dates. The steam engine 
can provide steam power not only for industry but also for the transportation, and was 
typically achieved by burning fossil fuels such as coal, oil, and gas. A vast amount of energy 
could be released through the combustion of these fuels which were at that time abundant 
in nature. Consequently, the society became dependent on them. However, the fossil fuel 
combustion emits tons of CO2 and H2O to the atmosphere causing global warming and 
environmental changes74–76. Since that era, the concentration of CO2 in the atmosphere 
has been increasing rapidly, from 280 ppm before 1750 to 400 ppm in 201677. The high 
concentration of CO2 can trap the heat and energy absorbed by earth from solar radiation 
and prevent the infrared radiation from earth back into space. This natural phenomenon 
is defined as the greenhouse effect, and it is well-known to be responsible for a rise in the 
earth’s surface temperature, also referred to as global warming which leads to climate 
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change, constituting a real threat to human and nature78–80. Global warming is also known 
to cause increased acidity and thus decreased the efficiency of the carbon sinks classified 
as land, forests, and oceans, which ultimately results in increasing CO2 accumulation and 
thus the global warming78,81. The probability of a catastrophe due to the greenhouse effect 
and global warming has triggered the society to take precautions and solid action plans for 
decreasing the concentrations of the greenhouse gases in the atmosphere. The most 
common greenhouse gases found in the nature are CO2, water vapor, CH4 and N2O, 
chlorofluorocarbons (CFC) and hydrofluorocarbons (HFC)82. Among them, CO2 
became the main anthropogenic greenhouse gas due to human activity83–87. The critically 
rising trend of CO2 concentration in the atmosphere can be reversed by adopting two 
types of strategies: (1) preventing the CO2 emissions and (2) utilizing the CO2 that is 
constantly being emitted by running processes, i.e., recycling84,88. The first strategy 
includes exchanging firmly established processes with new ones. This is a challenging task 
from a scientific (technical) point of view since it requires demolishment before rebuilding 
and therefore has high risks regarding industrial feasibility and financial balance of firms. 
The second strategy considered so far, has a better chance in surviving the economical 
limits of industry, since it includes only addition of a new process at the end of an existing 
production line in order to capture and convert CO2 into different sustainable products. 
3.2 CO2 utilization 
Elimination of CO2 from the environment by recycling emissions has three stages of 
action: (1) capture, (2) storage and (3) consumption/expenditure83,85,86,89,90.  
CO2 capture involves mainly separation68 and collection of emitted CO2 from an industrial 
site or a natural source such as geothermic wells and delivering to a facility where it can be 
stored, typically in geological structures underground which is a rather established issue in 
these days76,89,91. It was shown that capture of CO2 on site has a higher efficiency than from 
the atmosphere because higher concentration facilitates capturing materials and 
techniques62. The capture is typically done with the use of adsorbents such as amine 
solutions or hydroxides76,87. Capture and storage of CO2, as important as they are, do not 
constitute the ultimate solution of CO2 elimination but provide more of ‘swipe under the 
rug’ type of solution. Therefore, it is a crucial task to develop and improve processes where 
CO2 can be used up.  
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Consumption/expenditure of CO2 as an eco-friendly, value-added chemical feedstock has 
attracted a great deal of attention among the scientific community to develop several 
innovative processes where CO2 is recycled and employed as a building block for 
producing hydrocarbons and alcohols68,82,92,93. However, CO2 is a poor reactant, and its 
activation is a challenging task due to its high thermodynamic stability originating from 
the fact that CO2 is the highest oxidized state of carbon68,87,94. At this oxidation state, 
carbon does not have any tendency of changing its chemical environment. In order to 
transform CO2, one needs to overcome its Gibbs energy of formation (ΔGo298.15K =-394.4 
kJ mol-1), which means that a considerable amount of energy is required to be applied 95. 
Therefore, it is important to develop techniques to catalyze this type of reaction with a 
proper mechanism and a suitable catalyst. 
Several methods have been developed to break down CO2 through catalytic reactions and 
manufacture different organic compounds such as urea, salicylic acid, and various 
carbonates. CO2 is also used in certain applications in the food industry, dry cleaning and 
decaffeination of tea and coffee and most of these processes are commercially 
implemented82,87,91. Another well-established process to use CO2 as a reactant is RWGS 
(reverse water-gas shift) reaction where H2 is used to convert CO2 to CO (Eq. 3.1) which 
can then be used to produce several hydrocarbons like gasoline by employing the Fisher-
Tropsch process82.  
A strong application candidate for CO2 expenditure is through a hydrogenation reaction 
which follows through an artificial photosynthesis mechanism76,96. Syngas [CO+CO2+H2] 
is an established reactant mixture for creating hydrogenation mechanism to produce 
valuable fuel candidates such as methanol and dimethyl ether (DME)74,75. A similar 
mechanism can be used to convert pure CO2 in the presence of H2 and high pressure. 
During pure CO2 hydrogenation the RWGS (reverse water-gas shift reaction)68 also 
occurs due to its endothermic character causing formation of CO83. 
CO2 + H2   «  CO + H2O  (3.1)                       ∆H(298 K)= 41.2 kJ mol-1 
The total reaction rate of CO2 hydrogenation strictly depends on the water gas shift 
reaction due to forming CO and H2O in the catalytic medium. The CO that is produced 
with RWGS can be a secondary C source for the targeted product (e.g., methanol), and 
can affect the reaction balance. H2O is another product of the targeted methanol 
formation process so additional H2O introduced by RWGS into the reaction environment 
  Catalysis 
 
 34 
can inhibit the reaction which makes the product removal very important. Moreover, the 
formed CO and H2O can be converted back to CO2 and H2 by a water-gas shift reaction 
(WGS), as the concentrations of the reactants decrease due to the main catalytic reaction, 
the WGS can be a reactant supplying mechanism. It was reported earlier by Skrzypek et al. 
that adding CO to the feed gas can increase the CO2 conversion due to consumed H2O 
and recovered CO2 by RWGS97. 
The hydrogenation of CO2 is a catalytic reaction and can be done in a single-phase 
(homogeneous catalysis) or multi-phase (heterogeneous catalysis) manner98–100. It was 
shown in earlier studies that homogeneous catalysts had higher CO2 conversion 
performance compared to heterogeneous catalysts. However, the recovery and 
regeneration of homogeneous catalysts is much more difficult causing extra costs in larger 
scale, and thus not ideal68. 
CO2 hydrogenation via heterogeneous catalysis typically follows three reaction steps: (1) 
reactant adsorption on the catalyst surface, (2) diffusion of the adsorbed molecules on the 
surface until attaching on an active site, (3) transformation until a stable phase is reached 
and (4) desorption of the final material. It is typically conducted in a fluidized bed, or fixed 
bed reactor, whereas batch reactor or stirred tank reactors are less common for this type of 
a reaction99,101. These reactions are typically conducted with metal-based catalysts such as 
Co, Fe, and Cu which is chosen according to the target product91. 
The existence of many possible reaction pathways of a [CO2+H2] mixture makes it crucial 
to control the reaction environment carefully, especially by providing a suitable catalyst 
that would realize the primary aim. This way, it is possible to reach a specific target product 
such as methanol and DME76. 
3.2.1 Methanol 
Methanol is an important and established chemical feedstock and solvent in different 
industries such as chemical, petrochemical, pharmaceutical, and polymer80,102,103. It is a 
critical alternative energy source which is not based on petroleum. It is a safe alternative 
fuel due to its soot or smoke-free burning characteristic. One risk of methanol to human 
life and health is its toxicity in case of oral consumption in large amounts74–76,83. Therefore 
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it can replace the traditional fuels or can be used as an additive to traditional diesel or 
gasoline fuels due to its high octane number (~105) 68,104.  
Methanol, besides being a fuel, can also be used as a feedstock or intermediate for 
producing many different compounds. Another aspect of methanol has energy 
implications since it can be used to store hydrogen. Storage of hydrogen is otherwise a 
significant challenge due to a high risk of catastrophic combustion75,105, hence methanol 
storage constitutes a more safe way to store hydrogen83,104,106. As a result, many research 
groups have started to investigate direct methanol fuel cells (DMFC)76,102,107. 
The first industrial-scale methanol synthesis used syngas as the feedstock for a 
hydrogenation process (BASF 1923)106,108 and methanol production from syngas is still 
used in the industry by ICI83. For many years, scientists focused on producing methanol 
from syngas due to a constant supply of syngas via the burning of fossil fuels. However, it 
is not an easy challenge since methanol is the least probable (thermodynamically) product 
of CO and CO2 hydrogenation. Typically higher alcohols and hydrocarbons demonstrate 
larger negative DG0 values, and therefore they have a higher likelihood to be the final 
product of this type of reaction109.  
CO was known as the primary source of methanol, but it was also essential to have a small 
amount of CO2 as a complementary to CO, making syngas a perfect feed mixture for 
methanol production68,96,99,102,106,110. However, later on, an isotope labeling study showed 
that CO2 is the main carbon source of the synthesized methanol molecule and CO 
conversion to methanol proceeds through the CO2 intermediate, as confirmed by also 
other studies84,90,96,97,103,106,111. Due to this reason, also considering with the environmental 
concerns mentioned in an earlier section, hydrogenation of pure CO2 has become the 
focus of methanol production studies. During the CO2 hydrogenation into methanol (Eq 
3.2), RWGS also runs as a parallel reaction. The forming CO then can either converted 
back to CO2 by water gas shift (WGS) reaction as in Eq 3.1 or can proceed with another 
route to form methanol96. The reaction mechanisms are shown in Eq 3.2 and 3.3. 
CO2 + 3H2 « CH3OH + H2O  (3.2)                           ∆H(298 K) = -49.5 kJ mol-1 
CO (produced by RWGS) + 2H2 « CH3OH  (3.3)  ∆H(298 K) = -90.8 kJ mol-1 
These reactions may involve different intermediate steps and compounds depending on 
the reaction route driven by the catalyst surface. By using a catalyst consisting of Cu as the 
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main active phase, two main reaction routes for methanol synthesis from CO2 
hydrogenation are presented in the literature106 which are formate/formyl route and 
hydrocarboxyl route112. 
Formate/formyl route97,99,112–116 advances through the formation of HCOO (formate) by 
CO2 and a hydrogen atom which then continues by further addition of H atoms at each 
step. Finally, it forms methoxy (CH3O-) and then methanol. Formyl route proceeds in a 
very similar manner to formate route, but with an additional first step of CO2 conversion 
to CO by RWGS. In the next step, one molecule of CO merges with an H atom forming 
HCO (formyl) compound which is then further converted to methoxy and methanol. The 
basic schemes of these reaction routes can be found in Figure 3.1. 
Hydrocarboxyl route112,114,117 advances through the formation of COOH (carboxyl) by 
CO2 and a hydrogen atom which then continues with the further addition of hydrogen 
atoms at each step. The basic schemes of these reaction routes are as below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1– Formate/formyl 
and hydrocarboxyl routes of 
methanol formation from CO2 
hydrogenation 
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Among these two, formate route is the one that is mostly adopted in many studies since 
methoxy and formate were proven to be existent on the catalyst surface by infrared 
studies68,111,118. Moreover, it was theoretically shown that the energy barrier of the COOH 
formation is much higher than HCOO, making it less likely112.  
The methanol formation as a result of one CO2 molecule merging with three H2 molecules 
has a negative enthalpy indicating that it is an exothermic reaction68. Therefore, decreasing 
the reaction temperature, in principle, should favor the reaction to the products’ side 
(methanol and water) but it is hardly the case due to the necessity of catalyst activation by 
a sufficiently high temperature68. The pressure, on the other hand, can be increased if one 
aims to increase the CO2 conversion according to the Le Chatelier principle since every 4 
moles of reactants [CO2+H2] gives 2 moles of products [CH3OH+H2O]105,114,119,120. 
So far, the scientific studies which employed syngas as the reactant, obtain methanol at 
temperatures between 200-450 °C and 30-100 bar with a Cu-based catalyst84,97,99,110. The 
industrial-scale methanol production from syngas is performed by ICI (Imperial Chemical 
Industries, Ltd.)121 at temperatures between 220-300 °C and pressure between 50-100 
bars using a Cu/ZnO/Al2O3 catalyst83,105,111,116. An industrial-scale methanol production 
from captured CO2 is currently conducted by at least two companies under similar 
conditions (temperature and pressure). The tow companies are CRI (Carbon Recycling 
International) in the George Olah facility on Iceland and Mitsui Chemicals Inc. in Osaka, 
Japan89,122,123. In this temperature range, thermodynamics is a limiting factor for this type 
of reaction due to its highly exothermic character. Without any recycling one-time pass 
CO2 conversion to methanol by hydrogenation reaction is thermodynamically limited to 
a maximum of 25%115 and similarly at 200 °C and 50 bars theoretical CO conversion to 
methanol is around 20%116. On the other hand, under milder conditions such as 250°C 
and 30 bar, the reported CO2 conversion to methanol with a Cu based catalyst is typically 
between 5-15% 84,90,124–128. The thermodynamic limitations can be overcome by making 
alterations on the process characteristics, such as removal of a product or recycling the 
unreacted feed gas. However, in order to accelerate the reaction, the most crucial element 
is the catalyst. The catalysts studied and used so far for methanol synthesis are typically Cu 
based material systems where Cu constitutes the active phase with a support and/or a 
promoter. 
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3.2.2 Dimethyl ether (DME) 
Dimethyl ether (DME) is a significant feedstock for hydrocarbon manufacturing industry 
and an environmentally benign alternative fuel as a replacement or an additive to liquefied 
petroleum gas (LPG) which can be used in household utilities or internal combustion 
engines in the automative industry76,82,85,129,130. Although it is volatile, DME is not toxic, not 
carcinogenic or mutagenic and therefore is already in use as a propellant and 
coolant74,101,104,131. It has  good combustion performance compared to traditional fossil 
fuels due to its high cetane index (around 55-60)61,68,132. Moreover, it burns by emitting a 
quite low amount of NOx compound and without any soot or SO2 and producing almost 
no smoke68,101,130. The properties of DME are similar to those of LPG, and thus the delivery 
and storage means that are or can be employed for LPG are also suitable for DME 
transportation35,74,133. As a result of this ready infrastructure, DME is a quite attractive 
alternative fuel.  
The main synthesis route of DME is catalytic dehydration of methanol as shown in Eq 3.4 
85,134. 
2CH3OH   «   CH3OCH3 + H2O  (3.4)                            ∆H(298 K) = -23.5 kJ mol-1 
This reaction is typically catalyzed by a solid acid catalyst135. However, the surface acidity 
of a methanol dehydration catalyst is not a direct measure of the conversion to DME. It 
was determined that the acid site concentration could directly correlate to the value of 
methanol conversion to DME whereas this is not the case for the strength of these acid 
sites132. A high amount of moderate strength/weak acid sites can selectively produce DME 
whereas high strength of the acidic sites can further convert DME to other 
hydrocarbons35,36,131,133. Sites with strong acidity can accelerate water poisoning of the 
catalyst surface and also attract coke35. A considerable amount of sites with moderate 
acidity was reported to have a better catalytic performance compared to highly acidic 
sites68. It was also reported earlier that basic sites also play a role in methanol dehydration 
to DME along with the acidic sites133. 
DME can also be synthesized via a direct hydrogenation route from CO2 or syngas135,136. 
This direct route, in reality, consists of two subsequent mechanisms. The first one is CO2 
hydrogenation to methanol, or its surface adsorbed form called methoxy (Eq 3.2 and 3.3) 
and the second one is the dehydration of methanol to DME (eq 3.4). Methanol 
dehydration is not only a convenient method to produce DME, but a way to overcome the 
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thermodynamic limits of methanol production from CO2 hydrogenation by consuming 
methanol which eventually increases the amount of CO2 converted to methanol96,133,136. 
However, direct DME production from CO2 hydrogenation is not straightforward. A 
reason for this is the fact that the second step of this direct route, i.e., DME synthesis by 
methanol dehydration, requires higher reaction temperature compared to the CO2 
hydrogenation to methanol step. Another reason is that methanol synthesis from 
CO/CO2 hydrogenation proceeds on a metallic (typically Cu based) catalyst whereas 
methanol dehydration to DME requires an acidic catalyst. The catalytically active sites for 
CO2 hydrogenation to methanol are on the metal-metal oxide interfaces and the ones for 
methanol dehydration to DME are surface acid sites36,61,68,82. It was also shown in earlier 
works that the traditional methanol catalyst Cu/ZnO/Al2O3 is not sufficient for methanol 
dehydration to DME and it requires a more acidic component such as a zeolite61. As a 
result, a smart catalyst with dual functionality needs to be designed to carry out such a 
multi-site reaction124,131,135,137. 
It is suggested in some reports that for two methanol to dehydrate to one DME molecule, 
one methanol molecule needs to get adsorbed on the catalyst surface and become methoxy 
(CH3O-) on an acidic site. The second methanol molecule, on the other hand, needs to 
get protonated to form CH3OH2+ on a basic site and then these two molecules merge to 
form DME36,136,138. However, it is still a topic of debate.  
DME synthesis from methanol dehydration is typically performed under 250-400 °C 
temperature and pressures up to 10 bar101,130,132. Depending on the reaction conditions, the 
methanol conversion to DME can exceed 90%35,70. However, in a combined catalytic 
system which catalyzes both CO2 hydrogenation to methoxy/methanol and methanol 
dehydration to DME reactions, the CO2 conversion to DME strictly depends on the CO2 
conversion to methanol which is the limiting factor. 
3.2.3 Catalysts for CO2 hydrogenation 
According to IUPAC, a catalyst is ‘a substance that increases the rate of a reaction without 
modifying the overall standard Gibbs energy change in the reaction’98. A catalyst can be 
used in a reaction, and yet not consumed. Although it can accelerate the reaction in a 
particular direction, it cannot alter the thermodynamically most stable outcome. The main 
activity of a catalyst originates from its surface active sites and their affinity to the reactants 
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which leads to reactant adsorption on the catalyst surface irreversibly such that the 
desorption time is much longer than the reaction time106 and this way it promotes their 
transformation into products99. The conversion of the reactants to products does not 
typically occur in one step but rather through a series of reactions via several unstable 
intermediates at the catalyst-reactant interphase. In the final step, the products are 
formed99. Besides being catalytically active, a catalyst also needs to be stable, easy-to-
produce and cheap to maintain87. 
There are many catalytically active elements that have been studied for heterogeneous 
catalysis of CO2 hydrogenation process, and the selection of one or two of these elements 
depend mostly on the desired product. Ru100, Rh139, Pd59,88,140, Ir59 and Pt140 based catalysts 
have been investigated widely due to their high efficiency in dissociating H2 and the fact 
that they are more coke resistant59,68,80. However, Cu, Ni and Co-based catalysts 
maintained their popularity due to their low cost-to-yield ratio68. As for the products of the 
CO2 hydrogenation process, Cu based catalysts46,53,59,84,86 can yield CO, various 
hydrocarbons such as gasoline, alcohols and fuels like methanol and dimethyl ether via 
methanol route68 whereas Ni or Co-based catalysts mostly yield methane68,141. Dimethyl 
ether production mainly depends on the acidity of the final catalyst. Thus, the way  of Cu 
couples with the other species in the material systems that constitute the catalyst such as 
supports and promoters is crucial. 
The fabrication of combinations of different atoms or molecules that will act as the primary 
units of a catalyst assembly has been dominated by co-precipitation37,46,61,120 technique, 
also referred to as deposition-precipitation. For example, in the case of producing a Cu 
catalyst together with a promoter such as ZnO, one has been typically chosen to prepare 
the catalysts by co-precipitation such that both phases are in contact as nanoparticles61. 
This method is typically used for an assembly with no inter-particular pores but instead 
intra-particular voids. It is done by stirring a batch of promoter in a solution of the relevant 
precursor using a predetermined amount corresponding to a monolayer of coverage. The 
final material is typically obtained by direct evaporation under vacuum. Co-precipitation 
is the most common method of preparing Cu/ZnO based catalyst for methanol 
production from syngas83. This method can be coupled with an ultrasonic treatment stage 
to improve the dispersion131. Deposition-precipitation is conducted via vigorous stirring 
of the support material with the relevant metal solution with an assisting material such as 
urea or ammonia, followed by solvent evaporation by heating and calcination. It can also 
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be referred to as evaporation-induced wetness impregnation in case water is used as 
solvent with no other chemical aid. On the other hand, in case of porous supporting 
material usage, different methods such as infiltration or impregnation can also be used as 
described in Section 2.2.2 where SBA-15 modification techniques were described. 
Cu based catalysts, as clear by the name, contain Cu as their main component in 
combination with promoters and supports68,81. Cu, in metal form, was discovered to be 
active in adsorbing and dissociating CO2 and thus it is catalytically active for methanol 
production through hydrogenation of CO268,99,142. Cu has shown the highest methanol 
yield from CO2 hydrogenation among other metals96. On the other hand, Cu has been the 
focus of methanol synthesis studies not only due to this high catalytic activity but also due 
to its low price, ease of handling and low risk to human health (toxic effects appear only if 
it is ingested in large amounts)52,68.  
The catalytic activity of Cu was earlier attributed to its metal phase, and the metallic 
surface area of Cu was claimed to be directly proportional to the catalytic activity68, 
however later it was discovered that also the +1 oxide state is required which corroborates 
with the metal phase for catalyzing CO2 conversion due to their synergistic effect84,143. 
Freshly synthesized Cu nanoparticles are typically a mixture of various oxidized forms of 
Cu, and unlike the reduced Cu metallic state, oxides are stable upon exposure to air. 
Therefore, storing and transporting catalysts comprising of Cu nanoparticles in oxidized 
form is a good strategy from a stability point of view. The Cu oxides on the material can be 
reduced to get +1 oxide (Cu2O) and metal forms right before usage in CO2 hydrogenation 
reaction102. 
The phase of the catalytically active species is not the only yield-determining parameter. 
There are other factors contributing to the activeness of the catalyst such as metal-
promoter relationship46,83,84,131,144. In the following section, promoter types will be 
reviewed. 
Promoter53,68,86,99 is a modifier which can enhance the activity of a catalyst material, either 
by enhancing the activity of each site or increasing the number of active sites. The 
synergistic effect of multi metal oxide systems can improve the number of the active sites 
on the catalyst by introducing additional interface46,90,109,111,145. It was reported earlier that 
pure Cu is not sufficiently active to catalyze methanol formation through CO/CO2 
hydrogenation 143,146. Therefore, it is crucial, from the activity and selectivity point of view, 
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to complement Cu with a suitable promoter to boost the CO2 conversion efficiency. The 
choice of the promoter depends on the type of reaction and the targeted yield, selectivity, 
and conversion. More than one promoter can be used for a synergetic effect. In some 
instances, one promoter can also show both textural and electronic effects on the active 
phase. The supporting materials investigated so far are mainly binary and ternary oxides 
with different composition and morphologies. The most common reported promoters for 
Cu active phase in a heterogeneous catalysis of CO2 hydrogenation to methanol and DME 
are ZnO, Al2O3, TiO2, zeolites, ZrO2 and SiO268,99. 
Zinc oxide (ZnO) is the most preferred electronic promoter for the Cu active phase for 
CO2 hydrogenation reaction due to reports indicating its high efficiency136. This promoter 
is currently used in the commercial Cu catalyst for methanol production from CO2 
hydrogenation and also used in many scientific studies due to its beneficial properties for 
Cu. ZnO was observed to increase the dispersion and stability of the Cu metal phase and 
also contribute to the catalytic activity since the Cu-Zn interface is active for this type of 
reaction68,83. However, this hydrophilic phase can be quickly inhibited due to water 
produced during methanol and DME synthesis84,135.  
Alumina (Al2O3), is the most common support used for Cu/ZnO catalyst system for CO2 
hydrogenation to methanol36. It provides stability to the metal/oxide compounds83. 
However, it was also reported that due to its high concentration of Lewis acid sites, it 
attracts water and causes early deactivation of the catalyst90,136. On the other hand, due to 
its high surface acidity, Al2O3 is also known to catalyze methanol dehydration to DME and 
other hydrocarbons68. 
Titania (TiO2), is typically used as a photocatalyst due to its redox property in the photo-
excited state inducing water splitting reaction147–150. TiO2 has been reported to catalyze 
CO2 hydrogenation to produce methanol, alone or, as a promoter to improve the 
selectivity towards methanol by contributing to active metal sites81,96,151. It was also used 
as an additive to Al2O3 to improve the catalytic activity by minimizing the coke formation 
during the reaction. However, it requires a quite high temperature to operate at its 
optimum and therefore was never the primary choice for this reaction136. 
H-ZSM-5 has been typically used for methanol dehydration to DME as well as 
hydrocarbon formation due to its surface acidity36. However, due to possessing small pore 
diameter, H-ZSM-5 has a limited diffusion into the porous network136.  
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Zirconia (ZrO2), with its high stability under severe conditions (such as high T and P, 
reducing and oxidizing environments), is a very promising binary oxide catalyst support68. 
ZrO2 was also shown to increase the catalytic efficiency of the active Cu phase for 
producing methanol by both syngas and pure CO2 hydrogenation reactions37,120,136,142. The 
promotive effect of zirconia is mainly due to its ability to increase the dispersion of Cu 
metal and improve the active surface by providing additional sites on the catalyst system, 
both acid and base37,68,86,90,99,142,144,152,153. Zirconia was also shown to be better catalyst 
support compared to alumina due to its lower hydrophilicity since water poisoning of the 
catalyst is a bottleneck of such a reaction90. It can also ease the reduction capacity of 
CuO135, and it has an affinity to CO2 and thus can chemisorb and coordinate. This CO2 
affinity leads to carbonate formation on the Zr surface, and therefore it constitutes the 
perfect couple for the hydrogen coordinating Cu68,91,154. 
According to earlier reports, the catalyst systems with ZrO2 are typically composed of 
randomly shaped nanoparticles of oxides prepared with co-precipitation method and 
therefore has exhibited only up to 200 m2/g specific surface area86,144,152,155,156. However, 
studies that focus on testing different morphologies and states of zirconia to improve the 
support/promoter properties are very rare. 
Silica has been reported as a high stability support for Cu active phase to be used in various 
hydrogenation and dehydration reactions46,68,99,157 and it was shown to increase the 
methanol yield through CO2 hydrogenation by providing additional positive surface 
charge due to the Cu-SiO2 bonds at the interface106,158,159. Mesoporous silica can be 
prepared with a very high specific surface area (can be more than 700 m2/g) and uniform 
pore size distribution enabling improved dispersion and controllable particle size of the 
active phase nanoparticles53,59,147. High surface area of the support is beneficial not only to 
obtain a large catalytically active metal surface but also for keeping the active sites isolated 
from each other which can otherwise interact with each other instead of gas phase reactant 
molecules99. It was demonstrated in an earlier study the proximity between active sites can 
cause interaction hindrances and thus diminish the activity of the catalyst118 and since 
metals such as Cu tend to agglomerate in order to minimize their surface energy, choosing 
a favorable environment such as mesoporous silica for supporting Cu is crucial. The pores 
of mesoporous silica act as nano-shelters for Cu nanoparticles to prevent melting and 
sintering under high temperature46,68,145,160. On the other hand, silica can also be 
functionalized or doped with different atoms or molecules enabling functional 
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modifications99. The most common mesoporous silica types reported as catalyst support 
for Cu are MCM-41 and SBA-1546,51,52,57,59,71,158.  
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4 
DRUG DELIVERY 
 
The term ‘drug delivery’ describes the means and methods of drug administration into the 
body for a targeted therapeutic outcome. Controlled drug delivery has been in focus with 
increasing interest in the last decades due to the possibility to individualize therapies and 
ease dose compliance with the ultimate goal of ensuring patient comfort especially when 
they are life-long such as insulin administration for diabetes161,162. Controlled drug delivery 
primarily relies on ensuring the administration of the right amount of a chosen drug to a 
target organ with the right dosage by enabling gradual release over time163.  
A pharmaceutical drug is the formulation of an active ingredient (drug) in its suitable 
dosage form and selecting an efficient and safe drug delivery system for this dosage form 
is a crucial factor for determining the pharmacological action of a drug and thus tuning the 
therapeutic profile164. Administration of a drug delivery system should also be safe, reliable 
and repeatable165. Development of drug delivery systems, which can entrap the drug 
molecules within their structure due to their target-specific morphology, is considered as 
an important topic not only in the development of an effective disease therapy but also in 
different areas such as food/cosmetic industry as well as gene delivery166. In some 
applications, it is also possible to load the drug in a carrier and charge it on an implant 
which is then placed into the body, e.g., dental or hip implants164,167. 
A suitable carrier can improve the drug dissolution in the body69,168 by modulating the 
three main parameters of a release: location of the relevant site, drug concentration at this 
site (i.e., release rate) and duration of a chosen drug concentration at this site165,169. The 
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drug concentration at the target site should be within the therapeutic range which is 
defined as the region between the minimum effective concentration (MEC) and the 
minimum toxic concentration (MTC)165 against a particular microbiological agent. Drug 
support can also provide protection for this therapeutic molecule under severe conditions 
such as rapid pH change on the gastrointestinal tract166 and for ensuring a shelf life of a 
minimum two years for the drug it is carrying. 
Drug delivery mechanism of a carrier can be qualified by its drug loading capacity and drug 
release profile. Drug loading capacity represents the amount of drug held by the unit 
weight of its carrier under certain loading conditions. Drug release profile is the time-
dependent evolution of accumulated drug concentration in a release medium. 
4.1. Drug delivery systems 
Drug delivery systems can be classified through different parameters. The classification 
can be made according to the physical state of the drug carriers which includes solid, 
semisolid (i.e., ointment), liquid or gaseous, or possibly multiphasic systems165. Drug 
delivery systems can also be classified according to their route of administration which can 
be oral, parenteral (intravenous or intramuscular), transdermal (topical or rectal) or 
aerosol164. Drug administration from implants is considered as parenteral administration 
route. This method presents a unique advantage by enabling local drug delivery straight to 
the therapeutical site, which overcomes several challenges related to the conventional 
administration routes. For example, oral administration is well known to require quite high 
dosages of the drug to be able to reach the target site at desired concentrations. Another 
type of classification is based on the release profiles (Figure 4.1) which can be separated 
into two main branches referred as immediate release and modified release. Immediate 
release is the most conventional type of release profile that occurs by dissolution of the 
drug to the medium in a single and rapid action causing the drug concentration to quickly 
reach a maximum in the blood plasma and then to decrease. This profile is typically found 
in conventional oral dosage forms (e.g., paracetamol pills). Modified release, on the other 
hand, involves the release of a drug in a delayed or extended manner. Delayed release 
allows the release of a drug with a certain delay after administration of the drug. Extended 
release can be performed by either sustained release which enables release over time or by 
controlled release which extends the release in such a way that the drug concentration level 
in the plasma stays constant during a chosen duration165. 
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Figure 4.1. Drug 
release profiles 
Controlled drug delivery systems are capable of maintaining a constant drug 
concentration in the release medium, i.e., relevant site of the body, for the adequate time 
frame required for the therapy. Thus, a significant amount of research on pharmaceutical 
technology has been devoted to this issue. The controlled drug delivery has been mostly 
concentrated on polymeric materials and also some hybrid inorganic material systems5. 
In controlled drug release, many strategies have been employed such as varying the 
morphology or physicochemical properties of the drug carrier to achieve good control 
over the release kinetics. Also functionalizing drug carriers is a significant strategy for 
enhancement of the drug-carrier interactions and thus limiting the drug release rate166.  
4.2.! Drug release models 
Drug release profiles strictly depend on the behaviour of the drug carrier in the release 
medium which can either be biodegradable or biostable (un-dissolving)170. The diffusion-
controlled systems typically employ un-dissolving drug carrier171, and several 
theories/kinetic models can be used to describe this type of release from immediate and 
modified release dosage forms172. Most of these models are based on Fick’s diffusion 
equation under proper boundary conditions, and the most significant models for non-
degrading drug delivery systems include zero-order release, first-order release, Higuchi, 
Korsmeyer-Peppas, and Weibull170. 
Zero-order release173 is only valid when the drug release rate is constant, i.e., release rate is 
independent of the drug concentration in the release medium. It represents a linear drug 
accumulation over time where the release time is ‘infinitive’ 171. 
  Drug Delivery 
 
 48 
!" − !$ = &"' (4.1) 
where the Mt is the amount of drug released in time t, M0 the initial drug amount, and k0 
the zero order release constant. 
First-order release173 is valid when the release rate is dependent only on the drug 
concentration in the release medium. ()(+,+-) = &'           (4.2) 
where the Mt is the amount of drug released in time t, M0 the initial drug amount, and k 
the first order release constant. 
Higuchi model5,170,174 is valid when the drug is homogeneously distributed in a 
nondegradable drug delivery system which acts as a planar surface (monolithic delivery). 
It is good at estimating the cases where the drug concentration is much higher than the 
solubility limit of the drug.  !$ = &/'0/2  (4.3) &/ = [25678769]0/2  (4.4) 
where the Mt is the amount of drug released in time t, kH the Higuchi dissolution constant, 
D the diffusion coefficient, cini the initial drug concentration in the medium and cs the drug 
solubility. 
Korsmeyer-Peppas model5,170,173 is a more comprehensive model for drug release from a 
matrix. It represents diffusional release and typically used for polymeric systems. 
+-+; = &'8           (4.5) 
where the Mt is the cumulative released drug mass at a time t, M¥ the cumulative released 
drug mass at the time infinity (maximum released amount), k the release rate constant, t 
release time, and n the release exponent. The release exponent here mentioned hints 
whether the release follows Fick’s law or displays a more complex behavior.  
Finally, Weibull model175,176 is typically suitable for drug release from a matrix where the 
diffusion is in effect. It was earlier shown that this model can fit a release profile from 
mesoporous silica materials where not only diffusional release took place, but also 
desorption177. 
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where the Mt is the cumulative released drug mass at a time t, M¥ the cumulative released 
drug mass at the time infinity (maximum released amount), k the rate constant, and tl the 
lag time for a dissolution process.  
4.3. Drug supports: nanocarriers and antibacterial agents 
Pharmaceutical nanotechnology is a new area focusing on the development of drug 
delivery vehicles with advanced properties178 in nano-level, i.e., nanocrystalline and 
nanostructured materials. 
One of the main aims of this discipline is to achieve nano-sized or atomic level 
modifications to the previously studied drug delivery systems in order to improve drug 
bioavailability and develop more patient-friendly treatments by reducing the total dosage 
and side effects7,164,179. There are many nanotechnological drug delivery systems studied 
so far, including inorganic materials (such as silica, carbon, metals or polymers) as well as 
biological agents (such as chitosan)180.  
Nanoparticles, meanwhile, came to attention of the scientific community due to their high 
stability in the release medium5,181,  high surface-to-volume ratio leading to high 
adsorption capacity not only for drugs but also for genes, proteins, and probes7,182,  small 
enough size to penetrate into the smallest blood vessels and cells and still deliver a suitable 
amount of drug164,169,180, controllable morphology and surface properties, and their 
biocompatibility164,180. Economically they are favorable too since the same nanoparticle 
synthesis method can be used to produce different morphological properties and also they 
might be applied in many drug administration routes including oral, intravenous or topical 
and even for drug storage69,161,165.  
Mesoporous materials became popular as drug delivery matrices due to their high surface 
area and pore volume, narrow pore size distribution and pore size range of 2-50 nm which 
is suitable for hosting many different sized drug molecules183,184. They are not only suitable 
for drug delivery, but also for long-term drug storage5. 
Mesoporous silica has been proposed as an active drug delivery system due to its 
biocompatibility65,176,183. Its ordered network of bi-axially aligned pores covered with 
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silanol groups provide controllable mass transfer of fluids into and out of the ordered 
network, enabling good control of drug loading and release8,183. 
Silica sol was primarily studied as a drug carrier. However, mixing the drug molecules 
yielded unhomogeneous distribution of the drug in the carrier which resulted in 
inconsistent release profiles between different batches5,185. Mesoporous silica has been a 
good biocompatible alternative to the traditional systems due to its high hydrolytic 
stability186. 
The use of mesoporous silica for drug delivery studies was pioneered by Vallet-Regi et al. 
with a report from 2001 where they showed the drug delivery feature of MCM-41185. 
Mesoporous silica is a suitable candidate as a drug delivery system due to its ordered pore 
packing structure, high specific surface area, and large pore volume as well as its 
convenience of surface functionalization due to silanol rich domain183. They can 
accommodate drugs with a hydrophobic and unstable character as well as the ones for 
which the cellular uptake is a challenge, such as the cancer drugs7. They are also favorable 
candidates for targeted delivery by functional groups which require the porous system in 
an entirely homogenous structure183. After MCM-41, larger pore mesoporous silica types 
such as SBA-15, SBA-16, and SBA-1, as well as hollow mesoporous silica spheres were 
evaluated as drug carriers, but due to good control over the characteristics, the focus stayed 
on SBA-155. 
SBA-15 is a bioactive molecule with a pore size range of 5-15 nm and therefore has a 
considerable potential for hosting large drug molecules5,183. Its well-defined cylindrical 
pores are packed in a hexagonal order, and they run parallel to each other which is a 
perfectly aligned morphology for controlling the drug loading and release 
behaviour65,177,182. These properties are similar for MCM-41, which was the start of many 
drug release studies. However, there are some reports suggesting lack of bioactive property 
of MCM-415 unless functionalized with a biocompatible element such as phosphorus5,187. 
Moreover, the presence of –OH end groups on the well-defined surface of the SBA-15, its 
high specific surface area, and pore-connectivity make SBA-15 favorable for loading and 
controlled release of a drug depending on the ionic attractions5,184,188. SBA-15 has 
especially shown to interact with positively charged molecules, but even without strong 
electrostatic forces, it can still hold a considerable amount of a drug by physical mixing and 
capillary forces due to its extensive porous network7,69,189. Therefore SBA-15 is quite 
advantageous for drug delivery applications. SBA-15 has good hydrothermal and chemical 
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stability which enables long-term survival under harsh body conditions such as rapidly 
changing pH5. Bulky mesoporous structures were earlier determined to be limited to their 
capacity of the drug amount they can carry. For this reason, some studies are leaning 
towards hollow mesoporous spheres which perform as a reservoir system during the 
diffusional drug release171,183. Therein, a high pore volume and large SSA material such as 
SBA-15190 with homogenous monodispersed rod morphology can spare the scientists 
from developing hollow structures which typically have exhaustive multi-step synthesis 
routes and a great challenge to have a good synthesis yield with homogeneous powder 
morphology191,192.  
It has been shown in earlier studies16,21 that there are several ways of modifying the 
adsorption performance of SBA-15 by altering physicochemical properties of SBA-15, and 
this can provide good control over the drug release kinetics. Moreover attaching functional 
groups on its –OH terminating surface is a very convenient way to increase the drug 
attachment193. One very significant functional group studied so far is amine group (NH2-) 
which has influence on the drug loading potential and release behavior of SBA-155,188,194,195. 
It was shown before that amino functionalized SBA-15 is capable of a zero-order release 
which can be favorable especially for local delivery of drugs to repair bone defects183. In 
some cases, functionalization can be comprised of certain chemical groups that control the 
pore openings and regulate the encapsulation as well as the release of the drug loading190. 
These chemical groups can respond to different stimuli such as lights, pH or temperature 
and can change their configuration and they are referred as gate-keepers or gate-like 
ensembles65,183,196,197. This type of functionalization can become quite critical when a 
sensitive tuning in targeted delivery is required, especially in treatments such as cancer186.  
Moreover, SBA-15 is a potential dental filler which is promising for local delivery in dental 
applications involving dental composites198. It has been a common practice to utilize 
spherical nonporous silica particles as dental fillers in the composite materials199. The idea 
of using porous glass fillers was first introduced in 1976 by Bowen et.al.200. Later it came to 
attention that the large pores of SBA-15 can host molecules with a wide range of sizes and 
morphologies and can release them into a suitable medium by diffusion5. The high pore 
volume and large specific surface area of SBA-15  allow minimization of the amount of 
SBA-15 powder to be loaded in a dental composite since this concentration variable is also 
directly proportional to the collective toxicity of the drug delivery system183. Also, it was 
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shown earlier that SBA-15 and MCM-48 allow the formation of an apatite-like layer which 
also indicates a potential use in implantology10,167. 
The kinetics of the release from a mesoporous network depends a lot on the morphology 
and physical properties of the carrier material. Although this was investigated in earlier 
studies, some more research devoted to this is of interest, since kinetics can be much 
different when the material demonstrates considerably larger pores but also the high 
specific surface area. There is no universal view in the literature regarding the drug release 
kinetics of mesoporous silica, and earlier reports have revealed different release profiles. In 
these studies, it has been shown that the kinetics of the drug release from mesoporous silica 
can follow Korsmeyer-Peppas model5, zero order release201 or Higuchi model5 depending 
on the system. On the other hand, there are also many studies which indicate that there 
are two phases of drug release from mesoporous silica and therefore such a model needs 
two exponential terms to form the formula to represent different phases. The first phase is 
typically a burst release of the drug molecules that are free in bulk form within the carrier 
without being adsorbed to the carrier (physically encapsulated molecules) and the second 
phase is where the adsorbed molecules of the silica walls are desorped (chemically 
encapsulated molecules)163,202,203. The drug-drug interactions are dominant in the first 
phase whereas drug-carrier interactions become dominant in the second phase203. 
Depending on the electrostatic attraction between the drug and the carrier mesoporous 
silica, the significance of these phases can change, e.g., with a type of a drug weakly attached 
on the silica surface, the second phase can be ignored or not existent202. A double 
exponential function (Eq. 4.7) was reported by Demuth et al., which can be observed to 
be based on Weibull model, to explain this two-phase behavior for a cationic dye attached 
on a mesoporous silica5,203. 
+-+; = A0(1 − =>?B$) + A2(1 − =>?D$)       (4.7) 
where the Mt is the cumulative released drug mass at a time t, M¥ is the cumulative released 
drug mass at the time infinity (maximum released amount), P1 and P2 are the percentages 
released during phase 1 and 2, k1 and k2 are the release rate constant of phase 1 and 2203. It 
was also observed earlier that for certain mesoporous silica-drug molecule coupling, the 
absorption could be strong enough not to allow full release of the loadings5.  
Zirconia (ZrO2) is a biocompatible inorganic ceramic material which shows high stability 
under high temperature, pressure, oxidizing environments and changing pH conditions 
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and thus it is being investigated for bone implant applications as well as dentistry and 
dental implantology168,204. Moreover, it was studied as a drug and gene carrier168,205. 
Zirconia is currently in clinical use for the preparation of hip implants and suggested as a 
new generation of dental implants to replace or complement titanium to form hybrid 
implants for the clinical practice. This function of zirconia originates from the fact that it 
is osteoconductive, i.e., promotes bone formation when it becomes in contact with the 
injured bone, it helps to inhibite plaque formation, and improves soft tissue interactions, 
thus promotes periointegration204.  
On the other hand, when zirconia enters the body, it can get reduced in the cells by 
mitochondria and therefore can cause an increase in the ROS (reactive oxygen species) 
such as superoxide *O2-, and hydrogen peroxide H2O2. These species can cause 
cytotoxicity, therefore, the form and amount of ZrO2 taken into the body are crucial205–207. 
The ZrO2 concentration limit that can cause toxicity in the cells due to elevated oxidative 
stress was earlier published as 250 µg/ml168,205. The literature results have no common 
ground on the toxicity of Zr, and the debate is still going on. However, it became explicit 
that, the toxicity differs with test conditions as well as the physical form of zirconia which 
effects its oxidizing (getting reduced) properties204. For example, nanoparticle 
morphology can cause higher toxicity than the case where it is doped in the framework of 
a stable amorphous matrix. Doping method can overcome the oxidizing tendency. 
However, literature is lacking these type of trials. On the other hand, the oxidizing 
properties of ZrO2 can be additionally advantageous in the drug delivery applications due 
to its contribution to antibacterial effect206,208.  
Copper (Cu) has been utilized by the humankind since 5000s BC and was reported in the 
oldest medical record the Smith Papyrus written until 2600s BC to function for 
sterilization of chest wounds209.  Cu was first acknowledged to be a material with 
antibacterial properties in the 1800s when the scientists realized that Cu mine workers 
were immune to cholera and since then it has been used in medicine widely209,210. Cu, 
either in metal or oxide form, is a cheaper alternative to noble metals (gold or silver) for 
several antibacterial and antifungal applications such as preparation of dental cements, 
medical implants, and producing antibacterial coatings/materials to be used in public 
places such as hospitals, transportations vehicles, and food packaging209–215.  
In views of conferring or enhancing its antibacterial activity, Cu can be used as 
nanoparticles to obtain high specific surface area. The antibacterial activity of Cu 
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nanoparticles at the size range of 2-10 nm was shown to have antibacterial activity against 
both gram positive and gram negative bacteria179,213. Moreover, Cu nanoparticles, 
compared to Cu+ ions attached on the surface of the carrier, have higher stability under 
body conditions (e.g., changing pH) leading to slower ion release from the nanoparticles 
which provides a long period of antibacterial activity and a lower potential of being toxic 
against mammal cells199,211–213,216. Also, their long lifetime can enable them to be used in 
contact therapies such as wound plaster213.  
The antibacterial activity of materials such as Cu or Ag has become more attractive 
especially due to the increasing resistance of microorganisms to various broad spectrum 
antibiotics and antiseptic chemicals217. Due to their bacterial toxicity, Cu nanoparticles 
were used as a complementary agent to antibacterial drugs or antibiotics in many drug 
delivery studies216,217. 
The antibacterial activity of Cu nanoparticles can be both a contact-driven or ion releasing 
process which runs by cell wall destruction, production of ROS in the bacterial cells and 
DNA degradation leading to cell death209,212,216,218. The copper ions released from each 
nanoparticle are the toxic agent, and its release rate can determine how harmful the 
administered material is to bacterial cells and how safe it is to mammal cells216.  
Chlorhexidine digluconate (CHX) is an organic antibacterial and antiseptic drug which is 
well-established in dentistry and successfully used in the clinic for more than 20 years, 
especially for the treatment of periodontal deseases199,219,220. Moreover, it is used in 
handwashing and oral products due to its broad spectrum effect and low cytotoxicity 
which minimizes skin irritation220,221. It has both antibacterial and bacteriostatic activity, 
and it is effective against many gram-positive and gram-negative bacteria as well as 
fungi219,222, but it can not kill bacterial spores or myobacteria221,223. It is bactericidal by 
contact to which it is attached to the cell membrane of the microorganism. Afterwards, it 
goes through an easy uptake by bacteria by diffusion and it attacks the inner membrane 
causing the bacterial membrane disruption and thus the intracellular contents to leak. The 
second phase starts where the high concentration of CHX in the cell can cause the cellular 
contents to coagulate221. Chlorhexidine is a cationic molecule, and its antibactericidal 
property is originated from this charge which reacts with the lipopolysaccharides which 
contain negatively charged phosphate groups222. This molecular charge of CHX is also a 
valuable characteristic for loading it into any acidic carrier219. 
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Figure 4.2. 
Chlorhexidine 
digluconate 
 
Doxycycline Hyclate (Doxy) is a semi-synthetic wide spectrum antibiotic from 
tetracycline family which is effective against periodontal pathogens and shows anti-
inflammatory effect176,224. 
The topical administration of Doxy has been demonstrated to improve the management 
of periodontitis via systemic administration because by topical administration the amount 
of antibiotic delivered on-site is much higher, it is possible to apply it one time only and 
thus preventing any systemic side-effect224–226. 
 
 
 
 
 
 
 
 
Figure 4.3. Doxycycline hyclate 
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5 
ANALYSIS METHODS 
 
The characterization of mesoporous silica can be done with a wide range of techniques. 
The morphological identification can be made by imaging, more explicitly scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). The porous 
network is investigated with physisorption and small angle x-ray diffraction methods. 
Fourier transform infrared spectroscopy (FTIR) is utilized for identification of the silica 
network whereas Synchrotron radiation and in situ horizontal attenuated total reflectance 
(ATR) can help clarify the mesoporous silica network formation mechanism. The surface 
acidity is assessed by NH3-temperature programmed desorption (TPD) measurements. 
Using SBA-15 in applications, however, require slightly different analysis methods. In 
order to analyze the resulting gas from the CO2 hydrogenation, gas chromatography-mass 
spectrometry (GC-MS) were used in combination to get quantitative results. In situ 
diffuse reflectance infrared Fourier transform spectroscopy (DRIFTs) gives insights to the 
reactions occurring on the catalyst surface during CO2 hydrogenation. 
In drug delivery applications, the drug loading amount can be measured by 
thermogravimetry (TG), and drug release amounts can be calculated from the drug 
concentration in the release medium detected by a UV spectrometer. The antibacterial 
properties of a material are typically measured with agar diffusion test to obtain qualitative 
information and the microplate technique to obtain quantitative information. 
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5.1. Physisorption 
Physisorption (physical sorption) is the attachment of free gas molecules to the surface 
atoms of a material by weak van der Waals forces. A gas, at or near its boiling point, is used 
to expose the sample to different pressures, which are typically lower than the vapor 
pressure of the gas itself. The applied gas pressure is increased stepwise. During each step, 
the pressure is held constant to allow for adsorption and for the adsorbent temperature to 
equilibrate. The pressure change, as well as the amount of the dosed gas, are used to 
calculate the adsorbed amount which is then plotted against the adsorptive pressure to 
obtain isotherms227. Employing this technique, it is possible to determine the specific 
surface area and pore size distribution of porous materials by using nitrogen gas228.  
There are six types of isotherms according to the IUPAC classification2,229, and they are 
schematically depicted in Figure 5.1. They are based on multilayer coverage of gas 
molecules forming on the adsorbent. The first stage is monolayer adsorption, and it occurs 
when the surface of the mesoporous material is covered with one row of gas molecules. 
Then the gas molecules accumulate layer by layer forming a multilayer. As the final step of 
adsorption, the condensed gas molecules fill up the rest of the empty space. The 
desorption occurs in the opposite direction.  
Type I is typically observed for microporous materials. Indeed, due to micropores with a 
small diameter, the quantity of the adsorbed gas shows a fast increase at low pressures 
which approaches an equilibrium value as the accessible pores are filled. Type II isotherms 
represent non-porous or macroporous adsorbents where monolayer is formed until the 
first knee point, and the multilayer coverage goes up high as the partial pressure increases 
to high values after the second knee point. The type III isotherm occurs when the 
adsorbent-adsorbate interaction is very weak. Due to this reason, the gas molecules 
accumulate on the very few active sites on the adsorbent surface, and thus full layer 
coverage cannot be achieved. The mesoporous materials are represented by type IV which 
starts similar to type II but also shows a hysteresis due to capillary condensation. This 
phenomenon occurs with the gas condensing in the pores at pressures higher than the 
saturation pressure which causes delayed condensation, and finally the condensed 
molecules fill the pores. During desorption, however, the liquid stays in the pores until the 
equilibrium vapor pressure is reached, and at the right time, the gas molecules evaporate 
their way out of the pores. The type V isotherm is similar to Type III where the adsorbent-
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adsorbate attraction is very weak and a capillary condensation occurs. Finally, type VI is 
when multilayer gas deposition occurs on a nonporous or a very uniform surface2,229. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Isotherm 
types  
 
Hysteresis can occur in 5 different shapes depending on the pore shape of the material 
(Figure 5.2). H1 loop occurs for uniform, cylindrical mesopores as in MCM-41 or SBA-
15 where all the pores are filled and emptied at once. H2 is typically observed when the 
sample has pore blockings or bottle-necks causing percolation of the liquid. H3 loop 
typically represents a sample made up of platelet-shaped particle aggregates or slit-shaped 
pores with pore blockings. H4 is when the sample is made up of aggregated crystals of 
zeolites or slit-shaped pores without any pore blocking. Finally, H5 loop belongs to the 
samples where there are both blocked, partially blocked and open pores 229,230. 
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Figure 5.2. 
Hysteresis 
loops  
The surface area is typically calculated by the BET (Brunauer-Emmet-Teller) method231. 
This method includes using a multilayer coverage capacity to calculate the accessible 
surface for the gas molecules. The number of molecules forming the first layer can then be 
used with a molecular cross-section area to find the whole surface area. This theory 
assumes that the surface active sites are identical and adsorbed molecules do not interact 
with each other1,229. 
Pore size distribution is typically calculated by the KJS (Kruk-Jaroniec-Sayari) method for 
mesoporous silicas with ordered and cylindrically-shaped pores232,233. This method 
depends on BJH method which was determined to underestimate the pore size, and thus 
KJS method includes a correction to BJH method. BJH method assumes that all the pores 
are cylindrical and it calculates the pore radius by taking advantage of the capillary 
condensation from the Kelvin equation which is the basis of explaining partial pressure 
dependence of the curvature at the liquid-gas interface. Later, by comparing the XRD data 
of the MCM-41 type of mesoporous silica with the sorption data, the BJH method was 
improved228,229,232,234. 
5.2.! Temperature Programmed Desorption 
Temperature programmed desorption (TPD) is a chemisorption (chemical sorption) 
based technique. Chemisorption is the attachment of free gas molecules to the surface 
atoms of a bulk material by covalent or ionic bonds. It is a common method to analyze the 
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surface properties of solid catalysts and their affinity to the gas molecules in a 
heterogeneous reaction system. It is irreversible and a monolayer activity235.  
During TPD measurements a probe molecule, such as ammonia or carbon monoxide, is 
used to determine the properties and the density of the surface acid sites of a solid catalyst. 
A solid catalyst of a known weight is first saturated with the adsorbate flow at a temperature 
typically between 100-150°C for a sufficient amount of time to ensure a complete 
coverage. Afterwards, physisorbed molecules are removed from the catalyst surface by an 
inert carrier gas flow. The remaining chemisorbed molecules are then forced to desorb by 
increasing the temperature. While heating, the adsorbate concentration in the carrier 
stream is measured by using a thermal conductivity detector. The acquired TPD spectra 
are normalized with the weight of the sample powder and plotted versus temperature. 
TPD spectra exhibit peaks at specific temperatures at which the adsorbate molecules are 
detached from the acid sites. Therefore, stronger is the acid site, higher is the temperature 
required for desorption236–238. 
5.3. X-ray diffractometry 
Electromagnetic radiation with a wavelength of about 10-10 m is called X-rays. When X-
rays penetrate matter, they can interact with electrons and scatter, be emitted or absorbed 
in specific ways depending on the nature of the interacting atoms. Diffracted x-rays can be 
analyzed to determine the atomic structure of a crystalline phase. The diffraction 
technique requires long-range periodicity of the lattice planes in the material of interest. 
These planes cause scattering due to constructive interference, and this can be shown with 
a relationship between the scattering angle and lattice spacings called Bragg’s law239: )E = 2FG?HIJ)K          (19) 
where E is the wavelength of the x-ray beam, FG?H is the lattice spacing, K is the scattering 
angle and n is the order of reflection. 
Small angle x-ray diffraction is conducted in transmission geometry for ordered powders 
by analyzing the diffracted beam as a result of an incident beam striking the sample at a 
shallow angle. The diffracted angle of the incident beam (2q) is typically recorded 
between 0-2.5° for mesoporous silica. In this angle range, the hexagonal pore stacking 
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system of SBA-15 results in at least three peaks corresponding to  100, 110, 200 when using 
Cu radiation.  
The phase and size of the nanoparticles with well-defined crystallographic planes can 
typically be determined by x-ray diffraction at angles between 20-60°. Crystallite size, i.e., 
nanoparticle size for a single crystal material, with a size between 5 and 100 nm can be 
calculated by the Scherrer equation, utilizing the full width half maximum of the strongest 
peak of the material.240,241 
5.4. Electron microscopy and energy dispersive x-ray 
spectroscopy 
Electron microscopy enables imaging by projecting a beam of accelerated electrons onto 
the sample. In Transmission Electron Microscopy (TEM) the electrons that penetrate a 
specimen, are transmitted through the sample, and the resultant beam is recorded at the 
exit by suitable lenses whereas in Scanning Electron Microscopy (SEM) the reflected 
(secondary) electrons are used for imaging. TEM is more suitable for thin samples, while 
SEM is typically used for thick or very absorbent samples where electrons cannot be 
transmitted properly242. Dark-field images can be produced by TEM method by using only 
the diffracted electrons and avoiding the direct beam by an objective aperture. This 
method can provide enough contrast between different crystal structures87. Energy 
dispersive x-ray spectroscopy technique (EDS/EDX) is a common method for 
determination of the atomic content of a sample and it relies on the emitted x-rays from 
the sample which have a characteristic energy depending on the atomic content of the 
sample. This measurement is typically conducted with an SEM or a TEM equipped with 
an integrated x-ray detector. 
5.5. Infrared spectroscopy [FTIR, DRIFTS, and ATR] 
Infrared spectroscopy (IR) is a technique to analyze the presence of atoms, molecules and 
molecular interactions which are active under infrared beam, i.e., absorb/emit the IR 
beam. These vibrations include mainly stretching (bond elongation) and bending (bond 
angle change). IR spectroscopy relies on these vibrations to get excited under IR radiation 
and change their energy levels. As a result of this energy adsorption, less energy from the 
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incident radiation is transmitted at the relevant wavenumber which appears as peak 
formations on a spectrum. With Fourier transform infrared spectroscopy (FTIR), the 
main beam is split, and the partial beams are reflected back to the splitter where they 
recombine. The interference of the partial beams is interpreted in an interferometer by the 
Fourier transformation technique 243. 
Attenuated total reflectance (ATR) employs an internal reflection element, e.g., a crystal, 
with high refractive index enabling multiple reflection of the IR beam while going through 
this element. During that time, the beam is absorbed by the sample, and finally, the 
attenuated beam is measured (Figure 5.3). It is typically utilized to measure samples in 
liquid or solids that produce very strong peaks with the transmission IR technique243. 
 
 
 
 
 
 
 
Figure 5.3. 
ATR setup 
schematic 
 
In situ diffuse reflectance infrared Fourier transform spectroscopy (DRIFTs) is performed 
in a drifts cell which enables reflection of the beam over a solid sample(Figure 5.4). When 
the beam hits the sample, it is reflected by specular and diffuse reflectance. Specular 
reflectance occurs when the reflected beam is equal to the incident beam, which is valid 
for flat surfaces. The diffuse beam, however, is observed when the reflected light is 
scattered due to a rough surface causing various reflection angles. A rough sample can 
absorb a huge amount of the beam in case of transmission mode, and therefore the 
DRIFTS method is quite sensitive compared to traditional FTIR and thus is a convenient 
method of determining surface groups on a catalyst during a reaction243–245. 
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Figure 5.4. DRIFTs 
setup schematic. M1-
M5 represent  the 
mirrors in a specific 
order  from detector 
towards the source. 
5.6. UV/vis spectroscopy 
UV/vis spectroscopy works by exposing the material of interest (typically dissolved in a 
solution) to a beam in the UV and visible range and detects the transmittance/absorbance 
by the measured material due to electron excitation. The resulting change in the beam is 
reflected through the detector and outcome is presented as a spectrum where peaks/bands 
give clues regarding molecular structure246. The most common use of this method is in the 
determination of the concentration of a substance in a liquid such as metal ion or a drug 
molecule. 
5.7. X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy (XPS) is a surface-sensitive analysis technique that 
measures the elemental composition of the top surface (typically 1-10 nm) and provides 
information regarding the chemical state of the elements that compose the material being 
analyzed. XPS measurements are conducted in vacuum by irradiating a material with an 
X-ray monochromatic beam (commonly Al Kα or Mg Kα), which causes photo-emission 
of core-level electrons. As a result, the kinetic energy distribution of these emitted 
electrons is measured and used to identify and determine the concentrations of the 
elements present247,248. 
 
  Analysis Methods 
 
 65 
5.8. Gas chromatography and mass spectrometry 
Gas chromatography is an analysis method where a gas mixture is separated into its 
components by a stationary phase (capillary column) by using their different affinity to 
the analytes, and each component is identified/quantified. The sample gas mixture in 
question is transmitted through the detector with a non-polar and non-reactive carrier gas 
such as Ar, He, and H2. There are many different types of GC detectors, and they have 
their specific operation principle depending on a physical property of the molecules. For 
example, thermal conductivity detector (TCD) operates by measuring the changing 
thermal conductivity of the flowing gas and therefore determines the concentration in the 
gas while flame ionization detector (FID) burns the input gas with H2 and gets its signal 
from the mass of the formed ions.249,250 
Mass spectrometry (MS) provides identification of the components in a mixture by 
measuring the mass dependent deflection of the ionized molecules from the sample251. An 
ion source is employed to produce ions from the entering molecules. These molecules 
undergo fragmentation into radicals and ions when exposed to the ion flux from the ion 
source. Finally, the ions from the sample are passed through an electric field that deflects 
them differently depending on their kinetic energy. The abundance of ions are grouped 
according to their mass-to-charge ratio and presented as a bar graph which provides the 
mass-to-charge ratio of the species within the sample that is fed into the mass 
spectrometer251,252. 
5.9. Thermogravimetry 
Thermogravimetric analysis is done by changing (typically elevating) the ambient 
temperature of a material gradually and measuring its mass over time. The measured 
sample is typically a solid. As it is heated, desorption, phase transition and thermal 
decomposition can occur. It is a destructive method which can be used for quantification 
and determination of the composition of materials, as well as their water and solvent 
content, impurity levels, and the thermal stability237.
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6 
SUMMARY AND DISCUSSIONS OF THE 
PAPERS 
The papers appended to this thesis focus on synthesizing hybrid materials based on 
mesoporous silica for catalysis and drug delivery applications. 
6.1 Paper 1 
Synthesis of Cu-infiltrated Zr-doped SBA-15 catalyst for CO2 hydrogenation into 
methanol and dimethyl ether 
In Paper 1, a rapid sol-gel route15 was used to synthesize a Zr-doped SBA-15 matrix with 
Cu nanoparticles grown on its surface. The effects of Cu and Zr modifications were 
investigated from a chemistry viewpoint, and the catalytic efficiency in a CO2 
hydrogenation system was evaluated.  
Zr-doped SBA-15 materials (Zr-SBA-15) demonstrated very similar porous network as for 
SBA-15 with additional Zr-O-Si bonds with an overall Si/Zr atomic ratio of about 10. Zr 
doping has yielded pore size increase from 11 to 15 nm while the SSA remained constant 
around 700 m2/g. The particles for both SBA-15 and Zr-SBA-15 were rod-shaped, but 
wider in case of Zr doping. This structural difference was determined to be due to the 
decrease in F- ion concentration in the solution caused by the Zr salt addition which 
otherwise acts as a catalyst in SBA-15 formation. By changing the static duration in the 
synthesis and the hydrothermal treatment conditions, it was observed that the pore 
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characteristics of the Zr-SBA-15 could further be altered. When the synthesis catalyst salt 
NH4F was changed to NaCl the particle morphology was evolved to spheres due to slower 
formation rate in the presence of Cl- ions compared to F- ions. Cu nanoparticles grown on 
Zr-SBA-15 were determined to have a smaller average size compared to the ones grown 
on SBA-15. The reason for the improved Cu distribution in the presence of Zr is ascribed 
to the increase in the number of acid sites on the Zr-doped silica surface. In both cases, 
various oxidation states of Cu (Cu2+, Cu3+, and Cu+/Cu0) were detected to coexist in the 
sample despite reducing the samples under H2 flow at high temperature. On the other 
hand, Zr was detected only in Zr4+ oxidation state.  
The Cu-Zr-SBA-15 material was catalytically active for selective CO2 hydrogenation to 
methanol and DME with 15% CO2 conversion at the end of 5 days at 250°C and 33 bars, 
whereas SBA-15 and Zr-SBA-15 have shown less than 1% CO2 conversion. Moreover, the 
Cu-SBA-15 material yielded a CO2 conversion lower than 1% which demonstrates the 
importance of improved acidity with Zr existence in the mesoporous framework. The final 
conversion was still increasing after 5 days which indicates that a higher conversion can be 
expected from the Cu-Zr-SBA-15 catalyst at improved reaction conditions.  
6.2 Paper 2 
Effects of the chemical state of mesoporous CuOx-Zr-SiO2 catalysts on CO2 
hydrogenation 
In Paper 2, the investigation of the synthesis conditions for Cu-Zr-SBA-15 catalytic 
nanoassembly, which started in Paper 1, was taken one step further by altering the 
chemical state of the catalyst with different silica precursors, and Cu loading procedures 
and observing the impact of this alteration on the catalytic activity. The tested silica 
precursors were tetraethyl orthosilicate (TEOS) and sodium metasilicate (SMS) whereas 
the experimented Cu loading methods were infiltration (Inf) and evaporation induced 
wetness impregnation (EIWI).  
The Zr-SBA-15 particles synthesized with SMS were observed to yield wider particles, i.e., 
platelets compared to TEOS which yielded rods. This was attributed to the NaOH 
occurrence with SMS hydrolysis which increases the dissolution of the PEO chains of the 
micelles in the water media. The improved PEO solubility causes easier entanglement of 
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the PEO chains in the solution, and thus, the micelles and early-stage particles aggregate 
to become wider. On the other hand, Zr-SBA-15 produced with SMS showed lower 
microporosity also causing lower SSA. The dropped microporosity is due to the silica 
clusters being readily formed in the pre-hydrolized SMS which cause a rapid silica 
formation. As a result, the silica network formation terminates before PEO chains can 
penetrate into the silica walls. This rapid formation of SMS based Zr-SBA-15 has shown 
its impact also on the pore size. When SMS was used, the mesopores were observed to 
have smaller diameter since there was not enough time for heptane to penetrate the centers 
of the micelles to cause swallowing and pore enlarging, as in the case of TEOS based Zr-
SBA-15. Moreover, TEOS can also act as a swelling agent causing further pore enlarging 
which is not the case for SMS. The use of SMS as the silica precursor also resulted in 
weaker bonds of the Zr atoms to the SiO2 framework. The Cu reduction and re-oxidation 
were detected to be more efficient for SMS particles compared to TEOS particles. This is 
attributed to the weaker surface interaction of SMS with the Cu NPs compared to TEOS 
which facilitatess the reduction efficiency of the Cu nanoparticles. Using TEOS as the 
silica precursor in the Cu-Zr-SBA-15 catalyst was shown to provide a higher concentration 
of surface acid sites which ultimately results in a higher total CO2 conversion compared to 
SMS. 
As for the Cu infiltration methods, Inf method has yielded lower Zr content, smaller 
surface as well as less surface -OH groups compared to EIWI catalysts. Also, the reaction 
results have demonstrated that the Inf method promotes higher selectivity for DME than 
methanol. This is attributed to the higher strength of the medium acid sites of Inf which 
have more affinity for methoxy than the weaker ones which can adsorb hydrogen. As the 
surface methoxy concentration becomes higher for Inf methods, DME can be formed from 
two surface methoxy groups interacting with each other. It was shown in this paper that 
the medium acid sites were determined to be the most effective among the others in both 
activity and selectivity in CO2 hydrogenation whereas the strong acid sites can promote 
methanol selectivity and the weak acid sites do not show any considerable activity. 
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6.3 Paper 3 
Time evolution of the CO2 hydrogenation to fuels over Cu-Zr-SBA-15 catalysts 
In Paper 3, the time evolution of catalytic CO2 hydrogenation to methanol and dimethyl 
ether (DME) has been investigated at 250°C and 33 bars in a closed batch reactor where 
products accumulate over time. Two types of Cu-Zr-SBA-15 were prepared with the 
chemical routes described in Paper 1 and Paper 2. TEOS was used as the silica precursor, 
and Cu nanoparticles were loaded into the Zr-doped SBA-15 matrix with both Inf and 
EIWI methods in order to compare the trends of different reaction systems. The catalysis 
results were compared with the thermodynamical equilibrium calculations. 
The Cu-Zr-SBA-15 catalyst produced via Inf method has yielded 24 % CO2 conversion to 
methanol and DME. This percentage was shown to be the thermodynamically highest 
theoretical conversion where only DME and methanol are the products. When the EIWI 
Cu loading method was used, the resulting catalyst was methanol selective. In this case, 
when DME is not formed, calculations indicate CO as a product suggesting its 
involvement in DME formation. In both cases, several other molecules (such as methane, 
methyl formate, and butane) were detected on the catalyst surface by DRIFTS method. 
However, these molecules were, interestingly, not observed in the final gas mixture which 
was analyzed by GC-MS. Theoretical calculations showed that in case of formation of any 
(one or more) of these molecules, no conversion to methanol and DME is possible. 
Therefore, we concluded that the Cu-Zr-SBA-15 catalysts used in this study were not 
selective for any of the aforementioned molecules.  
DRIFTS measurements also showed increased surface CH3O- formation which drops 
during the reaction for the catalyst prepared via Inf method. EIWI, on the other hand, 
demonstrated a lower CH3O- concentration which stayed stable during the whole reaction 
where methanol was being formed. Therefore, we inferred that DME was formed by two 
CH3O- molecules reacting with each other, as also mentioned in Paper 2. The difference 
in the surface methoxy concentration is attributed to the strength of the medium acid sites 
which demonstrate a higher affinity for methoxy as they become stronger.  
The time evolution of methanol and DME formation was determined to be a sigmoidal 
function which indicates a seeding period followed by acceleration and deceleration until 
an equilibrium value is reached. The importance of seeding was also proven by repeated 
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reactions using a reacted catalyst isolated from the atmosphere. Methanol formation was 
determined to be faster than DME since it requires only one methoxy formation, rather 
than two. Since DME is formed of two methoxy groups, a higher surface methoxy 
concentration, i.e., a higher seeding duration, is needed.  
After the half-time of the reaction (7 days), the conversion increased from 20% to 24% 
which is a rather small contribution. It indicates that finalizing this reaction at its half-time 
can cut the energy usage by half but sacrifice only 4% of the total conversion. This is an 
important finding not only from economical but also from an environmental point. 
6.4 Paper 4 
Cu and Zr modified SBA-15 as drug carriers 
Mesoporous silica has potential use in the biomedical field as a drug carrier. Thus, a 
modified form of SBA-15 was investigated in Paper 4 as the means of releasing 
Chlorhexidine digluconate (CHX), an antibacterial drug. 
For this study, SBA-15, Zr-doped SBA-15, and Cu nanoparticle infiltrated Zr-doped SBA-
15 were prepared with the chemical routes described in Paper 1 and investigated as drug 
carriers. TEOS was used as the silica precursor, and Cu nanoparticles were loaded on the 
Zr-doped SBA-15 matrix by an infiltration procedure.  
The prepared materials were loaded with a 2% CHX solution and yielded a loading 
percentage of 25-40%. The chemical bonding between the drug and the carrier was 
confirmed by FTIR via N-H and O-H vibration bands. Cu and Zr contents of the carrier 
were observed to increase the drug loading amount per unit surface. This was attributed 
to increased surface active sites and enhanced acidity which improves the attraction of the 
drug molecules on the carrier walls. The same trend was also shown in released drug 
percentage which was the highest for SBA-15 (65%) and the lowest for Cu-Zr-SBA-15 
(28%), indicating better drug affinity to the carrier when Zr and Cu were added to SBA-
15.  
Drug release was shown to occur into two stages: a burst release and a slower release. Burst 
release involves the drug molecules which are weakly held inside the drug carrier whereas 
the slower release occurs while the drug molecules held on the carrier surface are desorbed. 
It was observed that for Cu-Zr-SBA-15 and Zr-SBA-15 the second stage is dominant. This 
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indicates that Zr and Cu improved the drug attachment to the carrier framework and thus, 
slowed down the drug release which is attributed to enhanced acidity. This effect was 
observed for Cu more dramatically due to its particle morphology which cause partial 
blockage in the pores.  
Antibacterial properties were investigated against Staphylococcus aureus and Escherichia 
coli qualitatively and quantitatively by employing agar diffusion. It was found that the 
release from Cu nanoparticles was too low to cause a considerable boost in the 
antibacterial properties. The antibacterial inhibition was observed to be in line with the 
released amounts. The quantitative antibacterial measurements showed that the 
maximum antibacterial efficiency was achieved between the first 2-6 hours for all the 
carriers. However, it dropped for Cu-Zr-SBA-15 after a while due to the lower amount of 
released CHX.  
6.5 Paper 5 
Tuning the pore size of a mesoporous carrier as means for control of antibiotic release  
The study reported in Paper 4 was complemented with Paper 5 where SBA-15 was used 
as a drug carrier and the effect of its pore size on the control of the release of doxycycline 
hyclate (Doxy), an antibiotic widely used in dental applications, was investigated. 
In this study, the pore size of the SBA-15 carrier was tuned between 6.5 and 14.0 nm by 
changing the synthesis conditions such as temperature and time. The SBA-15 particle 
morphologychanged from platelet to rods under different synthesis conditions as the 
pores got wider. Also, specific surface area and microporosity dropped as the pore size got 
bigger whereas the wall thickness increased. 
This study showed that the pore size has a strong effect on the amount of the drug loading 
on SBA-15. As the pore size increased, the drug loading was observed to increase linearly. 
On the other hand, the effect of the pore volume as well as the specific surface area on the 
drug loading amount was found to be minimal. 
All the drug release profiles were observed to be diffusion controlled, i.e. burst release. The 
release rates were found to be inversely proportional to the drug loading per pore volume, 
i.e. drug concentration. This indicates a slower drug release as the drug concentration in 
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the pores gets higher. We inferred this behaviour to  the drug-drug interactions dominating 
the release profiles due to weak drug-carrier attachment. 
All the drug loading was released for 14 nm pore-sized sample whereas some sample 
entrapment was observed for 11.5 nm, and 6.5 nm pore sized samples. This was inferred 
to the changing microporosity. 
Finally, the antibacterial activity against Staphylococcus aureus and Escherichia coli was 
observed to follow the drug release amounts, i.e., pore sizes. 
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7 
CONCLUSIONS AND FUTURE WORK 
 
In this work, SBA-15 and its modified forms as Zr-SBA-15 and Cu-Zr-SBA-15 were 
prepared and their structural properties as well as their activity in catalysis and drug 
delivery were investigated. I believe these applications can be taken further in more multi-
disciplinary environments. Moreover, the modifications for SBA-15 can be varied to 
obtain additional/tunable properties in different application areas such as catalysis and 
drug delivery. 
In Paper 1-3, SBA-15 and Zr-SBA-15 were synthesized with different pore sizes and 
morphologies by changing synthesis conditions. For all studied conditions, these materials 
have shown narrow pore size distributions, hexagonal pore arrangements, and large 
specific surface areas. In Zr-SBA-15, Zr was incorporated into the SBA-15 framework 
whereas in Cu-Zr-SBA-15, Cu was incorporated by growing as nanoparticles with a 
diameter smaller than 10 nm in the pores of Zr-SBA-15. Cu-Zr-SBA-15 was later shown to 
be catalytically active and can promote CO2 hydrogenating into DME and methanol. The 
highest thermodynamically possible CO2 conversion to DME and methanol, which is 
24%, was achieved. Changing the silica source and Cu loading procedure, the catalytic 
activity and selectivity between DME and methanol was modified. The time evolution of 
the CO2 hydrogenation have shown that methanol formation is faster than DME. High 
methanol selectivity requires sufficient surface H affinity, whereas high DME selectivity 
requires high surface methoxy concentration. It was concluded that methoxy can join the 
formation  of DME without going through hydrogenation into a methanol molecule. On 
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the other hand, the equilibrium point of the conversion was achieved only after 14 days. 
The slow evolution is due to two reasons: 1) a batch reactor is used for this reactor where 
each molecule of a product works against the CO2 conversion, and 2) pressure was as low 
as 33 bars. 
As the future work, I suggest a full study employing a flow type reactor which can improve 
the reactant-catalyst contact and help to remove the products from the catalyst 
environment simultaneously. On the other hand, under 50 bars it was shown to improve 
the total CO2 conversion. A full study for the conversion and selectivity at 50 bars or higher 
should be conducted. Our findings can guide all this suggested conversion improvement 
efforts. Synthesis-wise, Cu-Zr-SBA-15 systems should further be investigated by using 
different elements such as Ni or Co. Also as the dopant, Zn or Al can be used in different 
combinations. As the next step, the industrialization process should take place where the 
studied catalyst powders can be brought to disc forms and appropriate catalytic systems 
possibly composed of recycling and additional columns installed in series to the reactor 
for separation of fuels such as methanol and DME. 
A Cu-Zr-SBA-15 material prepared within this thesis work was shown in Paper 4 to 
respond well as a drug carrier. Cu and Zr components were shown to slow down the drug 
release and improve the drug loading. Moreover, when Cu was prepared as nanoparticles, 
the resulting ion release was different from a simple ion doping. Paper 5 have 
demonstrated that changing the pore size of SBA-15 can affect the drug loading and release 
amount directly. To achieve a final drug delivery device in the future, the Cu-Zr-SBA-15 
powder should further be treated since dental procedures require well mixing of the drug 
loaded SBA-15 particles with the dental composite is crucial. Also, in vivo pharmacological 
tests and toxicity measurements are important for future applications. 
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Zr doped SBA-15; Cu nanoparticles; CO2 hydrogenation; methanol; dimethyl ether 
ABSTRACT: A catalytic assembly consisting of Zr-doped mesoporous silica (Zr-SBA-15) supports with intergrown Cu nanoparticles was 
used to study the effects of its chemical states on CO2 hydrogenation. The chemical states of the final material was altered by using tetraethyl 
orthosilicate (TEOS) or sodium metasilicate (SMS) as the silica precursor in the synthesis of the Zr-SBA-15 framework, and infiltration (Inf) 
or evaporation induced wetness impregnation (EIWI)) as the Cu loading method. It was found that the silica precursor mainly affects the 
activity of the catalyst whereas the Cu loading method alters the selectivity of the reaction products. Samples prepared with TEOS exhibit a 
higher catalytic activity compared to SMS materials due to different Zr dispersion and bonding to the silica matrix. Catalysts prepared by 
EIWI display selectivity for methanol formation, while the ones prepared by Inf enable methanol conversion to DME. This is correlated to a 
higher Zr content and lower Cu oxidation states of EIWI prepared catalysts. The results demonstrate the importance of taking the chemical 
state of a hybrid catalyst into account to control the yield and selectivity of the catalyzed reaction. 
1. INTRODUCTION 
The increasing concentration of CO2 in the atmosphere affects the 
global climate. To reverse this trend, two main world-wide strate-
gies are adopted: (1) reducing the amount of CO2 emissions by 
modifying processes or (2) eliminating/consuming the already 
emitted CO2 by introducing new processes[1,2]. In this respect, 
consumption of CO2 in processes such as hydrogenation is an 
important way to reduce the CO2 emission and instead convert it 
into valuable resources such as methanol and dimethyl ether 
(DME). Methanol, is a potent molecule, not only for use as a chem-
ical feedstock and solvent, but also as a H2 storing agent and a 
fuel[2–5]. DME can also be used as a fuel and to store methanol 
since methanol production from CO2 hydrogenation is thermody-
namically limited[6,7]. Potentially, many products may form when 
hydrogenating CO2, e.g. CO, CH4, ethanol, butane etc. and there-
fore a selective catalyst is needed. 
Among the metals studied so far, Cu with a favorable morphology 
integrated in a support has shown significant catalytic properties 
and remains as the main component of a heterogenous catalyst for 
CO2 hydrogenation[2,8–11]. In an integrated catalyst, SiO2 and 
ZrO2 are favorable supports and promoters for Cu due to their high 
chemical and mechanical stability, low price, lack of toxic effects, 
and contribution to the Cu dispersion efficiency[2,4,6,12–17]. 
Catalyst development typically relies on tailoring the properties of 
the support to add features for a targeted task[13,18–20], e.g. by 
introducing porosity to increase the surface area. Using SBA-
15[21], a mesoporous SiO2, as a support for Cu is a result of this 
strategy. SBA-15 offers a large specific surface area and its tunable 
pore size can be used to control the size of the nanoparticles (NP) 
grown in the pores. Moreover, it is possible to dope an alien atom 
into the SiO2 framework to introduce new properties. It has been 
shown that doping SBA-15 with Zr improves the catalytic activity 
due to promoted acidity of the catalyst and improved dispersion of 
the active Cu phase [14,22]. 
Various nanoassemblies based on SBA-15 have been reported in 
earlier studies[19,23,24]. However, systematic studies of how 
alterations of the chemical state of these catalysts affect CO2 hydro-
genation are sparse. In most studies where SBA-15 (doped or 
undoped) is used as the support, tetraethyl orthosilicate (TEOS) is 
used as the silica precursor[25]. TEOS is not toxic and it provides a 
robust formation route giving opportunity to physical alterations 
and atomic modifications without destroying the mesoporous 
framework[26–30]. It has also been reported that the cheaper 
sodium metasilicate (SMS) can be a good candidate to replace 
TEOS[31,32]. However, nanoengineering SBA-15 with SMS as the 
precursor remains a challenging task since SMS is a less studied 
reagent.  
The method for incorporating Cu in the porous network can also 
influence the physical characteristics of the catalytically active 
assembly. Wetness impregnation technique is one of the most 
common method for growing Cu NPs in a porous 
support[19,28,33,34]. In comparison, the infiltration method 
(Inf)[35] offers better Cu NP dispersion since functional groups 
are attached to the support surface. Another technique for Cu 
incorporation is evaporation induced wetness impregnation 
(EIWI)[36]. Despite the efficiency in Cu NP confinement to the 
pores and advantages in terms of price, time, health risks, and envi-
 ronmental hazardousness, EIWI has received less attention com-
pared to Inf.  
In this paper, a hybrid catalyst comprising of Cu NPs integrated 
into a Zr-SBA-15 mesoporous support has been synthesized using 
two different silica precursors (TEOS and SMS) and two Cu load-
ing methods (Inf and EIWI). The impact of the resulting different 
chemical states of the final nanoassembly on the physical character-
istics of the Zr-SBA-15 support and the resulting CO2 catalytic 
activity such as yield and selectivity are discussed. 
  
 
2. EXPERIMENTAL SECTION 
Pluronic P123 block copolymer (EO20PO70EO20, av. Mn~5800, 
Aldrich), ammonium fluoride (NH4F) (≥98.0%, puriss p.a., ACS 
reagent,Fluka), HCl (≥37.0%, puriss. p.a., ACS reagent, fuming, 
Sigma-Aldrich), heptane (99%, ReagentPlus®, Sigma-Aldrich), 
tetraethyl orthosilicate (TEOS, 98%, reagent grade, Sigma-
Aldrich), sodium metasilicate (Na2SiO3), zirconium(IV) oxychlo-
ride octahydrate (ZrOCl2·8H2O, ≥98.0%, puriss p.a., Sigma-
Aldrich), chlorotrimethylsilane (TMCS, ≥99.0%, Aldrich), (3-
aminopropyl)trimethoxysilane (APTMS, 97%, Aldrich), toluene 
(≥99.7%, puriss p.a., ACS reagent, reag. ISO, reag. Ph Eur, Sigma-
Aldrich), and copper(II) sulfate pentahydrate (CuSO4.5H2O, 
≥99%, ACS reagent, reag. ISO, reag. Ph Eur, Sigma-Aldrich) were 
used as received. 
 
2.1.  Catalyst Synthesis 
The catalysts were prepared in two main steps. First Zr-SBA-15 
supports were synthesized which was followed by the incorporation 
of Cu NPs into the supports. 
The Zr-SBA-15 synthesis used is based on a method described 
elsewhere[37]. In a typical synthesis, 2.4 g of P123, 28 mg of NH4F 
and 0.74 g of ZrOCl2 were dissolved in 80 ml (for TEOS) or 66 ml 
(for SMS) of 1.84 M HCl at 20 °C. The silica precursor (5 ml of 
TEOS or 2.73 g of SMS pre-hydrolyzed in 14 ml of 1.84 M HCl) 
and 2 ml of heptane were mixed, added to the main solution, and 
vigorously stirred for 4 minutes. The final solution was kept under 
static conditions at 20 °C for 5 hours and then transferred to a 
PTFE flask for hydrothermal treatment at 100 °C for 24 hours. The 
final slurry was filtered and washed with deionized water. Parts of 
the recovered powder was calcined at 550°C for 5 hours for future 
analysis. The samples are labeled as [TEOS] and [SMS], according 
to the used silica precursor. 
Cu NPs were grown in the pores of the Zr-SBA-15 supports via two 
methods: infiltration (Inf) or evaporation induced wetness im-
pregnation (EIWI). Inf was performed by a selective functionaliza-
tion procedure[35,37] where the external surface of the Zr-SBA-
15-particle was passivated by attaching methyl (-CH3) groups and 
the internal pore walls were activated by attaching amine groups. 
For the external passivation, uncalcined Zr-SBA-15 was stirred into 
15 vol% TMCS in toluene with a concentration of 10 g/L at 80 °C 
for 8 hours under reflux. The suspension was then cooled down, 
filtered, and the recovered particles washed with toluene. The 
collected material was then calcined at 300°C for 5 hours. For 
internal activation, the TMCS treated sample was stirred in 6.25 
vol% APTMS in toluene with a concentration of 5.9 g/L for 24 
hours at room temperature. Excess APTMS was removed by 
soxhlet extraction for 5 hours. The suspension was then cooled 
down, filtered, and the recovered particles washed with toluene. 
For Cu incorporation, the functionalized material was stirred at a 
concentration of 20 g/L at room temperature in 0.06 M CuSO4 
overnight. The mixture was then filtered and the recovered parti-
cles washed with deionized water. The powder was then mixed (20 
g/L) with 0.1 M NaBH4 to reduce the Cu ions attached to the 
surface of the support. Finally the sample was calcined at 550°C for 
5 hours. The obtained samples are labeled as [TEOS_Inf] and 
[SMS_Inf]. 
EIWI was performed by mixing (20 g/L) calcined Zr-SBA-15 into 
0.06 M CuSO4. The mixture was stirred at 80 °C with the outlet 
open until all the water had evaporated. The powder was then 
mixed (20 g/L) with 0.1 M NaBH4 for Cu reduction. The resulting 
material was calcined at 550 °C for 5 hours and labeled as 
[TEOS_EIWI] and [SMS_EIWI]. 
 
2.2. Characterization 
The Cu NPs and the pore structure of Zr-SBA-15 supports were 
imaged by transmission electron microscopy (TEM) using a FEI 
Tecnai G2 operated at 200 kV. The samples were prepared by 
suspending the powders in ethanol and drop-vise placed on carbon 
coated copper grids.  
Imaging of the support and external Cu NP morphology was car-
ried out with scanning electron microscopy (SEM) using a LEO 
1550 Gemini operated at 3 kV and equipped with an Oxford X-Max 
80 energy dispersive x-ray spectrometer (EDS). For EDS analysis 
the SEM was operated at 20 kV. The EDS was calibrated using 6 
different powder mixtures of SiO2 and ZrO2 with known Si/Zr 
atomic ratios. 
A Micromeritics ASAP 2020 was used to measure the nitrogen 
physisorption isotherms at 196°C. The recorded data was used to 
extract the specific surface area (SSA) with the Brunauer Emmet 
Teller method[38] within a P/P0 interval of 0.08-0.16, and the total 
pore volume at P/P0=0.997. The pore size distribution was calcu-
lated using the Kruk Jaroniec Sayari (KJS) method[39] at the 
adsorption branch of the isotherms. The micropore volume with 
calculated by t-plot method[40] . 
Fourier transformed infrared spectroscopy (FTIR) was performed 
in transmission mode for bond structure investigation. For this, a 
Bruker Vertex 70 device equipped with a LN2 cooled broad band 
MCT detector and a water cooled glowbar MIR source was used 
with 2 cm-1 resolution. The measurement was conducted on 
pressed KBr tablets containing 1 mg of sample. 
X-ray diffractometry (XRD) was performed using a Panalytical 
Empyrean x-ray diffractometer equipped with a Cu Ka x-ray source 
operated at 45 kV and 40 mA. Small angle x-ray diffractometry 
(SAXRD) was conducted in transmission mode at 0-2.5° for de-
termining the pore packing structure in the samples and extracting 
the unit cell parameter. The pore wall thickness was determined by 
subtracting the pore size from the unit cell parameters. The same 
equipment but operated in reflection mode was used to determine 
the crystalline structure of the Cu NPs. 
X-ray photoemission spectroscopy (XPS) spectra were recorded on 
a Kratos Ultra photoelectron spectrometer equipped with a mono-
chromated Al Kα (1486.6 eV) x-ray source operating at 150 W. 
The pressure in the analysis chamber was kept below 10-7 Pa at all 
times during the acquisition process. The experimental conditions 
were such that the full width at half maximum (FWHM) of Ag3d5/2 
peak from the reference Ag sample was 0.45 eV. High-resolution 
spectra of Cu2p and Zr3d core levels were recorded using a pass 
energy of 20 eV at θ = 0° take-off angle (angle between the speci-
 men surface normal and the detection direction). All spectra were 
calibrated in energy by setting adventitious carbon C1s at 284.7 eV 
(binding energy). In this study, no Ar-etching was carried out 
before spectra acquisitions. The data were treated with the Cas-
aXPS software, using Shirley backgrounds and a Gaussian-
Lorenzian (70-30 ratio) function to account for the different com-
ponents. 
NH3 temperature programmed desorption (NH3-TPD) measure-
ments were carried out using a Micromeritics 3-FLEX. The NH3-
TPD spectra were recorded with a thermal conductivity detector 
(TCD). Prior the measurements, each catalyst was reduced at 
400°C under a 100 ml/min hydrogen gas flow (4% in Ar), then 
cooled to 100°C, and exposed to NH3 with a constant flow of 10 
ml/min during 10 min. Afterwards, all catalysts were exposed to a 
constant helium flow of 10 ml/min for 1 hour at 100°C, in order to 
evacuate the physisorbed NH3. Finally, the temperature was 
ramped up to about 750°C at a rate of 10°C/min while recording 
the amount of desorbed ammonia.  
 
2.3. Catalytic activity 
The catalytic activity was analyzed in a high-pressure high-
temperature (HPHT) cell with a 13 mL total internal volume from 
Harrick Scientific. For each test, 0.4 g of catalyst material was 
pressed into discs, placed in the cell, and reduced under H2 flow at 
400 °C for 9 hours. The temperature was then reduced to 250°C 
and CO2 and H2 were fed into the cell at a molar ratio of CO2/H2  = 
1/3 to a total pressure of 33 bar. The reaction was monitored for 5 
days during which the reactants and products were analyzed in-situ 
by diffuse reflectance infrared Fourier transform spectroscopy 
(DRIFTS) using the previously described IR-spectrometer. Spectra 
were acquired with a 4 cm-1 resolution and each spectrum is an 
average of 128 scans. KBr was used as background.   
A Bruker 450-GC gas chromatograph equipped with a flame ioniza-
tion detector (FID) and a Bruker SCION mass spectrometer (GC-
MS) was used for determining the conversion of CO2. For this, the 
resulting gas mixture was transferred from the HPHT cell to the 
GC-MS in three portions. The molar content in each portion was 
measured and the average of the measured concentrations was used 
to calculate the CO2 conversion to DME and methanol (MeOH). 
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where CP is the molar concentration (%) of the product(s) of 
interest in the final gas mixture and CRr is the molar concentration 
of all other spices in the final gas mixture.  Therefore the ‘conver-
sion%’ in Eq (1) represents conversion to the chosen products 
only. Accordingly, for our experiments, the conversion% values are 
calculated using Eq (2), (3) and (4) below.  
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3. RESULTS 
Figure 1 shows the morphology of the Zr-SBA-15 synthesized with 
TEOS (Figure 1(a)) and SMS (Figure 1(b)). [TEOS] displays 
monodispersed particles with rod morphology whereas [SMS] 
consists of particles with a platelet morphology.  
Both materials show similar 500±100 nm particle heights, i.e. pore 
lengths, but different cross sectional diameters: 400±100 nm for 
[TEOS] and 2.5±0.5 µm for [SMS].  
 
Figure 1. SEM micrographs of Zr-SBA-15 samples: [TEOS] (a) 
and [SMS] (b), and the Cu-Zr-SBA-15 samples [TEOS_Inf] (c), 
[TEOS_EIWI] (d), [SMS_Inf] (e), and [SMS_EIWI] (f).  
 
Table 1. The physicochemical properties of the as-synthesized materials. 
Sample Name Si/Zr ato-mic ratio 
Mean Cu 
weight % 
Specific Surface 
Area (m2/g) 
Pore size 
(nm) 
Pore volume 
(cm³/g) 
Micropore volume 
(cm³/g) 
d-spacing 
(nm) 
Wall thickness 
(nm) 
[TEOS] 10.8 - 736 14.8 1.3 0.05 16.0 1.1 
[SMS] 10.2 - 482 11.7 0.9 0.00 12.7 1.0 
[TEOS_Inf] 19.0 12.7 422 13.3 0.8 0.02 15.8 2.5 
[SMS_Inf] 28.3 14.6 450 10.9 0.7 0.00 13.0 2.1 
[TEOS_EIWI] 11.3 15.6 316 13.0 0.8 0.00 14.9 1.9 
[SMS_EIWI] 11.5 15.6 279 9.7 0.6 0.00 11.5 1.8 
 
 
 Figure 2. TEM micrographs of [TEOS_Inf] (a), [TEOS_EIWI] 
(b), [SMS_Inf] (c), and [SMS_EIWI] (d).  
 
SEM micrographs of the as-synthesized Cu-Zr-SBA-15 catalysts are 
presented in Figure 1(c-f). Formations of Cu NPs on the outer 
surface (external Cu NPs) of the Zr-SBA-15 supports were ob-
served for all materials. The concentration of external Cu NPs is 
higher for SMS materials than TEOS, while no distinct difference 
was observed for the two Cu-loading methods. TEM micrographs 
in Figure 2 show the porous network of Zr-SBA-15 with cylindrical 
pores hexagonally packed parallel to each other as well as the inter-
nal Cu NPs in all the supports. No alteration in the morphology of 
Zr-SBA-15 particles could be observed upon growth of Cu NPs.  
The Si/Zr atomic ratio was found to be ~10 for both [TEOS] and 
[SMS] prior to Cu loading, indicating a complete incorporation of 
Zr into the mesoporous silica framework (Table 1). A similar value 
was also found for EIWI materials, whereas half of the Zr was lost 
during Cu loading by the Inf method (Table 1) due to the high 
elution strength of toluene[37]. The Cu-content was found to be 
between 12 and 16 wt.% for all samples. 
Nitrogen sorption measurements show type IV isotherms for both 
unloaded and Cu-loaded supports with type 1 hysteresis loops, 
characteristic for mesoporous materials with open cylindrical 
pores[41] (Figure 3(a,b)). After Cu-loading, the desorption 
branch of the hysteresis loop is distorted as a result of blockage of 
Cu NPs present inside the mesopores[19,42–44]. The narrow pore 
size distributions (Figure 3 (a,b)) confirm uniform pore size for all 
materials. As expected, the pore size decreases slightly when Cu 
NPs are present. The textural parameters of all synthesized samples 
are summarized in Table 1 including pore size, specific surface area 
(SSA), and pore volume. These parameters are higher for all TEOS 
samples compared to SMS samples and all decrease upon Cu-
loading.  
Figure 3(c,d) shows FTIR transmission spectra of unloaded and 
Cu-loaded Zr-SBA-15 supports. All the FTIR spectra show an 
absorption band at around 975 cm-1, which is assigned to the Zr-O-
Si bond[14,45,46]. All the other bands, 465, 801, 1085, and 1230 
cm-1 are typical for SBA-15 supports and attributed to the bending 
vibration of Si-O-Si bonds[47,48]. The band at 1640 cm-1 and the 
broad peak between 3200-3600 cm-1 are assigned to the H-O-H 
symmetrical vibrations of adsorbed water and the hydroxyl groups 
on the silica surface[33,49], respectively. The intensity (I) of these 
peaks varies as IInf>IEIWI>Iunloaded support for both TEOS and SMS sam-
ples. After Cu loading, all the main bands are still present with the 
addition of a band at about 590 cm-1 which is ascribed to Cu-
O[50,51].  
The SAXRD diffractograms (Figure 3(e)) of [TEOS] and [SMS] 
display one intense 100 reflection and three smaller peaks assigned 
as 110, 200 and 210. This confirms the ordered, 2-dimensional, 
hexagonal pore structure. These peaks remain upon Cu loading 
even though the intensities decreased for [SMS] samples.  
The d-spacings and the extracted wall thicknesses are listed in 
Table 1. Cu-loading by EIWI decreased the d-spacings while Inf 
did not affect the d-spacings (Table 1). The wall thickness in-
creased upon Cu loading, and more so for samples prepared by the 
Inf method compared to the EIWI method (Table 1). 
The x-ray diffractograms of the as-synthesized Cu loaded catalysts 
are shown in Figure 4(a). All observed peaks stem from copper 
oxide, CuO (PDF#00-048-1548), except [SMS_EIWI], which 
shows additional peaks from ZrO2 (PDF#01-079-1764) at 30.2° 
and 50.2° 2θ. The presence of ZrO2 in the [SMS_EIWI] indicates 
inhomogeneous Zr-doping or aggregation of Zr-O during the Cu-
loading. XRD diffractograms of reduced samples (Figure 4(b)) 
display the presence of Cu metal (PDF#00-004-0836) in 
[SMS_Inf], [TEOS_EIWI] and [SMS_EIWI], indicating a nearly 
complete reduction of the Cu NPs. However, in [TEOS_Inf], 
traces of CuO could still be observed. 
XPS results of Zr 3d3/2 and 3d5/2 core levels (Figure S1 in the Sup-
porting Information) indicate the existence of Zr-O bonds in all the 
samples in their as-synthesized and reduced forms. Representative 
XPS core-level Cu 2p spectra of as synthesized Cu/Zr-SBA-15 
samples (Figure 4(c)) reveal the presence of Cu with different 
oxidation states. All Cu 2p spectra exhibit a main peak at 933.5 ± 
0.2 eV accompanied by shoulders at 935.2 ± 0.2 eV and at 932.3 ± 
0.3 eV, indicating contributions of Cu2+, Cu3+ and Cu+ species, 
respectively[52–55]. However, it is not possible to distinguish Cu0 
from Cu+ at 932.2-932.4 eV because of their spectral overlap[56]. 
This peak is therefore labeled as Cu+/Cu0. The strongest signal is 
seen for Cu2+ while Cu3+ and Cu+/Cu0 are weaker, which is in a 
good agreement with the XRD results. The content of each Cu 
oxidation state was determined by fitting the spectrum with three 
component curves (see Figure S2 in the Supporting Information) 
and calculating the relative peak areas. The results of these calcula-
tions are presented in Figure 4(e). Accordingly, the relative high 
contribution of Cu2+ (~59 %) and Cu3+ (~34 %) species in all XPS 
spectra implied that the Cu is present in its high oxidation states 
while the contribution of Cu+/Cu0 peak was only ~7 %. The contri-
bution from each Cu state was similar for all as-synthesized materi-
als, independent of the preparation procedure. These results to-
gether with XRD analysis confirm successful incorporation of CuOx 
species within the structure of the Zr-SBA-15 supports for both Inf 
and EIWI methods. After the reduction, the main Cu XPS peak was 
observed to shift to lower binding energies for all the samples (Fig-
ure 4(d)) indicating an increase in the reduced state of the Cu NPs. 
The relative contents of the Cu oxidation states after the reduction 
were extracted from the Cu 2p XPS spectra (Figure 4(d)) and 
presented in Figure 4(f). It is observed that the degree of reduction 
depended on the silica precursor. For both SMS samples, 60% of 
the Cu NPs (within the near surface sampling volume of XPS) 
displayed Cu+/Cu0 as the oxidation state and the rest was Cu2+ after 
reduction. For TEOS samples, the oxidation states of 40% of the 
NPs were Cu+/Cu0 and the remaining was in higher oxidation 
 form. This demonstrates that a more efficient reduction was 
achieved for SMS compared to TEOS samples, which indicates 
different surface reactivity of the Cu NPs depending on the sup-
port. The lower reducing degree of Cu in the TEOS samples sug-
gest a stronger interaction between the Cu NPs and the [TEOS] 
support compared to [SMS] support[57,58]. 
 
Figure 3. Pore size distributions and isotherms (a,b), FTIR spectra 
(c,d), SAXRD diffractograms (e) of the materials. 
 
Figure 6 summarizes the CO2 conversion efficiency of as-
synthesized Cu-Zr-SBA-15. The catalytic tests reveal that the main 
products from the CO2 hydrogenation were methanol and DME. 
GC-MS showed the existence of other hydrocarbons and alcohols 
such as propane, butane, methoxy ethane and methyl formate 
where each one contributed with less than 0.05 % to the total con-
version. These compounds are regarded as impurities in the final 
gas mixture. The chromatograms obtained by the flame ionization 
detector (FID) in GC are presented in Figure S3 in the Supporting 
Information.  
 
Figure 4. XRD diffractograms (a-b), Cu 2p core-level spectra (c-d) 
and the Cu oxidation states at the very thin surface (e-f) of the as-
synthesized (a, c and e) and reduced (b, d and f) catalysts. 
 
Figure 5. NH3-TPD profiles of the catalysts with horizontal offset.  
 
NH3-TPD profiles of the materials (Figure 5) reveal six distinct 
peaks distributed in three temperature ranges. The appearance of 
the peaks is due to NH3 desorption from acid sites that have differ-
ent strength. The peak positions represent the strength of this acid 
 sites whereas the intensities reflect the concentration of that specif-
ic acid site on the catalyst surface. 
The two peaks between 500-600 °C (HT) indicate the presence of 
strong acid sites, while the ones observed between 200-300 °C 
(MT) and 100-200 °C (LT) are attributed to the presence of me-
dium and weak acid sites, respectively[59,60]. All the Cu loaded 
catalysts, with the exception of SMS_EIWI, exhibit a large amount 
of strong acid sites, which is seen by the strong intensity of the HT 
peaks. This is in contrast to the SMS_EIWI sample which reveals 
the unique presence of only weak acid sites by displaying just LT 
peaks. This suggests a strong influence on the catalytic activity by 
the medium and strong acid sites since the CO2 conversion of 
SMS_EIWI is very low. The MT peaks of TEOS_Inf appear at a 
higher temperature than the corresponding peaks of SMS_Inf and 
TEOS_EIWI, revealing a higher strength for the medium acid sites 
of TEOS_Inf. The strong acid sites for TEOS_EIWI and SMS_Inf 
have higher strength compared to TEOS_Inf.  
The intensity of the peaks (area under the graph) of the NH3-TPD 
experiment computed for two temperature ranges (100-400 and 
400-750 °C) are presented in Table 2. Accordingly, TEOS sup-
ports display a higher total intensity compared to SMS supports for 
the same Cu loading method indicating a higher number of acid 
sites. The intensity between 400-750 °C is similar between 
TEOS_Inf, SMS_Inf and TEOS_EIWI, which means that all these 
samples have similar concentration of strong acid sites. The con-
centration of medium acid sites is promoted by the EIWI method. 
 
Table 1. Intensities of the NH3-TPD curves 
Sample Name Intensity (100-400 °C)  Intensity (400-750 °C) 
[TEOS_Inf] 67.1 236.3 
[SMS_Inf] 41.4 211.2 
[TEOS_EIWI] 91.7 242.3 
[SMS_EIWI] 107 41.7 
 
Figure 6 shows that both CO2 conversion efficiency and product 
selectivity are strongly affected by the synthesis methods of the 
nanoassembly. For catalysts prepared via the Inf method, the one 
having TEOS as the silica precursor exhibits up to 15% CO2-
conversion, which is nearly twice the conversion obtained for cata-
lysts prepared with SMS (~9%). A similar trend can also be seen for 
catalysts prepared by EIWI, i.e. low catalytic activity (0.4%) for 
[SMS_EIWI] compared to ~6.5% for [TEOS_EIWI]. Also cata-
lysts synthesized by EIWI demonstrated a higher selectivity for 
methanol formation during the CO2 conversion, while catalysts 
fabricated via Inf produced more DME.  
 
 
Figure 6. CO2 conversion to methanol and DME for the prepared 
catalysts. 
The chemical reactions which take place on the catalyst surface 
during CO2 hydrogenation were investigated by DRIFTS (Figure 
7). [TEOS_Inf] and [SMS_Inf] show a DME peak at 2890 cm-1 for 
the 2δ(CH3) vibrational mode[61]. This peak is not present in the 
spectra from [TEOS_EIWI] and [SMS_EIWI] (Figure 7), which 
corresponds well with the conversion results (Figure 6). Compar-
ing the DME peak intensity relative to the methoxy peak, the 
amount of DME relative to methanol is higher for [TEOS_Inf] 
than for [SMS_Inf], This is also in good agreement with the con-
version results (Figure 6). The surface reactions on the 
[TEOS_EIWI] catalyst were the most rapid ones, indicating fast 
formation of methanol. [TEOS_Inf] showed a more gradual con-
version (Figure 7) indicating slower synthesis of DME compared 
to methanol. Methane was detected at 3015 cm-1 (Figure 7) but 
there was no trace of methane in the GC-MS measurements. The 
ratio of the methane peak at 3015 cm-1 to the methoxy peak at 2854 
cm-1 is considerably higher in [SMS_Inf] and [SMS_EIWI] than in 
the TEOS samples. This indicates that when the catalyst is based 
on SMS, a higher concentration of surface methane is formed. All 
the other peaks appearing in Figure 7 correspond to the impurities 
detected by GC-MS and are listed in Table S1 in the Supporting 
Information. 
 
Figure 7. DRIFTS spectra of the chemical groups detected on the 
catalyst surface during the CO2 hydrogenation reaction. Each line 
represents 8 hours progress from t=0 h to t=120 h. 
 
 To investigate the phase changes of the Cu NPs upon CO2 hydro-
genation, all catalysts were re-analyzed by XRD and XPS. Figure 
8(a) represents the X-ray diffractograms of the catalysts after the 
CO2 conversion. It is noted that the Cu oxidation levels change in 
all the nanoassemblies after the reaction. [TEOS_Inf] shows a 
weak CuO peak similar to its reduced form (Figure 4(b)) while 
[SMS_Inf] and [TEOS_EIWI] both display Cu2O and Cu metal. 
[SMS_EIWI] exhibits a very similar XRD pattern as the one rec-
orded from the as-synthesized material, i.e. peaks attributed to 
CuO and ZrO2 (Figure 4(a) and 7(c)). This indicates complete 
reversibility of the reduction process for [SMS_EIWI], which was 
not the case for the other samples. In addition, crystalline ZrC 
(PDF#03-065-9888) appeared on [SMS_Inf] and [TEOS_EIWI] 
after the reaction (Figure 8(a)).  
  
 
Figure 8. XRD diffractograms (a), Cu 2p core-level spectra (b), and 
Cu contents (c) of the catalysts after reaction. 
 
The Cu 2p3/2 core-level spectra of the used catalysts are presented 
in Figure 8(b) and fractions of the different Cu oxidation states are 
shown in Figure 8(c). After the CO2 hydrogenation, the chemical 
environment of Cu includes all its oxidation states: Cu+3, Cu2+ and 
Cu+/Cu0, where Cu2+ is the most dominant. This is similar to the 
as-synthesized catalysts (Figure 4(c)), even though fractions vary. 
The only exception is [SMS_EIWI], which shows the same Cu 
oxidation state fraction as for the as-synthesized, which is in accord 
with the XRD results in Figure 8(a).  
Comparing the fractions of the Cu oxidation states in the as-
synthesized and reduced samples (Figure 4 (d,f)) with the used 
catalysts (Figure 8(b,c)) yields Cu NPs in the SMS samples re-
oxidize during (or after) the CO2 hydrogenation to a higher degree 
compared to those in TEOS samples. This again indicates a higher 
surface reactivity of Cu NPs on SMS supports compared to TEOS 
supports. We attribute this to a stronger interaction between TEOS 
supports and the Cu NPs, similar to what was seen for reduced 
samples[57,58]. When comparing TEOS supports, Cu NPs in 
[TEOS_Inf] re-oxidize to a higher extent than Cu NPs in 
[TEOS_EIWI]. This suggests that DME formation contributes to 
the catalyst’s surface oxidation, since [TEOS_Inf] produces DME 
while [TEOS_EIWI] is selective to methanol. 
A ZrO2 phase as well as indications of Zr0 metal were also observed 
in the used catalysts (Figure S1 in the Supporting Information).  
 
 
4. DISCUSSION 
In this work, different chemical states of Cu loaded Zr-SBA-15 
supports and their effects on the catalytic activity during CO2 hy-
drogenation were studied. The different chemical states were ob-
tained by changing the silica precursor in the Zr-SBA-15 synthesis 
and the technique for loading Cu NPs in the supports. This is 
addressed in the first part of the discussions. In the second part, the 
effects of these alterations on the catalytic activity and selectivity in 
terms of CO2 conversion into methanol and DME, are discussed. 
 
4.1.  Synthesis of Cu-Zr-SBA-15 
Both TEOS and SMS silica precursors yield a Zr-SBA-15 material 
with hexagonally ordered pore structure and a similar Zr content. A 
morphological difference was observed. [SMS] has a larger particle 
cross-sectional diameter than [TEOS]. In addition, the pore size, 
microporosity and specific surface area (SSA) are larger for 
[TEOS]. 
The difference in the particle width is attributed to the lower PEO 
solubility of the micelle in the synthesis solution of [SMS]. The 
material formation occurs by silica oligomers attaching to the PEO 
corona of the micelles[62]. During the hydrolysis of SMS, NaOH is  
released as silica is formed, Eq.(5,6)[63,64].  G93H(2I + ;32 → ;3H(2I + 2G92;       (5) ;3H(2I + ;32 → H((2;)K         (6) 2LM + 2G92; → 2G9L +;32+ N323       (7)     
Formation of NaOH does not only reduce the acidity but it can 
also interact with F- ions in the solution (Eq. (7)). A decreased F- 
concentration results in an increased solubility of the PEO-chains. 
As a consequence, the elongated PEO-chains cause more micelles 
to aggregate due to entanglement[63,65], which causes a widening 
of the particles before the mesoporous structure of [SMS] is 
locked. Since Na is not part of the [TEOS] synthesis, less PEO-
chain entanglement occurs and the formed particles are more 
narrow. 
The microporosity is less for [SMS] than [TEOS] samples. Mi-
croporosity is typically induced by PEO-chains that remain pene-
trated in the silica walls during condensation[66]. Pre-hydrolysis of 
SMS results in pre-formed silica clusters and as this silica precursor 
is added into the synthesis the silica framework forms rapidly[67]. 
As a result, the PEO chains cannot penetrate into the silica wall as 
efficiently as in case of [TEOS]. A low level of microporosity causes 
a lower SSA of [SMS] compared to [TEOS]. 
The pore size is larger for [TEOS] compared to [SMS] because 
TEOS may act as a swelling agent in the synthesis solution prior to 
its hydrolysis. Not-yet hydrolyzed TEOS, due to its immiscibility in 
water, penetrates into the hydrophobic core of the micelles and 
results in larger pores[68]. SMS is miscible in water and does not 
act as a swelling agent. Additionally, expansion of the micelles by 
heptane occurs to a lower degree because of the rapid formation of 
[SMS]. 
Zr bonds stronger to the silica framework in [TEOS] compared to 
[SMS]. The weaker Zr attachment to [SMS] causes a larger loss of 
Zr in [SMS_Inf] than [TEOS_Inf] during Cu-loading. Inf is a 
method that previously has been shown to decrease the Zr content 
in a Zr-SBA-15 material due to high elution strength of the used 
toluene[37]. As a consequence, ZrO2 detached from [SMS_Inf] 
can form ZrO2 clusters and due to their low interaction with the 
SiO2 framework they can be reduced to Zr metal. The strong bond-
ing of Zr to [TEOS_Inf] prevents such reduction. This is further 
 corroborated by the observation of ZrO2-clusters with long-range 
order in [SMS_EIWI] and not in [TEOS_EIWI]. The reason for 
the poor Zr-interaction with the SiO2 framework of [SMS] can be 
traced back to the pre-hydrolysis of the SMS precursor. During the 
pre-hydrolysis, small silica clusters are formed, which reduces the 
Zr – Si interaction, and also causes a faster material formation 
which compromise the Zr incorporation.  
Cu NPs were grown in the Zr-SBA-15 supports without causing 
modification of the hexagonal pore order. The presence of Cu NPs 
results in a decreased SSA of the mesoporous material as they block 
some of the pores. Despite this, the number of -OH groups increas-
es by attachment to the not fully oxidized Cu NPs. However, be-
tween the Cu loading methods the number of -OH groups were 
higher for Inf compared to EIWI even though their Cu oxidation 
state fractions were similar. This is an effect of the overall higher 
SSA of Inf compared to EIWI. 
The wall thickness of the mesoporous supports increases when Cu 
loaded due to incorporation of Cu-atoms in the walls. It has been 
shown that adsorbed atoms on a surface can make their way into 
the body by displacing existing atoms in their way such that the 
displaced atoms now exist on the surface[69–72]. This leads to 
decreased pore size and increased wall thickness. This phenome-
non can also result in unexpected oxidations states, such as Cu3+ as 
the local chemistry surrounding the embedded atom affects the 
oxidation state. The higher level of Cu diffusion into the walls of 
[TEOS] is an indication of a stronger interaction between Cu NPs 
and the [TEOS] support, i.e. a stronger interface between the 
particle and the support resulting in a higher resistance against a 
reducing environment[57,58]. As a result of the difference in affini-
ties between particle and support and possible Cu diffusion into the 
walls, TEOS materials are reduced and re-oxidized (after the CO2 
conversion) to a less extent than SMS materials. The reason for the 
different affinity is not clear, but likely associated with the acidity of 
the support, as TEOS showed a higher surface acidity than SMS. 
Similarly, Cu atomic diffusion into the walls was slightly more 
favored for Inf compared to EIWI. This is in a good agreement with 
the fact that SSA for Inf samples are higher than EIWI due to better 
distribution of Cu on the support causing less pore plugs. 
 
 
4.2. Catalytic activity 
The good adhesion between the [TEOS] support and the Cu NPs 
have resulted in a more efficient collective CO2 conversion into 
methanol and DME compared to [SMS]-based assemblies. The 
selectivity for methanol and DME was also different for [TEOS] 
and [SMS]-based catalysts due to their distinct surface acidity. 
TEOS materials have shown to exhibit a higher amount of acid sites 
with a higher strength compared to SMS materials yielding DME, 
which is known to from by acid catalysts[73]. The different surface 
acidity is a consequence of the different synthesis solution envi-
ronment of [SMS] compared to TEOS. In the SMS synthesis, 
NaOH is a side product of [SMS] and more Zr is lost during Cu 
loading[37,74,75] compared to TEOS. The high concentration of 
surface methane groups on the SMS catalysts is also attributed to 
its low acidity. A high acidity causes methane decomposition[76] 
while improved catalyst basicity has been shown to increase the 
methane yield[77,78]. In addition, the formed methane can poison 
the catalyst and cause lower catalytic conversion rates.  
As for the Cu loading methods, the Inf method tends to promote 
higher CO2 conversion to DME whereas EIWI produced catalysts 
are highly selective for methanol formation. One reason for this 
difference in terms of catalytic selectivity can be the Zr content of 
the catalysts which is higher for EIWI compared to Inf. Zr contrib-
utes to the electron/oxygen mobility of Cu[79], and thus provides 
higher collective amount of weak and medium acid sites to the 
EIWI catalysts although they exhibit lower strength than the corre-
sponding sites in Inf. The weak acid sites do not impact the CO2 
conversion as evident from the low catalytic activity of SMS_EIWI. 
Instead, the difference in activity and selectivity of the catalysts 
mainly depends on the amount and strength of medium and strong 
acid sites.  
TEOS_EIWI has a high total concentration of acid sites and yields 
a high selectivity for methanol. This is a result of a sufficient 
amount of H attached to the catalyst sur-face to react with the 
surface methoxy groups and form methanol. In case of TEOS_Inf, 
a higher strength of the medium acid sites was observed compared 
to TEOS_EIWI. We note that as the strength of the medium acid 
sites increases the selectivity of the catalyst for DME formation 
increases. This is in accord with previous studies showing that 
DME is preferentially catalyzed at medium strength acid sites[59]. 
We then infer that a higher strength of the medium strength acid 
sites favors methoxy attachment caused by the increased attraction 
between the positively charged surface acid sites and the negatively 
charged methoxy groups. The improved DME selectivity is then 
caused by a higher sur-face methoxy concentration, which enhanc-
es the probability of neighboring methoxy groups to form DME 
(Figure 9). 
The relevance of acid site strength to the methoxy affinity is also 
corroborated by the XPS results from the reduced samples. Com-
parison of the same Zr-SBA-15 support shows that higher DME 
selectivity is caused by a less reduced sample, e.g. TEOS_Inf versus 
TEOS_EIWI. Catalysts with less reduction can demonstrate a 
higher concentration of surface Cu-O-H+ acid sites which donate 
protons and thus can couple with the negatively charged methoxy 
surface groups. On the other hand, more reduced catalysts would 
involve more unsaturated cationic acid sites (such as Cu+) which 
would strongly attract single-electron hydrogen.  
[TEOS_Inf] is more re-oxidized compared to [TEOS_EIWI] after 
the CO2 hydrogenation reaction This is due to the DME formation 
on the catalyst surface of [TEOS_Inf] which leads to re-oxidation 
of the reduced Cu species. It has previously been proposed[80] 
that DME can be converted directly from methoxy without going 
through the methanol formation step, which causes excess oxygen 
atoms to remain on the catalyst surface with a mechanism shown in 
Eq. (8) and Figure 9. Such reaction promotes re-oxidation of the 
reduced catalyst.  !;I2M +	!;I2M 	→	!;I2!;I +	23M         (8) 
 
 
 
Figure 9. Catalyst surface reactions during CO2 hydrogenation. 
  
 
5. CONCLUSIONS  
Zr-SBA-15 was synthesized using two different silica precursors: 
TEOS and SMS, and was loaded with Cu using two different meth-
ods (Inf and EIWI). TEOS yields materials with larger pores, spe-
cific surface area, and microporosity compared to SMS whereas 
[SMS] particles are wider compared to [TEOS] particles. Cu NPs 
grown in the pores of the supports cause a reduction in the specific 
surface area and pore size, as well as wall thickness increase due to 
Cu atomic diffusion into the walls. All the nano-assemblies show 
catalytic activity in CO2 hydrogenation but with different level of 
activity and selectivity due to their different chemical states. SMS 
samples exhibit lower catalytic activity compared to TEOS samples 
due to a lower Zr content, lower acid site content, and formation of 
methane. The interaction of the Cu NPs with the support surface 
affects the reducibility and thus the performance in terms of cata-
lyzing CO2 hydrogenation. The Inf method yields DME and meth-
anol with higher selectivity for DME whereas EIWI selectively 
produces methanol. DME formation from two methoxy molecules 
on the catalyst surface causes re-oxidation of the Cu and points out 
the possibility of direct DME synthesis, bypassing the methanol 
formation step. 
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Figure S4. Comparative XPS spectra for Cu (a) and Zr (b) of catalysts [TEOS_Inf], [SMS_Inf], [TEOS_EIWI] and [SMS_EIWI]: as-
synthesized (BR: before reaction), after reduction (A_red) and reacted (AR: after reaction). 
The Cu 2p and Zr 3d core levels spectra are presented in the Fig S3.(a) and (b). All the Cu 2p spectra exhibit three main features: a main peak 
located at ~933.4 eV, a second peak at ~935.2 eV and a shoulder at ~932.3 eV. According to the literature, all the contributions are attributa-
ble to Cu atoms engaged in Cu-O frameworks with different oxidation states: Cu2O (Cu+) for the shoulder, CuO (Cu2+) for the major peak 
and Cu2O3 (Cu3+) for the second peak at higher energy. The main Cu peak is fitted to these components as presented in Figure S4. The Zr 3d 
spectra show a sharp doublet shape at ~ 182.6 eV and ~184.6 eV due to the spin-orbit splitting into the Zr 3d 5/2 and Zr 3d 3/2 which can be 
assigned to zirconium atoms belonging to the Zr-O framework (ZrO2)1,2.    
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Figure S2. Cu 3p core-level spectra of catalysts [TEOS_Inf], [SMS_Inf], [TEOS_EIWI] and [SMS_EIWI]: before (a) and after reaction (b) 
with the corresponding spectra deconvolution. 
 
 
Figure S3. FID chromatograms obtained from GCMS. 
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Table S1. Peak identification of DRIFTS spectra. 
Wavenumber (cm-1) Compound ID Wavenumber (cm
-1) Compound ID Wavenumber (cm
-1) Compound ID 
3730 CO2 2947 
Methanol 
Butane 
Propane 
2845 Methanol 
3702 CO2 2935 
EME 
Butane 
Propane 
MF 
2834 
DME 
EME 
Methanol 
3627 CO2 2926 
Methoxy 
DME 
MF  
2818 Methoxy DME 
3597 CO2 2918 DME 2806 Methoxy 
3015 methane MF  2907 
EME 
Ethanol 2388-2281 CO2 
2978 
Methanol 
EME  
Ethanol  
Butane  
Propane 
2890 
DME 
EME 
Ethanol 
Butane 
2177 CO 
2967 
Methanol 
EME 
Ethanol 
Butane 
Propane 
MF 
2877 Butane Propane 2112 CO 
2957 
Methoxy 
MF 
Propane 
EME 
2854 Methoxy 
    
*  including the noise between 3220-3050 
 
The bands of CO23,4, methane3–5, methyl formate (MF)3,6,7, methanol3,6,8–12, dimethyl ether (DME)3,13,14,  methoxy3,10,14,15, ethyl methyl ether 
(EME)3,16, ethanol3,17–19, butane3,20,21, propane3,22,23 and CO3,5,24,25 were obtained from references. 
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ABSTRACT: Mesoporous silica is a potential drug carrier due to its porous network and its antibacterial activity is of interest. In this context, 
we have synthesized bioactive nanoassemblies of SBA-15 composed of Zr doping (Zr-SBA-15) and Cu nanoparticles (Cu-Zr-SBA-15) through 
self-assembly and infiltration processes. The self-assembly process yielded monodispersed cylindrical particles (rods) of SBA-15 and Zr-SBA-
15 with pores running along the length of these rods with diameters larger than the traditional SBA-15 pore size (>10 nm). The infiltration 
process yielded Cu nanoparticles grown inside the pores of these mesoporous rods to take advantage of the high specific surface area and obtain 
nanoparticle diameter smaller than 10 nm. The prepared drug carriers were loaded with a 2% chlorhexidine digluconate solution. For each 
carrier, a loading percentage of 25-40 % [g drug/g (drug+carrier)] was achieved without destroying their porous network. Release occurred in 
two stages. First, a burst release of the drug weakly attached to the carrier followed by a slow desorption of the drug more strongly attached to 
the pore walls of the porous framework. Release profiles reveal that Zr in the SBA-15 framework and Cu nanoparticles positioned in the pores 
of the carrier can be used to control the release rate, i.e. restrict the burst and slow down the release, which is attributed to the enhanced acidity 
and possibly to increased tortuosity. The chemical bonding between the drug and the carrier is confirmed by FTIR via N-H and O-H vibration 
bands. Antibacterial efficiency is shown qualitatively and quantitatively by employing agar diffusion and dynamic tests against Staphylococcus 
aureus and Escherichia coli. 
 
Keywords: Zr doped SBA-15, Cu nanoparticles, mesoporous materials, chlorhexidine, drug delivery, antibacterial
1. INTRODUCTION 
Drug delivery has been one of the major application areas of meso-
porous materials for more than a decade, and in many studies they 
are acknowledged as valuable pharmaceutical molecule hosts due to 
their large specific surface area and pore volume[1]. After the first 
report of MCM-41 molecular sieve in 1992[2], mesoporous silica 
stood out as a favorable bioactive drug carrier with its high mechan-
ical and thermal stability, and hexagonal pore structure with narrow 
pore size distributions [3–8]. These materials can be coated with 
functional groups (such as methyl and amine) due to the presence 
of silanol groups on the their surfaces and this functionalization can 
be controlled independently for the outer surface of the mesoporous 
particles and the pore surface[9]. Later on, SBA-15 was developed 
with larger pore size and thicker walls than MCM-41 resulting in 
higher adsorption capacity and improved stability [1,10–12]. How-
ever, drug release reports with SBA-15 carriers are usually restricted 
to small pore sizes (below 10 nm) and to specific surface area below 
600 m2/g [11,13–16]. Moreover, it is very rare to see a good particle 
morphology control while maintaining a large pore size and high 
specific surface area, especially in the presence of additional atoms 
such as Zr incorporated into the framework (SiO2-ZrO2). 
It is the objective of this work to develop hybrid materials based on 
SBA-15. To that aim, SBA-15, Zr-SBA-15 and Cu-Zr-SBA-15 were 
synthesized via a recently reported route[17]. The synthesized ma-
terials were used for delivery of an antibacterial drug: Chlorhexidine 
(CHX). CHX is a typically  used as an antibacterial drug which is 
mostly used for the treatment of periodontal diseases due to its anti-
septic properties against several gram-negative and gram-positive 
bacteria as well as fungi [18–21]and in this study it is chosen as a 
model cationic drug molecule to study release from the prepared 
SBA-15 based carriers. It is typically  
The drug carrier design was chosen to provide a material with con-
trollable and reliable characteristics including high loading diffusion 
capacity. To achieve this a mesoporous matrix with high specific sur-
face area, large pore diameter and monodispersed rod particle mor-
phology was chosen. Such kind of morphology has proven beneficial 
for other drug delivery systems investigated, for instance, in cancer 
therapy[22,23]. In our work, the addition of Zr and Cu provides ad-
ditional functionalities of relevance to the aimed drug delivery appli-
cation, such as polarity and antibacterial activity. Doping SBA-15 
with Zr was done to enhance the acidity in order to increase the af-
finity to cationic molecules such as CHX, while high stability is main-
tained [17,24]. Zirconia has been previously reported to increase the 
acidity [28] of mesoporous silica when doped and favors the disper-
sion of Cu nanoparticles [29]. Cu nanoparticles were grown in the 
mesopores of Zr-SBA-15 by an infiltration method 17. Copper has 
antibacterial properties and is commonly used on surfaces that are 
 exposed to repetitive human contact, especially in hospitals and 
against parasites in agriculture[30,31]. Cu has been shown to have 
antibacterial activity not only as a bulk material but also as nanopar-
ticles in metal or oxide forms [30–42]. Therefore, in our work, Cu 
was added to enhance the antibacterial effect of CHX for potential 
applications. Additionally, its contribution to the polarity of the mes-
oporous support is investigated with regards to the drug release 
properties and its relationship regarding the interactions between 
the carrier and the drug. 
Although mesoporous silica has been reported as a drug carrier[42–
44], publications on the use of mesoporous silica for CHX release 
are rare. SBA-15 is previously shown to be a potential bone filler for 
dental applications [3,43,44], therefore it is of interest to study this 
material and its diversified forms for release of a model antibacterial 
drug. Hereby we report the in-vitro drug delivery performance 
(CHX loading, release and antibacterial activity) of a molecular sieve 
in its pure and modified forms: SBA-15 w/wo Zr doping and w/wo 
Cu nanoparticles infiltrated inside the pores 
2. EXPERIMENTAL SECTION 
Poly(ethylene glycol)-block-poly(propylene glycol)-block-
poly(ethylene glycol) (Pluronic P123, EO20PO70EO20, av. Mn~5800, 
Aldrich), ammonium fluoride (NH4F) (≥98.0%, Fluka), sodium 
chloride (NaCl) (≥99.8%, Sigma-Aldrich), hydrochloric acid HCl 
(≥37.0%, Sigma-Aldrich), heptane (99%, Sigma-Aldrich), tetraethyl 
orthosilicate (TEOS, 98%, Sigma-Aldrich), zirconium(IV) oxychlo-
ride octahydrate (ZrOCl2·8H2O) (≥98.0%, Sigma-Aldrich), chloro-
trimethylsilane (TMCS, ≥99.0%, Aldrich), (3-aminopropyl)tri-
methoxysilane (APTMS, 97%, Aldrich), toluene (≥99.7%, Sigma-
Aldrich) and copper(II) sulfate pentahydrate (CuSO4) (≥99%, 
Sigma-Aldrich) were used as received in the synthesis of the meso-
porous materials. Chlorhexidine digluconate solution (20% in H2O, 
Sigma) was used without further purification. 
2.1. Synthesis and Characterization of the Mesoporous Drug 
Carrier 
SBA-15 
SBA-15 was synthesized via a hydrothermal route reported by Jo-
hansson et. al. [45] where a TEOS-heptane mixture was stirred in 
the precursor solution for 4 minutes (precursor solution: P123 and 
NH4F dissolved in HCl solution) at 20°C. The molar ratios in the 
synthesis solution were H2O:HCl:P123:NH4F:TEOS:heptane = 
9116:356:1:1.8:54:16.5. Subsequently, the solution was left under 
static conditions at 20 °C for one hour and then hydrothermally 
treated in a PTFE bottle at 80 °C for 24 hours. The obtained slurry 
was filtered and washed. To remove the remaining P123 micelles in 
the pores of the nanoparticles, the solid material was calcinated at 
550 °C for 5 hours.  
Zr-SBA-15 
Zr-SBA-15 was prepared as reported in Atakan et. al.[17] . Briefly, 
the same route as SBA-15 was used with the same molecular ratios 
in the synthesis solution except for two altered steps: (1) zirconium 
oxychloride (with Si/Zr=10 molar ratio) was premixed into the pre-
cursor solution before the TEOS-heptane mixture was added, (2) 
the static time after stirring was prolonged to 5 hours to obtain com-
plete formation of Zr-SBA-15 rods.  
Cu-Zr-SBA-15 
Cu was added to the mesoporous matrix as nanoparticles via an in-
filtration route. The mesoporous particles were functionalized with 
chemical groups for selective Cu settlement inside the pores rather 
than large agglomerations on the outer surface of the particles. The 
outer surface of the mesoporous particles was covered with methyl 
groups in order to passivate the outer surface. The inner surface of 
the pores was functionalized with amine groups (NH2-) in order to 
enhance Cu ion (Cu+) attachment by electrostatic forces on these 
surfaces.  
In those cases, when an outer surface passivation was applied, calci-
nation was not performed at the end of the (Zr-)SBA-15 synthesis in 
order to keep the pores filled with P123 and thereby limit the 
amount of methyl groups inside the pores. The methyl functionali-
zation was obtained by stirring Zr-SBA-15 particles with 15 vol% 
TMCS in toluene at 80 °C for 8 hours, filtrating the solid and calcin-
ing at 300°C for 5 hours in order to remove P123 while maintaining 
the methyl groups. For activation of the surface of the pores, the Zr-
SBA-15 powders were stirred with 6.25 vol% APTMS in toluene for 
24 hours at room temperature. Subsequently, soxhlet extraction was 
performed to remove excess APTMS and the product was obtained 
after filtering and washing with toluene. 
The functionalized mesoporous materials were dried at 100 °C for 2 
hours and stirred with 0,06 M Copper sulfate (CuSO4) solution with 
a concentration of 20 mg/ml for 24 hours at room temperature. The 
product was recovered by filtering and carefully washed with deion-
ized water. The filtrate was stirred with NaBH4 solution to reduce 
the Cu. Finally, the recovered solid was calcined at 550°C for 5 hours 
for complete micelle removal from the micropores, degradation of 
the functional groups, and Cu nanoparticle growth. 
The synthesis routes of all three materials are schematized in Figure 
1. 
Characterization 
The mesoporous particle morphology and pore arrangement were 
determined by Scanning Electron Microscopy (SEM) (LEO 1550 
Gemini operated at 3 kV) and Transmission Electron Microscopy 
(TEM) (FEI Tecnai G2), using carbon coated copper grid sample 
holders. The elemental analysis (atomic ratios of Si/Zr and Si/Cu) 
was obtained by an EDS system (Oxford X-Max 80) coupled to the 
SEM. An electron accelerating voltage of 20 kV and correction fac-
tors provided by the manufacturer were used for the elemental anal-
ysis.  
The pore size and shape were characterized by determining the ni-
trogen physisorption behavior of the material using a Micromeritics 
ASAP 2020 device. The Kruk-Jaroniec-Sayari (KJS) method [46] 
was used to compute the pore size distribution from the adsorption 
isotherm, and the Brunauer-Emmet-Teller (BET) method [47] was 
to determine the specific surface area (SSA) at a pressure ratio 
(P/P0) between 0.08 and 0.16.  
Small angle x-ray diffractometry (SAXRD) was performed using a 
Panalytical Empyrean equipped with a Cu Ka x-ray source operated 
in line focus. The recorded data was used to determine the pore ar-
rangement of the materials. A Panalytical X’Pert Pro diffractometer 
and also equipped with a Cu Ka x-ray source was used for phase 
identification and size determination of the Cu nanoparticles. The 
particle size was extracted using the Scherrer equation [48]. 
 
 
 2.2. Drug loading 
The mesoporous materials were loaded with CHX by the following 
procedure: 20 mg of each material were vortexed in 6 ml of a 2% 
CHX solution for 1 minute followed by 30 minutes of ultrasonic 
treatment. The dispersed powders were further vortexed during 1 
more minute and left to impregnate for 4 h with 50 rpm shaking 
(IKA KS 260 basic orbital shaker). The final suspensions were cen-
trifuged, and freeze dried. The CHX loaded samples are referred to 
as CHX-[sample name] where the [sample name] is [SBA-15], [Zr-
SBA-15] or [Cu-Zr-SBA-15]. 
The drug-loaded powders were analyzed by thermogravometric 
analysis using a Mettler-Toledo TGA/STDA 851e device. 3 mg of 
sample were analyzed in a 70 ml aluminium crucible and heated at 
10 °C/min from 25 to 800 °C under a flow of 50 ml/min N2. Liofil-
ized CHX digluconate was analyzed as reference. The final CHX 
loading of the samples was calculated by the formula below based on 
the mass loss between 120 and 800 ºC. The mass loss before 120 °C 
is due to water desorption from the mesoporous matrix. 
 !"#	%&'()*+ = %	.'//	%&//	%&'(0(	/'.1%0/ −%	.'//	%&//	0.134	/'.1%0/	%	.'//	%&//	1560	(65+ ∗ 100							(1) 
 
The drug loading was further investigated by transmission Fourier-
transform infrared spectroscopy by preparing KBr pellets that con-
tained 0.8-1.0 mg of sample. Measurements were conducted by a 
Bruker Vertex 70 spectrometer equipped with a water cooled MIR 
source and a DLaTGS detector. Spectra were acquired with 2 cm-1 
resolution and each spectrum is the averaged from 16 scans. Final 
spectra were normalized against the characteristic Si-O-Si band of 
SBA-15 for each sample. 
2.3. Drug release 
CHX loaded powder samples were liofilized and pressed into flakes 
in a uniaxial isostatic press by applying 8 tons for 8 minutes at room 
temperature. In vitro release tests were performed by immersing 20 
mg of the prepared flakes in 40 ml of MilliQ H2O at 37 °C and 350 
rpm stirring rate. Flakes were contained in USP baskets to prevent 
impact with the stirring magnet. 1 ml aliquots were withdrawn at 
predetermined time points and replaced by 1 ml of MilliQ H2O to 
keep the volume constant.  The concentration of each aliquot was 
measured by UV-Vis Spectroscopy at lmax=254 nm using a UV-
visible-NIR Shimadzu ISR-3100 device. The obtained concentra-
tion values were corrected taking into account the evaporation oc-
curred during the experiment, the drug amount in the withdrawn so-
lution, and the dilution introduced by the additions of H2O after 
sampling.  The release results are presented as cumulative release 
fractions, and Mt/Minf where Mt is the cumulative drug concentra-
tion in the solution at a specific time t and Minf is the maximum 
amount of drug released when stationary conditions was reached. 
The release kinetics was evaluated over four replicates by fitting the 
Mt/Minf vs. time plot to the suitable mathematical models using 
Matlab software (The Mathworks Inc., USA). 
 
 
 
 
2.4. Antibacterial activity 
The antibacterial activity of the drug-loaded materials was tested 
against two bacterial strains commonly found in nosocomial infec-
tions: Staphylococcus aureus (CCUG 15915) and Escherichia coli 
(CECT 101).   
 
Qualitative antibacterial testing  
To evaluate the qualitative antibacterial effectiveness the agar diffu-
sion test was employed. This test qualitatively determines the effec-
tiveness of a diffusible antimicrobial agent to inhibit bacterial 
growth, while being a relatively quick and easy assay. The culture 
media was prepared by dissolving 15 g/l agar bacteriological (Schar-
lau, ref.no. 07-004-500) and 37 g/l brain heart infusion (Scharlau, 
ref.no. 02-599-500) in 1 L water which was then sterilized by auto-
claving. The test was performed by plating 107 colony forming units 
(CFU) on agar plates. A flake of each sample weighing between 1 
and 2 mg was gently placed on the seeded agar plate.  After 24 hours 
of incubation at 37°C digital images were recorded. The software 
Photoshop’s quick selection tool was used to determine the total 
number of pixels at the bacteria-free zone around each flake and it is 
presented as inhibition zone (I).  
The results are presented by normalizing the I values by mass: I/m 
(cm/g). 3 replicates of each sample type were evaluated. 
Quantitative antibacterial testing 
For quantitative antibacterial assessment, continuous measurement 
of the growth curves of bacterial suspensions were employed. The 
test briefly consisted of placing the samples in a suspension of either 
S. aureus or E. coli adjusted to an optical density of 0.02, and meas-
uring the evolution of the optical absorbance (Synergy HTX Multi-
mode Reader, BioTek Instruments, Inc.) every 10 min for 24 h at 
37ºC. To avoid interference from the materials in the readings, the 
test was performed in 48 well plates, where the wells had been con-
nected in groups of 2. 2 ml of bacterial suspension media were added 
in each group of 2 wells, the drug containing flakes of around ~20 mg 
were placed in one of the wells and the readings were made in the 
other well. The % of the bacterial inhibition of S. aureus and E. coli 
at each time point are presented along with the fitted curve to data 
in order to show the trend. 
The resulting optical density values are converted to percent inhibi-
tion I(%) with the formula below [49–51]: 
 <(%) = =1 − >?@3−>?@0>?!3 A ∗ 100              (2) 
 >?BC : Optical density of a sample loaded test well at a time point t >?BD : Optical density of a sample loaded test well at the time point 
0 >?EC : Optical density of a positive control (bacterial suspension) 
well at a time point t. 
The results are averaged over three replicates. 
2.5. Statistics 
The overall statistical differences between test groups were analyzed 
by applying Tukey’s post hoc method via one way ANOVA (Minitab 
16 software, Minitab Inc., USA) with 95% significance level. 
 3. RESULTS and DISCUSSIONS 
Characterization of the Mesoporous Drug Carriers 
In this study, three types of mesoporous carriers were investigated: 
SBA-15, Zr-SBA-15 and Cu-Zr-SBA-15. All the carriers are mono-
dispersed rods with ordered single sized pores throughout each sam-
ple, which offer means to obtain controlled release. The SEM and 
TEM micrographs (Supporting information Figure S1(a-i)) con-
firm the targeted morphology where the obtained rods are observed 
to have a diameter between 200 and 500 nm and being 400-600 nm 
long.  Zr-SBA-15 has the largest rod dimensions. The cylindrical 
pores are extended along the long dimension of the rods and they 
run parallel to each other. Pore size distributions of the carrier mate-
rials prior to loading are presented in Figure S1(j) in the supporting 
information, and all samples have a narrow pore size distribution, 
with a maximum between 10 and 20 nm. The hexagonal pore pack-
ing of all the materials is confirmed by three distinct x-ray diffraction 
peaks representing the planes 100, 110 and 200 and also observed by 
TEM (Figure S1(k)). 
Cu infiltration resulted in Cu nanoparticles with sizes below 10 nm 
within the pores (Figure S1 (i) – darkest dots/areas). Moreover, Cu 
infiltration did not change the hexagonally pore structure (Figure 
S1(k)). EDS analysis revealed the mesoporous carrier composition 
as: Si/Zr = 12.6±0.2 for Zr-SBA-15, and Si/Zr = 19.6±0.9 and Si/Cu 
= 2.5±0.0 for Cu-Zr-SBA-15.  
SSA of SBA-15 increases with Zr doping from 570 m2/g to 723 m2/g 
caused by a change of the synthesis environment in the presence of 
a Zr salt. Cu nanoparticles in the pores result in decreased SSA (336 
m2/g) and pore volume due to blockage (from 1.07 cm3/g in SBA-
15 and 1.32 cm3/g in Zr-SBA-15 to only 0.58 cm3/g). 
 
Drug Loading 
The mass loss measured by TGA between 25-800°C of as-synthe-
sized carriers: SBA-15, Zr-SBA-15 and Cu-Zr-SBA-15, without any 
drug loading, display only one distinct mass decrease due to water 
loss between 25-120 °C (Figure 2(a)) when tested up to 800°C. 
This mass decrease is attributed to evaporation of physisorbed water 
and H2O molecules that are formed when –OH surface groups react 
with each other [52]. The loss of water is more pronounced for the 
carriers without drugs (Figure 2(a)). Loss of water may occur during 
drug loading, as drug molecules penetrate the pores, and force water 
molecules out. Another contributing factor is entrapment of –OH 
groups by the drug molecules, which suppresses their evaporation. 
No mass change due to reactions involving carbon is expected since 
the carriers are calcined as the final step of their synthesis at 550°C 
for 5 hours. The slight mass loss at temperature values above 120°C, 
is due to dehydroxilation i.e. depletion of the remaining –OH surface 
groups [52]. The mass losses due to dehydroxilation are 3.6% for 
SBA-15, 5.5% for Zr-SBA-15 and 5.9% for Cu-Zr-SBA-15. The ratio 
of mass loss percentage per unit surface area (mass loss%/m2) be-
tween the samples is SBA-15 : Zr-SBA-15 : Cu-Zr-SBA-15 = 
1:1.2:2.7. The marked difference in Cu-Zr-SBA-15 can be related to 
a greater density of surface –OH groups on this material, which a pri-
ori can result in an enhanced surface activity for drug attachment, 
enabling higher drug retention. This complies with the improved 
surface acidity (resulting from more –OH attachment) of Zr and Cu 
integrated mesoporous materials[28,53,54]. 
Two distinct mass loss steps in the TGA curves of CHX digluconate 
(Supporting information Figure S2) and loaded mesoporous mate-
rials (Figure 2(a)) are observed. This mass loss due to complete 
CHX decomposition between 120 and 800°C, is determined to be 
80.01 %.  This value is used in Equation (1) to calculate the CHX 
loading. The CHX loading (as defined by Eq. 1) in the different ma-
terials is between 26.7 ± 1.0 % and 40.0 ± 0.1 % (Figure 2(b)). The 
loadings were also normalized by the SSA in order to elucidate any 
carrier-drug interactions. The loading performance of Cu-Zr-SBA-
15 per unit surface area is higher than the other two carrier types 
where Zr-SBA-15 also shows better loading characteristics per unit 
SSA than SBA-15. The differences in loading per SSA can be at-
tributed to an enhanced acidity of the mesoporous carrier by the ad-
dition of metal atoms (Zr or Cu) [28,53,54]. Moreover, it has been 
reported that merging of multiple metal atoms in the same system 
enables synergetic effects between different acid sites (Lewis and 
Brönsted) and therefore enhancing the acidity of the material [55]. 
This acidity could account for weak acid/base interactions between 
the drug and the substrate, which would be enhanced by having two 
elements, Cu and Zr simultaneously present in the mesoporous ma-
terial.  
The physisorption test results showed that the N2 adsorption iso-
therms (Figure S3 (a)) are type IV isotherms displaying a type 1 hys-
teresis loop that indicates well-defined open cylindrical pores with 
and without the drug loading [56]. Micropore volumes (which were 
of 0.2 cm3/g in SBA-15 and in Cu-Zr-SBA-15 & 0.5 cm3/g in Zr-
SBA-15) become zero upon drug loading, which indicates penetra-
tion of the drug into the micropores. The drug loaded mesoporous 
particles show a distinct drop in pore volume due to drug occupa-
tion. The size of this drop follows the same trend as loading per SSA. 
Drug infiltration did not modify the pore structure as seen in the 
SAXRD results when comparing the drug loaded samples in Figure 
S3 (b) with the materials prior to loading in Figure 1(k). For further 
investigation of drug attachment, FTIR spectroscopy measurements 
were performed on the loaded samples as well as the materials with-
out any drug loading (Supporting Information Figure S4).  
Figure 1. Synthesis route of SBA-15, Zr-SBA-15 and Cu-Zr-SBA-15 
The FTIR results (normalized) of the carriers before and after drug 
loading allowed detecting the characteristic bands of the mesopo-
rous material at 3400 cm-1 for OH vibration, 1627 cm-1 for water de-
formation dH2O; 1240 cm-1, 1086 cm-1, 800 and 465 cm-1 as Si-O-Si 
bands, 960 cm-1 for Si-OH vibrations, and 980 cm-1 as Zr-O-Si band 
[57–60]. 
The drug loaded samples exhibit additional bands characteristic for 
CHX digluconate: 1680-1510 cm-1 for multiple vibrations of C-C, 
C=Caromatic, N-H, C-O and C-N; 1493 cm-1 for C-Cl stretching; 1417 
cm-1 for COO stretching; 824 cm-1 CH bending of the aromatic 
group; and 726 cm-1 for C-N stretching [28,59,61–65]. The chlor-
hexidine digluconate drug spectrum is presented in the supporting 
information Figure S5. 
 
  
Figure 2. Thermogravimetric mass loss of (a) of the different sam-
ples prior to and after drug loading and (b) drug loading % and drug 
loading % / SSA calculated from the TGA data. Different symbols 
(*, **) and (a,b,c) indicate statistically significant differences 
 
The band between 3430-3412 cm-1 corresponding to OH vibrations 
on the surface of the carriers prior to drug loading, shifts to lower 
vibrational wavenumbers upon CHX addition, especially in Cu-Zr-
SBA-15. This shift is 10 cm-1 for SBA-15, 11 cm-1 for Zr-SBA-15 and 
73 cm-1 for Cu-Zr-SBA-15. The -OH vibrations originate from the 
OH end surface groups of the mesoporous carrier as well as the phy-
sisorbed water. This shift can be attributed to two reasons: (i) Mo-
lecular attachment of drug on the surface via OH groups, and (ii) 
increase in the amount of the NH stretching band of the drug that 
normally occurs at 3340 cm-1, due to their overlap (Figure S4 and 
S5). Additional data on the pore characteristics of the drug carriers 
after loading are included in Supporting Information Table S1.  
 
Drug Release 
The cumulative CHX release data is presented in Figure 3(a) as cu-
mulative released % vs. time, and the corresponding final values are 
presented in Table 1. The release kinetics of the three materials dis-
play similar profile, with a burst release in the first hours, followed by 
stabilization. The three materials reach the stationary state after 10-
20h depending on the sample, so in all cases a certain fraction of the 
drug remains trapped in the material. The relatively fast  release in 
water in 10-20 h can be expected to be translated to a much more 
gradual release in PBS, as shown in an earlier study also dealing with 
CHX release[66]. It can be observed that the cumulative released % 
follows: SBA-15 > Zr-SBA-15 > Cu-Zr-SBA-15. Cu-Zr-SBA-15 re-
leases the lowest final amount (Minf) while Zr-SBA-15 releases the 
most (Table 1). This result is consistent with the specific surface 
area values of the carriers prior to drug loading presented in the pre-
vious section. The fact that the CHX released % from SBA-15 is 
higher than Zr-SBA-15 (Figure 3(a), Table 1), while the released 
amount (Mt) follows an opposite order, being lower for SBA-15 
compared to Zr-SBA-15 (Figure 3(b), Table 1), indicates less strong 
bonding between the drug and the mesoporous material in SBA-15. 
Cu-Zr-SBA-15 having the lowest released % and Mt may indicate the 
strongest bonding between the drug and the carrier. As mentioned 
earlier, TGA results showed that –OH surface group density was 
higher for Cu-Zr-SBA-15 compared to other carriers, so the electro-
negative surface attachment between the carrier and the cationic 
drug is possibly related to the low percentage (28.2 ± 0.7 %) of the 
drug loaded being released after 72h (Table 1), in addition to in-
creased tortuosity due to the presence of the Cu nanoparticles par-
tially blocking the pores.  Similarly, the total released percentage of 
CHX-Zr-SBA-15 is around 15% lower than that of CHX-SBA-15, 
which is consistent with TGA results that indicated similar surface 
OH group concentrations for Zr-SBA-15 and SBA-15, although 
slightly higher for Zr-SBA-15.  
Table 1. Drug release final percentage, cumulative amount released 
and modelling results. 
Sample Final CHX Released % Final CHX Minf 
(mg) 
CHX-SBA-15 64.5 ± 2.3% 2.78 ± 0.10 
CHX-Zr-SBA-15 50.5 ± 1.4 % 4.09 ± 0.09 
CHX-Cu-Zr-SBA-15 28.2 ± 0.7 % 1.68 ± 0.14 
CHX-SBA-15 
Phase k (1/h) P Mt (mg CHX) 
fast 8.46 ± 0.80 84.53 ± 2.76 % 2.35 
slow 0.30 ± 0.13 13.95 ± 2.87 % 0.39 
CHX-Zr-SBA-15 
Phase k (1/h) P Mt (mg CHX) 
fast 5.70 ± 1.94 34.87 ± 5.69 % 1.43 
slow 0.49 ± 0.08 62.58 ± 6.18 % 2.56 
CHX-Cu-Zr-SBA-15 
Phase k (1/h) P Mt (mg CHX) 
fast 13.36 ± 4.30 39.33 ± 3.85 % 0.66 
slow 0.43 ± 0.07 56.64 ± 3.90 % 0.95 
 
 
Figure 3. Cumulative CHX (a) released % and (b) released amount 
(Mt) from CHX-SBA-15, CHX-Zr-SBA-15 and CHX-Cu-Zr-SBA-
15.  Different symbols (*, **, ***) indicate statistically significant dif-
ferences. 
 
To reveal the kinetics behind the release trend of each sample the 
sum of two exponential functions was fitted to the data according to: FGFHIJ = 	 KL(1− 0MNOC) + KQ(1 − 0MNRC)          (3) 
where P1 is the percentage of release in the first phase, P2 is the per-
centage of release in the second phase, k1 is the rate constant at the 
first phase and k2 is the rate constant at the second phase. The fits are 
given in the supporting information Figure S6. The inserts show the 
early-time release behavior. CHX-Zr-SBA-15 and CHX-Cu-Zr-
SBA-15 release the drug in a slower manner (Figure 3) and the sta-
tionary stage is reached after 26 hours, which should be compared to 
CHX-SBA-15 where a strong burst occurs in the first hour where 
more than 60% of the drug is released and the stationary stage is 
reached after 10 hours.  
 The release from our mesoporous carriers can be explained by two 
phases: release of the drug molecules loosely held on the surface and 
in the void volume of the pores (first phase) and the drug molecules 
attached to the mesoporous framework/walls (second phase). The 
molecules attached to the walls release less easily compared to the 
loosely held ones. The first phase can be seen as the initial release 
burst and second one as slow release over a long time period. Previ-
ous works [67] studying the release of a dye (Rhodamine G) from 
mesoporous silica nanoparticles at different pHs, found similar two-
phase release profiles. In line with our observations Ng et al [68] 
stated that a cationic molecule can have a second phase of release 
(following a simple diffusion phase) due to strong attachment to the 
anionic mesoporous silica surface, which was referred to as a ‘self-
rate-limiting mechanism’ and therefore the whole release process 
cannot be described by simple diffusion activity. 
The CHX amounts released during two phases of drug release (fast 
and slow) were determined by multiplying the Minf value for each 
sample by the percentages (P) in either phase 1 or 2 (Table 1). Ac-
cordingly, drug release from SBA-15 can be observed to be domi-
nated by the fast regime and only 14% of the released drug corre-
sponds to the slow regime. For Zr-SBA-15 and Cu-Zr-SBA-15 the 
slow regime dominates the release behavior, during which more than 
50% of the release occurs. The stronger anionic character of the 
metal containing carrier surfaces and thus a stronger connection be-
tween the carrier and the drug causes this change in behavior. The 
anionic character of Cu-Zr-SBA-15 surface is explained with a high 
OH surface group density. However, for Zr-SBA-15 this is likely 
caused by a negative charge on the surface generated by the presence 
of Zr. 
Antibacterial Activity 
Qualitative antibacterial activity of the drug-loaded mesoporous ma-
terials was tested against staphylococcus aureus and escherichia coli 
(Figure 4) since chlorhexidine has bactericidal effect and broad-
spectrum efficacy [69]. Empty carriers were used as negative control 
and they demonstrated no inhibition zone. Accordingly, all CHX-
loaded carriers display antibacterial activity, showing greater effi-
ciency vs. E. coli (Figure 6(a)). It is interesting to note that the inhi-
bition areas of the different materials are in direct correlation with 
the % released, being CHX-SBA-15 the material showing more inhi-
bition and CHX-Cu-Zr-SBA-15 the one showing less inhibition 
(Figure 4(b)). It was previously described[69] that E. coli and S. au-
reus uptake chlorhexidine very fast depending on the chlorhexidine 
concentration and pH. The minimum inhibitory concentration of 
CHX for S. aureus is reported in 4 µg/mL, and that of E.coli in 2.67 
µg/mL [70]. This lower susceptibility for S. aureus can explain the 
smaller inhibition areas found for S. aureus than for E.coli. 
 
Figure 4. Inhibition zone normalized per unit mass (a) and images 
of the inhibition areas of the different materials (b). Different sym-
bols (*, **) and (a,b) indicate statistically significant differences. 
 
The maximum antibacterial efficiency during the quantitative anti-
bacterial testing was reached between the first 2-6 hours for E. coli 
depending on the material tested and in 2 hours for S. aureus for the 
three samples and remained stable (Figure 5). SBA-15 and Zr-SBA-
15 showed converging profiles in the quantitative antibacterial tests. 
The inhibition percentages of SBA-15 and Zr-SBA-15 reached 93% 
and 90% for S. aureus and of 73% and 97% for E.coli, respectively. 
Cu-Zr-SBA-15 displayed a slightly different behavior: while it ini-
tially displayed similar % of inhibition than the other materials, the 
% of bacterial inhibition decreased with time. This can probably be 
explained by the fact that CHX-Cu-Zr-SBA-15 displays much less 
CHX amount released: only 135.5 µg/mg carrier (Table 1, Figure 
3), compared to other samples, which in turn, is related to the SSA. 
As a result, the antibacterial efficiency of the material is progressively 
reduced with time. Despite this, the maximum value of inhibition % 
 (Figure 5), which was reached at around the time point of 250 min 
for S. aureus and 160 hours for E. coli, is almost the same for Cu-Zr-
SBA-15 as Zr-SBA-15 which has a release amount of more than dou-
ble of Cu-Zr-SBA-15. This could be due to fact that an antibacterial 
agent: Cu was integrated into the carrier.   
 
Figure 5. Inhibition percentage of SBA-15, Zr-SBA-15 and Cu-Zr-
SBA-15 against staphylococcus aureus (a) and escherichia coli (b). 
 
4. CONCLUSIONS  
The potential of 3 different mesoporous carriers (SBA-15, Zr-SBA-
15 and Cu-Zr-SBA-15) as drug delivery systems was studied with an 
antibacterial drug (chlorhexidine digluconate). Zr doping and Cu 
infiltration was shown to affect the morphology of the SBA-15 parti-
cles as well as its porous properties. As a result different CHX loading 
and release behaviors were obtained for the modified mesoporous 
materials. All samples displayed burst release profile at first, and 
good antibacterial activity.however significant differences in release 
% have been observed, being SBA-15 the sample with the highest re-
lease (65%) and Cu-Zr-SBA-15 the lowest  (25%). BothZr-SBA-15 
and Cu-Zr-SBA-15 show slower initial release profiles, possibly con-
ferred by the stronger interactions carrier-drug due to the additions 
of Zr and Cu on the mesoporous network. While not all drug is re-
leased from the mesoporous materials, the fact that the stationary 
stage is reached in all cases and that the materials designed are not 
resorbable can avoid potential problems of bacterial resistance.
  
 
AUTHOR INFORMATION 
Corresponding Author 
* E-mail: cristina.canal@upc.edu 
 
Notes 
The authors declare no competing financial interest. 
 ACKNOWLEDGMENT  
This work was financially supported by: 
EU’s Erasmus-Mundus program: The European School of Materials 
- Doctoral Programme - DocMASE;  
Project MAT2015-65601-R, co-funded by the EU through Euro-
pean Regional Development Funds, and Ramon y Cajal fellowship 
of CC; Support for the research of MPG was received through the 
‘‘ICREA Academia’’ prize for excellence in research, funded by the 
Generalitat de Catalunya. 
 
 
REFERENCES 
[1] M. Moritz, M. Geszke-Moritz, Mater. Sci. Eng. C 49 (2014) 114–
151. 
[2] J.S.C. Kresge, C. T. Leonowicz, M. E.Roth, W. J.Vartuli, J.Beck, 
Nature 359 (1992) 710–712. 
[3] H. Fullriede, N. Timpe, L. Borchers, M. Stiesch, H. Menzel, P. 
Behrens, A. Chemie, L.U. Hannover, T. Chemie, T.U. Braunschweig, 
Z. Prothetik, 58 (2013) 9–10. 
[4] E. Aznar, M.D. Marcos, R. Martínez-Máñez, F. Sancenón, J. Soto, P. 
Amorós, C. Guillem, J. Am. Chem. Soc. 131 (2009) 6833–43. 
[5] A. Bernardos, L. Mondragon, E. Aznar, M.D. Marcos, R. Martinez-
Mañez, F. Sancenon, J. Soto, J.M. Barat, E. Perez-Paya, C. Guillem, P. 
Amoros, ACS Nano 4 (2010) 6353–68. 
[6] C.-P. Tsai, C.-Y. Chen, Y. Hung, F.-H. Chang, C.-Y. Mou, J. Mater. 
Chem. 19 (2009) 5737. 
[7] C.-Y. Lai, B.G. Trewyn, D.M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija, 
V.S.-Y. Lin, J. Am. Chem. Soc. 125 (2003) 4451–9. 
[8] V. Mamaeva, C. Sahlgren, M. Lindén, Adv. Drug Deliv. Rev. 65 
(2013) 689–702. 
[9] E. Escalera, M.A. Ballem, J.M. Córdoba, M.-L. Antti, M. Odén, 
Powder Technol. 221 (2012) 359–364. 
[10] D. Zhao, J. Feng, Q. Huo, N. Melosh, G.H. Fredrickson, B.F. 
Chmelka, G.D. Stucky, Science (80-. ). 279 (1998) 548–552. 
[11]  a L. Doadrio, E.M.B. Sousa, J.C. Doadrio, J. Pérez Pariente, I. 
Izquierdo-Barba, M. Vallet-Regí, J. Control. Release 97 (2004) 125–
32. 
[12] G.D. Mihai, V. Meynen, M. Mertens, N. Bilba, P. Cool, E.F. Vansant, 
J. Mater. Sci. 45 (2010) 5786–5794. 
[13] M. Van Speybroeck, V. Barillaro, T. Do Thi, R. Mellaerts, J. Martens, 
J. Van Humbeeck, J. Vermant, P. Annaert, G. Van den Mooter, P. 
Augustijns, J. Pharm. Sci. 98 (2009) 2648–2658. 
[14] M. Moritz, M. Łaniecki, Appl. Surf. Sci. 258 (2012) 7523–7529. 
[15] S.-Y. Park, P. Pendleton, Powder Technol. 223 (2012) 77–82. 
[16] J.M. Rosenholm, A. Penninkangas, M. Lindén, Chem. Commun. 
(Camb). (2006) 3909–11. 
[17] A. Atakan, P. Mäkie, F. Söderlind, J. Keraudy, E.M. Björk, M. Odén, 
Phys. Chem. Chem. Phys. 19 (2017) 19139–19149. 
[18] A.D. Russell, M.J. Day, J. Hosp. Infect. 25 (1993) 229–238. 
[19] A. Kovtun, D. Kozlova, K. Ganesan, C. Biewald, N. Seipold, P. 
Gaengler, W.H. Arnold, M. Epple, RSC Adv. 2 (2012) 870. 
[20] T. Attin, T. Abouassi, K. Becker, A. Wiegand, M. Roos, R. Attin, Clin. 
Oral Investig. 12 (2008) 189–96. 
[21] A.M. Young, P.Y.J. Ng, U. Gbureck, S.N. Nazhat, J.E. Barralet, M.P. 
Hofmann, Acta Biomater. 4 (2008) 1081–8. 
[22] D. Karaman, D. Desai, R. Senthilkumar, E.M. Johansson, N. Råtts, M. 
Odén, J.E. Eriksson, C. Sahlgren, D.M. Toivola, J.M. Rosenholm, 
Nanoscale Res. Lett. 7 (2012) 358. 
[23] D. Şen Karaman, S. Sarwar, D. Desai, E.M. Björk, M. Odén, P. 
Chakrabarti, J.M. Rosenholm, S. Chakraborti, J. Mater. Chem. B 4 
(2016) 3292–3304. 
[24] Y. Usami, T. Hongo, A. Yamazaki, J. Porous Mater. 19 (2011) 897–
902. 
[25] M. Hisbergues, S. Vendeville, P. Vendeville, J. Biomed. Mater. Res. - 
Part B Appl. Biomater. 88 (2009) 519–529. 
[26] E. Asadpour, M.T. Boroushaki, A. Ghorbani, H.R. Sadeghnia, Iran. J. 
Pharm. Res. 13 (2014) 1141–1148. 
[27] X. Wang, D. Chen, L. Cao, Y. Li, B.J. Boyd, R. a Caruso, ACS Appl. 
Mater. Interfaces 5 (2013) 10926–32. 
[28] L.F. Chen, X.L. Zhou, L.E. Noreña, J. a. Wang, J. Navarrete, P. Salas,  
a. Montoya, P. Del Angel, M.E. Llanos, Appl. Surf. Sci. 253 (2006) 
2443–2451. 
[29] Á. Reyes-Carmona, A. Arango-Díaz, E. Moretti, A. Talon, L. Storaro, 
M. Lenarda, A. Jiménez-López, E. Rodríguez-Castellón, J. Power 
Sources 196 (2011) 4382–4387. 
[30] J. Konieczny, Z. Rdzawski, Arch. Mater. Sci. Eng. 56 (2012) 53–60. 
[31] G. Grass, C. Rensing, M. Solioz, Appl. Environ. Microbiol. 77 (2011) 
1541–1547. 
[32] L. Argueta-Figueroa, R.A. Morales-Luckie, R.J. Scougall-Vilchis, O.F. 
Olea-Mejía, Prog. Nat. Sci. Mater. Int. 24 (2014) 321–328. 
[33] G. Borkow, J. Gabbay, R. Dardik, A.I. Eidelman, Y. Lavie, Y. 
Grunfeld, S. Ikher, M. Huszar, R.C. Zatcoff, M. Marikovsky, Wound 
Repair Regen. 18 (2010) 266–275. 
[34] G. Borkow, S.S. Zhou, T. Page, J. Gabbay, PLoS One 5 (2010). 
[35] A.K. Chatterjee, R. Chakraborty, T. Basu, Nanotechnology 25 
(2014) 135101. 
[36] N. Cioffi, L. Torsi, N. Ditaranto, G. Tantillo, L. Ghibelli, L. Sabbatini, 
T. Bleve-Zacheo, M. D’Alessio, P.G. Zambonin, E. Traversa, Chem. 
Mater. 17 (2005) 5255–5262. 
[37] A. Esteban-Cubillo, C. Pecharromán, E. Aguilar, J. Santarén, J.S. 
Moya, J. Mater. Sci. 41 (2006) 5208–5212. 
[38] J. Gabbay, J. Ind. Text. 35 (2006) 323–335. 
[39] S. Jadhav, S. Gaikwad, M. Nimse, A. Rajbhoj, J. Clust. Sci. 22 (2011) 
121–129. 
[40] G. Ren, D. Hu, E.W.C. Cheng, M. a. Vargas-Reus, P. Reip, R.P. 
Allaker, Int. J. Antimicrob. Agents 33 (2009) 587–590. 
[41] M. Raffi, S. Mehrwan, T.M. Bhatti, J.I. Akhter, A. Hameed, W. Yawar, 
M.M. Ul Hasan, Ann. Microbiol. 60 (2010) 75–80. 
[42] R.J.B. Pinto, S. Daina, P. Sadocco, C.P. Neto, T. Trindade, Biomed 
Res. Int. 2013 (2013). 
[43] S.P. Samuel, S. Li, I. Mukherjee, Y. Guo, A.C. Patel, G. Baran, Y. Wei, 
Dent. Mater. 25 (2009) 296–301. 
[44] L. Wei, N. Hu, Y. Zhang, Materials (Basel). 3 (2010) 4066–4079. 
[45] E.M. Johansson, M.A. Ballem, J.M. Cordoba, M. Oden, Langmuir 27 
(2011) 4994–4999. 
[46] M. Jaroniec, L.A. Solovyov, Langmuir 22 (2006) 6757–6760. 
[47] S. Brunauer, P.H. Emmett, E. Teller, J. Am. Chem. Soc. 60 (1938) 
309–319. 
[48] A.L. Patterson, Phys. Rev. 56 (1939) 978–982. 
[49] Y. Sultanbawa,  a. Cusack, M. Currie, C. Davis, J. Rapid Methods 
Autom. Microbiol. 17 (2009) 519–534. 
[50] T. Patton, J. Barrett, J. Brennan, N. Moran, J. Microbiol. Methods 64 
(2006) 84–95. 
[51] J.T. Casey, C. O’Cleirigh, P.K. Walsh, D.G. O’Shea, J. Microbiol. 
Methods 58 (2004) 327–334. 
[52] T. López, O.-I. Emma, M. López, J. Flores, T. Corona, J. Nanomater. 
 Mol. Nanotechnol. 2 (2013) 2–7. 
[53] S. Xin-Chao, D. Lin-Hai, W. Yu-Ye, Q. Wen-Guang, Y.-C. YU, W. 
Yuan, L. Huai-Lei, S. Zhao-Lin, S. Li-Juan, 28 (2012) 1467–1473. 
[54] D. Zhao, Y. Wan, W. Zhou, in:, Ordered Mesoporous Mater., Wiley-
VCH Verlag GmbH & Co. KGaA, 2013, pp. 219–242. 
[55] S. Telalović, A. Ramanathan, J.F. Ng, R. Maheswari, C. Kwakernaak, 
F. Soulimani, H.C. Brouwer, G.K. Chuah, B.M. Weckhuysen, U. 
Hanefeld, Chem. - A Eur. J. 17 (2011) 2077–2088. 
[56] K.S.W. Sing, Pure Appl. Chem. 54 (1982) 2201–2218. 
[57] L. White, C. Tripp, J. Colloid Interface Sci. 232 (2000) 400–407. 
[58] M.L. Martínez, M.B. Gómez Costa, G. a. Monti, O. a. Anunziata, 
Microporous Mesoporous Mater. 144 (2011) 183–190. 
[59] E.M.G. Raso, M.E. Cortes, K.I. Teixeira, M.B. Franco, N.D.S. 
Mohallem, R.D. Sinisterra, J. Incl. Phenom. Macrocycl. Chem. 67 
(2010) 159–168. 
[60]  a. Alizadeh, M.M. Khodaei, D. Kordestani,  a. H. Fallah, M. 
Beygzadeh, Microporous Mesoporous Mater. 159 (2012) 9–16. 
[61] M. Badea, R. Olar, M. Iliş, R. Georgescu, M. Călinescu, J. Therm. 
Anal. Calorim. (2012) 1763–1770. 
[62] M. Călinescu, T. Negreanu-Pîrjol, R. Georgescu, O. Călinescu, Cent. 
Eur. J. Chem. 8 (2010) 543–549. 
[63] B.V. Reddy, G.R. Rao, Indian J. Pure Appl. Phys. 46 (2008) 611–616. 
[64] T. Tanaka, S. Murayama, N. Tuda, M. Nishiyama, K. Nakagawa, Y. 
Matsuo, Y. Isohama, Y. Kido, J. Heal. Sci. 51 (2005) 357–361. 
[65] J. Coates, R. a M. Ed, Encyclopedia of Analytical Chemistry, John 
Wiley & Sons, Ltd, Chichester, UK, 2006. 
[66] D. Luo, S. Shahid, R.M. Wilson, M.J. Cattell, G.B. Sukhorukov, ACS 
Appl. Mater. Interfaces 8 (2016) 12652–12660. 
[67] P. Demuth, M. Hurley, C. Wu, S. Galanie, M.R. Zachariah, P. 
Deshong, Microporous Mesoporous Mater. 141 (2011) 128–134. 
[68] J.B.S. Ng, P. Kamali-Zare, H. Brismar, L. Bergstr??m, Langmuir 24 
(2008) 11096–11102. 
[69] G. McDonnell, A.D. Russell, Clin. Microbiol. Rev. 14 (2001) 227–
228. 
[70] C.V.G. do Amorim, C.E. Aun, M.P.A. Mayer, Braz. Oral Res. 18 
(2004) 242–246. 
 
 
 
 
 Supporting Information 
 
 
Figure S1.  SEM micrographs of (a,d) SBA-15, (b,e) Zr-SBA-15, (c,f) Cu-Zr-SBA-15, at different magnification 
and, (j) Pore size distributions by N2 sorption, (k) SAXRD diffractograms with marks on the peaks and TEM 
micrograph of the cross-section of an SBA-15 particle. 
 
Figure S2.  Thermogravimetric mass loss of pure CHX 
 
  
Figure S3. N2 adsorption isotherms of the particles before and after CHX loading (a), and SAXRD of drug loaded samples (b).  
  
  
 
Figure S4. Normalized FTIR spectra of SBA-15, Zr-SBA-15 and Cu-Zr-SBA-15 with and without CHX loading ((a) drug loaded samples, (b) 
samples prior to drug loading) 
 
  
Figure S5.  FTIR spectrum of CHX digluconate 
 
 
Table S1. Pore characteristics of the drug carriers before and after the drug loading 
Sample 
SSA (m2/g) Pore Volume* (cm3/g) Micropore Volume (cm3/g) 
Not loaded CHX loaded Not loaded CHX loaded Not loaded CHX loaded 
SBA-15 570 356 1.07 0.84 0.2 0 
Zr-SBA-15 723 278 1.32 0.65 0.5 0 
Cu-Zr-SBA-15 336 64 0.58 0.13 0.2 0 
* Single point adsorption total pore volume of pores less than 289,7731 nm width at P/P0 = 0,993354442 
 
 
 
 
 
 
 
  
Figure S6.  Fractional release as Mt/Minf of CHX-SBA-15, CHX-Zr-SBA-15 and CHX-Cu-Zr-SBA-15 with the corresponding fitting curves 
(zoomed in the embedded graphs).  
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ABSTRACT: Mesoporous silica is a bioactive material with favorable pore properties, which makes it attractive for applications in the bio-
medical field. In this study we employ SBA-15 with different pore sizes as a carrier for an antibiotic drug, doxycycline hyclate. We use the 
antibiotic as a model to evaluate the influence of porosity in the design of dosage forms. The influence of the pore size of SBA-15 is studied in 
terms of drug loading, drug release, and antibacterial activity. It was observed that the pore size is directly related to the drug loading amount 
as well as the fraction and amount of the drug released. The release profile is affected by the microporosity.  During loading and release, the 
effects from interactions between the drug molecules and the SBA-15 support were small compared to drug-drug interactions, due to the large 
pore sizes compared to the size of the drug molecule. The antibacterial activity against staphylococcus aureus and Escherichia coli was ob-
served to follow the drug release amounts. 
1. INTRODUCTION 
Since the discovery of mesoporous silica in 1990s 1,2, it has been of 
interest for application areas such as drug delivery, catalysis and 
adsorption3,4. This interest is due to their capacity for carrying and 
releasing molecules, e.g. drugs, in various sizes and shapes. One of 
the characteristics of mesoporous silica is that it can have high 
micro- and mesoporosity, which can collectively yield specific 
surface areas larger than 1000 m2/g. Moreover, it typically has a 
narrow pore size distribution with tunable size. The framework of 
mesoporous silica is chemically and mechanically stable, bioactive 
and it allows chemical surface modifications. Among many types of 
mesoporous silica, SBA-15 has been studied extensively due to the 
fact that it possesses larger pores and thicker pore walls compared 
to the traditional mesoporous silica, MCM-414–7. Moreover, the 
unidirectional pores of SBA-15 with the same cross-sectional diam-
eter throughout the material facilitate good mass transfer of the 
load. Thus, SBA-15 is a candidate for drug encapsulation and has 
been reported as carriers for molecules such as ibuprofen, gentami-
cin, chlorhexidine etc8.  
Tuning the pore size of SBA-15 is a strategy to control drug loading 
and release in order to maintain the therapeutical level of the drug 
9,10 for a chosen amount of time. However, it is not common to 
analyze the pore size effect in a large pore size range such as be-
tween 6 nm to 15 nm by maintaining the cylindrical pore shape and 
similar particle morphology. For example, a study was reported 
earlier for MCM-41 in terms of ibuprofen for a pore diameter range 
of 2.5-3.6 nm 11.  
Nosocomial infections are still a battle field following open surger-
ies, for instance in bone applications. SBA-15 was earlier reported 
as a potential bone filler 12–14. In this paper we report on the effect of 
the pore size of SBA-15 on the release of doxycycline hyclate (re-
ferred to as ‘Doxy’). Doxy is an antibiotic utilized for bone and 
dental infections 15,16. This paper elucidates the effect of SBA-15’s 
most important textural property (pore size) in terms of loading 
and delivering drugs. For this purpose, a range of large pore sizes 
was synthesized with the same chemistry and their loading capacity 
and release profiles were evaluated. 
 
2. MATERIALS AND METHODS 
Poly(ethylene glycol)-block-poly(propylene glycol)-block-
poly(ethylene glycol) (Pluronic P123, EO20PO70EO20, av. 
Mn~5800, Aldrich), ammonium fluoride (NH4F) (≥98.0%, Fluka), 
sodium chloride (NaCl) (≥99.8%, Sigma-Aldrich), HCl (≥37.0%, 
Sigma-Aldrich), heptane (99%, Sigma-Aldrich), tetraethyl orthosil-
 icate (TEOS, 98%, Sigma-Aldrich), doxycycline hyclate (doxycy-
cline hydrochloride hemiethanolate hemihydrate, MW:1025.89, 
Sigma-aldrich) were used as received. 
 
Synthesis 
SBA-15 was synthesized with three different pore sizes using two 
different versions of the self assembly method: the classical route 17 
and a more rapid route 18. The amounts of the chemicals used in the 
synthesis are listed in Table 1. According to the classical route, a 
micellar solution was prepared by stirring P123 in a HCl solution at 
35 °C for at least 8 hours. Afterwards, the silica source (TEOS) was 
added to the micellar solution and stirred for 20 hours. Finally the 
maturation was achieved by hydrothermal treatment at 60 °C for 
24 hours. The more rapid route, on the other hand, was conducted 
by stirring the micellar solution composed of P123 and NH4F in a 
HCl solution and 28 mg NH4F, at 20 °Cfor at least 3 hours. Upon 
full dissolution of P123, a mixture of TEOS and heptane was added 
into the micellar solution followed by 4 minutes of vigorous stirring 
and a static duration.  For maturation, the solution was kept in an 
oven at 100°C for 24 hours. In the end, all the materials were cal-
cined at 550 °C for 5 hours to remove the P123 from the pores. 
Table 1. Synthesis conditions of different materials 
Pore Size  
(route) 
6.5 nm  
(classic route) 
11.5 nm  
(rapid route) 
14 nm  
(rapid route) 
Sample name PS6.5  PS11.5 PS14.0  
Synthesis Parameters 
Micellar Solution 
Concentration 
of HCl in water 
and total volume 1.4 M - 80 mL 1.84 M - 80 mL 
1.84 M - 80 
mL 
P123 2 g 2.4 g 2.4 g 
NH4F - 28 mg 28 mg 
Stirring temper-
ature and time 
35 ºC overnight 20 ºC until the 
polymer is fully 
dissolved (2-3 
hours) 
20 ºC until the 
polymer is 
fully dissolved 
(2-3 hours) 
Precursor Addition 
TEOS 4.25 mL 5.5 mL 5.5 mL 
Heptane - 1 mL 17 mL 
Stirring temper-
ature and time 35 ºC for 20 hours 
20 ºC for 4 
minutes 
20 ºC for 4 
minutes 
Static time - 40 minutes 3 hours 
Maturation (Hydrothermal Treatment) 
Temperature 60 ºC 100 ºC 100 ºC 
Time 24 hours 24 hours 24 hours 
 
Characterization 
Scanning Electron Microscopy (SEM) (LEO 1550 Gemini operat-
ed at 3 kV) and Transmission Electron Microscopy (TEM) (FEI 
Tecnai G2 operated at 200 kV and using carbon coated copper 
grids as sample holder) were used for imaging the particle mor-
phology.  
A Micromeritics ASAP 2020 device was employed for measuring 
N2 physisorption isotherms. The pore size distribution was ob-
tained by the Kruk-Jaroniec-Sayari (KJS) method 19 and the specific 
surface area (SSA) at P/P0 between 0.08 and 0.16 by the the 
Brunauer-Emmet-Teller (BET) method 20. The internal SSA (pore 
surface area) was calculated by subtracting the external SSA from 
SSA and external SSA was obtained by t-plot method at P/P0 be-
tween 0.24-0.54 corresponding to 0.46-0.68 nm film thickness of 
adsorbed N2. 
The pore packing structure of the mesoporous framework was 
investigated by small angle x-ray diffractometry (SAXRD) using a 
Panalytical Empyrean equipped with Cu Ka x-ray source operated 
at 45 kV and 40 mA in line focus. The results of SAXRD measure-
ments were employed to calculate unit cell parameter (d-spacing), 
which was later used together with the pore size to obtain the wall 
thickness of the SBA-15 frameworks.  
 
2.1. Drug loading 
The drug-loading procedure included dispersion of 20 mg of mes-
oporous particles in a 50 mg/mL doxycycline hyclate solution by 1 
minute vortexing followed by 30 minutes in an ultrasonic bath. The 
suspensions were resuspended again by vortexing and then agitated 
by an IKA KS 260 basic orbital shaker for ~3.5 hours at 50 rpm. 
Finally, the drug-loaded powders were recovered by centrifugation 
where the supernatant was collected, and the materials were freeze-
dryed. 
Drug loading was taken as the weight difference of the particles 
before and after the described procedure. 
Fourier-transform infrared spectroscopy (FTIR) was used to inves-
tigate the drug attachment to the mesoporous framework. For this, 
a Bruker Vertex 70 spectrometer equipped with a water-cooled 
MIR source and a DLaTGS detector was used. Spectra were ac-
quired with 2 cm-1 resolution and each spectrum is the average of 
16 scans. The peak areas were calculated following a baseline cor-
rection. 
 
2.2. Drug release 
The in vitro drug release tests were performed by immersing 1 mg 
of drug loaded SBA-15 sample into 1 mL of phosphate buffer saline 
(PBS) in an eppendorf. Independent samples were employed for 
each time point. All the eppendorfs were sealed tight, then loaded 
on floating micro-centrifuges and placed in water filled beakers to 
allow for the release experiments to perform the at 37 °C whilst 
mildly stirring. At each time point the powder and the liquid in this 
eppendorf were centrifuged and the drug concentration in the 
receptor media was measured by UV spectroscopy analysis at 351 
nm wavelength using a Microplate Reader (TECAN Infinite H200 
Pro Microplate Reader). Three replicates were studied for each 
sample. The final concentration values were used to calculate the 
cumulative release % (the released drug amount/total amount of 
loaded drug), released drug amount Mt (mg Doxy/mg carrier) and 
Mt/Minf (M: mg Doxy/mg carrier) where Mt is the amount of drug 
in the solution at a specific time t, and Minf is the maximum amount 
of drug released after infinite time. These values are graphically 
presented vs. time. The released percentage value after infinite time 
was approximated with the value recorded for the sample with the 
longest release time. At this point the (cumulative) released value 
had reached the stationary stage.  
The release kinetics were evaluated by fitting a mathematical func-
tion to the Mt/Minf vs. time plot using the MATLAB® software. 
 
2.3. Antibacterial activity 
The drug-loaded samples were tested against two common bacteria 
in nosocomial infections. i.e. Staphylococcus aureus (CCUG 
15915) and Escherichia coli (CECT 101) by agar diffusion tests. 
Such test determines the effectiveness of a diffusible anti-microbial 
agent to inhibit bacterial growth. For preparation of the culture 
 media, 15 g/l agar bacteriological (Scharlau, ref.no. 07-004-500) 
and 37 g/l brain heart infusion (Scharlau, ref.no. 02-599-500) were 
dissolved in 1liter water and then sterilized by autoclaving. The test 
was performed by seeding the bacteria uniformly on the petri dish-
es. The samples for this test were prepared by weighing 0.5 mg of a 
drug-loaded SBA-15 powder into an eppendorf and filling it with 
0.5 mL PBS. Then 50 µL of these solutions were carefully dropped 
on the prepared agar plates at different areas and they were then 
incubated at 37 °C for 24 hours. Each drop caused a spherical 
inhibition zone and the diameters of these apertures were measured 
in terms of pixels by the aid of an Adobe® Photoshop software and 
then converted to mm. The reported result is the average inhibition 
zone obtained from three test areas for the each sample. 
 
2.4.! Statistics 
The overall statistical differences between test groups were ana-
lyzed by applying Tukey’s post hoc method via one way ANOVA 
(Minitab 16 software, Minitab Inc., USA) with 95% significance 
level. 
 
3.! RESULTS and DISCUSSIONS 
Materials chemistry 
In this study, two methods were employed to obtain SBA-15 with 
large but different pore sizes which are a classical high-temperature 
self-assembly route and a low-temperature rapid self-assembly 
route. The influence of pore size is investigated for Doxycycline 
incorporation and release from SBA-15. The classical high temper-
ature synthesis, conducted at 35º C, yielded a particle morphology 
of mono-dispersed platelets (Figure 1(a)) with a pore size of 6.5 
nm (Table 2). The platelet morphology is a result of using a long 
static time during the synthesis 17,18. In the low-temperature rapid 
route heptane was used as swelling agent21 to obtain two different 
pore sizes (11.5 and 14 nm) by adding 1 or 17 mL of heptane to the 
synthesis solution, see Table 2. These two samples (PS11.5 and 
PS14.0), have rod morphology and the same pore length as PS6.5, 
i.e. the length of the PS11.5 and PS14 rods are the same as the 
thickness of the PS6.5 platelets. The difference between the two 
morphologies is seen in the diameters of the circular cross-section 
of the particles (D), which is smaller for the rods (Table 2 and 
Figure 1(a-c)). Keeping the pore length constant is important for 
this study as it has been shown that pore length can be a crucial 
variable for the access of a drug molecule in and out of the pores22. 
The physisorption properties of all the SBA-15 materials prepared 
here reveal a narrow pore size distribution with a type IV isotherm 
and a type 1 hysteresis loop (Figure 1(d)). This is typical for meso-
porous materials with open cylindrical pores23. According to the 
SAXRD results, all the synthesized SBA-15 frameworks were ob-
served to have a hexagonal pore packing order indicated by the 100, 
110 and 200 diffraction lines (Figure 1(e)). The hexagonal packing 
order suggests the pores to be parallel to each other, which enables 
easy access of molecules to be adsorbed.   
The physical properties of the synthesized SBA-15 materials such 
as specific surface area (SSA), pore volume (PV), micro-pore vol-
ume (µ-PV), particle diameter, and wall thickness (nm) are pre-
sented in Table 2. The thickness of the pore walls increases as the 
pore size decreases. Consequently, the microporosity is largest for 
the smallest pore size, i.e. the µ-PV of PS6.5 was observed to be 
almost double of that of PS11.5 and PS14. Micropores (pores 
smaller than 2 nm24) are important since small drug molecules can 
also be accommodated in the micropores, so this parameter is 
expected to affect the drug loading and release characteristics. 
 
Figure 1. SEM micrographs of SBA-15 with pore sizes of 6.5 nm 
(PS6.5) (a), 11.5 nm (PS11.5) (b), and 14 nm (PS14.0) (c), pore 
size distributions (d), BET isotherms (e) and small angle x-ray 
diffractograms (SAXRD) (f). 
Table 2. Physical properties of the produced SBA-15 materials. 
Sample 
name 
Pore 
size 
(nm) 
SSA 
(m2/g) 
PV 
(cm3/g) 
µ-PV 
(cm3/g) 
Particle 
diameter 
Wall 
thickness 
(nm) 
PS6.5 6.5 706 0.68 0.134 1 µm 3.6 
PS11.5 11.5 584 1.16 0.064 150 nm 1.7 
PS14.0 14.0 495 1.18 0.059 90 nm 0.8 
 
Drug Loading 
The ordered cavities within the material are expected to act as 
reservoirs for relatively high amounts of the drug, which in this 
study is doxycycline. The amount of drug loaded is presented as a 
function of pore size in Figure 2. 
 
Figure 2. Relative amount of drug loaded as function of the pore 
size. Different symbols (*, **, and ***) indicate statistically signifi-
cant differences. 
  
The loading capacity of the mesoporous carrier increases with 
increasing pore size while SSA and µ-PV increase do not seem to 
favor the loading capacity.  
FTIR measurements of the mesoporous carrier before and after 
being loaded with Doxy are presented in Figure 3. The characteris-
tic peaks of the mesoporous material are detected at 3400 cm-1 
(OH), 1627 cm-1 (water deformation), 1240 cm-1 (dH2O), 1086 
cm-1, 800 and 465 cm-1 (Si-O-Si), and 960 cm-1 (Si-OH) 10,25–27. The 
Doxy peaks are concentrated between 1700-1300 cm-1, except for 
O-H and N-H band contribution to the wide H2O peak at 3400 cm-
128,29. These spectra confirm the presence of Doxy in the three cases. 
 
Figure 3. FTIR spectra of pure (no Doxy) and Doxy loaded sam-
ples: (a) PS6.5, (b) PS11.5, and (c) PS14. (d) shows the chemical 
structure of doxycycline hyclate (Doxy). 
 
Drug Release 
Figure 4(a) shows the cumulative release percentage of Doxy from 
the three mesoporous carriers. All the carriers display a burst re-
lease during the first hour, which is more significant for PS11.5 & 
PS14.0 than PS6.5. Instead, carrier PS6.5 displays a more restricted 
release. All the drug content is released from PS14 by the time it 
reaches the stationary stage, whereas PS11.5 has released ~86% and 
PS6.5 ~76% of its initial Doxy content within the same timeframe 
which appears to be a function of the pore size (Fig. 4b). This is 
attributed to the increasing µ-PV with decreasing pore size result-
ing in some drug molecules being trapped in the micropores. Doxy 
is a low  molecular weight drug and its size is estimated to be be-
tween 1.5-2 nm based on bond length values 30. Hence, some Doxy 
molecules are expected to be trapped in the micropores (or diffuse 
slower), which have a size of 2 nm or less. 
We also note that all samples have completed their release within 1-
2 hours, which is too fast for most medical applications and the 
release system needs to be improved such that a slower release rate 
is achieved. However, this system displays an improved and slower 
release profile compared to earlier studies where a similar mesopo-
rous silica (MCM-41) released all its Doxy content in the first 10 
minutes in a similar PBS solution 28. Our results show that the pores 
are easily accessible for the receptor media, and therefore the ex-
change of drug from the material is favorable. Future strategies may 
consider capping or partial blocking of the pores, chemical gate 
keeping at the pore openings, and enhancing the chemical interac-
tions between the drug and the substrate to better control the drug 
release. 
The total amount of Doxy released (Mt) decreases with decreasing 
pore size, i.e. Mt,PS6.5 < Mt,PS11.5 < Mt,PS14 (Figure 4(a)). This is ex-
pected based on the decreasing pore volume with decreasing pore 
size, which is magnified by the decreasing fraction of the loaded 
drug released as the pore size decreases (insert in Fig. 4b). This 
indicates that the drug release was only affected by the pore size. In 
contrast to previously studied materials15, the release does not 
follow the trend of the SSA. The specific surface changes following 
SSAPS6.5>SSAPS11.5>SSAPS14, while the release has the opposite trend. 
Moreover, the release trend as a function of the pore size (Figure 
4(b)) is similar to the trend of the drug loading (Figure 2). These 
observations indicate that in this system drug-carrier interactions 
are weak, which is also confirmed by the fast release recorded. 
Consequently, the amount of drug released is proportional to the 
amount of drug loaded. 
  
Figure 4. Amount of drug released, Mt[mg] vs. time [h] (a),  and 
released fraction of Doxy [%] vs pore size and vs. mass of drug 
loading / mass of support [mg/mg] (b). Different symbols (*, **, 
***) indicate statistically significant differences.  
The release of the drug, Mt as a function of time can be described 
by a function that takes into account both a burst release (through 
diffusion) and a self-rate-limiting stage (slow out-leaching)31. Equa-
tion (1) has previously been shown to describe the release process 
well for SBA-15 mesoporous systems. 
!"!#$% = 	 ()(1− -./01) + (4(1 − -./51)                 (1) 
where Minf is the amount drug released after infinite time (here 
approximated with M8h where the stationary stage has already been 
reached), P1 and P2 are the fraction of drug released during stage 
one and two, and k1 and k2 are the rate constants during the two 
stages. Equation (1) is then fitted to the experimental data to yield 
the following relationships for the different samples as shown in Eq 
(2,3, and 4).  In all three cases the self-rate-limiting step has been 
detected very low and thus almost all the release was observed to be 
diffusion-controlled, i.e. P1=1 and P2=0 . 
 
 
PS6.5  !"!#$% = 	 (1 − -.).781)        (2) 
PS11.5  !"!#$% = 	 (1 − -.9.)41)                       (3) 
PS14  !"!#$% = 	 (1 − -.).8:1)                  (4) 
 
According to the release rates of the different carriers, k1, were 
observed to follow the order of k1,PS6.5 < k1,PS14 < k1,PS11.5 which inter-
estingly does not correlate to any of the structural parameters 
presented in Table 2, instead it is reversely related to the drug 
loading per pore volume values which are 0.51, 0.40 and 0.50 for 
PS6.5, PS11.5 and PS14, respectively. This indicates that when 
there is a higher drug concentration (drug amount per volume) in a 
carrier, a tighter packing of the drug molecules can be observed 
which intensifies inter-molecular interactions. As a result, the re-
lease becomes slower. This can be attributed to the fact that the 
drug-drug interactions dominate this system whereas drug-carrier 
interactions remain unaffected. 
 
Antibacterial Activity 
The antibacterial activity of the drug-loaded carriers was tested 
against Staphylococcus aureus and Escherichia coli (Figure 5) 
given their incidence in nosocomial infections. The inhibition 
zones were observed to follow the trend of the release amount 
released drug Mt and the pore size for both bacteria. The controls 
indicate no antibacterial activity of empty carriers, i.e. SBA-15 
materials without being loaded with Doxy. The inhibition zones 
were clean in the case of Escherichia coli while they contained 
some colonization in case of Staphylococcus aureus. This suggests a 
higher activity for Escherichia coli, which is attributed to the higher 
minimum inhibitory concentration of Doxy against Staphylococcus 
aureus compared to Escherichia coli32. 
 
Figure 5. Inhibition zone size I (cm) graph normalized to the mass 
of nanoparticles tested and sample images of PS6.5, PS11.5 and 
PS14 against staphylococcus aureus and escherichia coli. Different 
symbols (*, **) indicate statistically significant differences. 
 
4. CONCLUSIONS  
In this study, an antibiotic of use in bone and dental infections, 
doxycycline hyclate, was loaded into SBA-15 mesoporous supports 
with the same chemistry. The influence of the supports’ pore size 
on loading and release performance was evaluated. The pore size 
directly affects the drug loading and released amount of the drug. 
All carriers display a burst release profile, which can be controlled 
by the pore size. The drug showed antibacterial efficiency upon 
loading and inhibition was proportional to the pore size, and thus 
the released amount. 
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